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DELAYED HYPERSENSITIVITY TO HERPES SIMPLEX VIRUS
CHAPTER I 
INTRODUCTION
From an  e x a m i n a t i o n  o f  t h e i r  u l f r a s f r u c f u r e ,  v i r u s e s  a p p e a r  t o  
be t h e  s i m p l e s t  o f  i n d e p e n d e n t  g e n o m e - c o n t a i n i n g  s y s t e m s .  P r e s e n t l y ,  
t h e  e v e n t s  w hi ch  o c c u r  a t  t h e  v i r u s - h o s t  c e l l  l e v e l  a r e ,  a t  b e s t ,  o n l y  
p a r t l y  u n d e r s t o o d .  High  on  t h e  l i s t  o f  h o s t  r e a c t i o n s  t o  v i r a l  p r o ­
d u c t s  which  m e r i t  t h o r o u g h  i n v e s t i g a t i o n  a r e  t h o s e  r e s p o n s e s  which  
i n t e r r u p t  t h e  s p r e a d  o f  v i r u s e s ,  s u c h  a s  h e r p e s  s i m p l e x  v i r u s  (HSV) o r  
v a c c i n i a  v i r u s ,  f rom o n e  c e l l  t o  a n o t h e r  and  wh ich  le ad  t o  r e c o v e r y  
f rom v i r a l  d i s e a s e .  Of p a r t i c u l a r  i n t e r e s t  in t h i s  d i s s e r t a t i o n  i s  t h e  
p a r a d o x  o f  r e c u r r e n t  h e r p e s  s i m p l e x ,  in w h ic h  p e r s o n s  who r e c o v e r  f rom 
p r i m a r y  d i s e a s e  d e v e l o p  h i g h  t i t e r s  o f  v i r u s  n e u t r a l i z i n g  a n t i b o d y  b u t  
c o n t i n u e  t o  h a v e  l o c a l i z e d  v i r a l  l e s i o n s .
D i s e a s e  Caused  by H e r p e s  S i m p l e x  V i r u s
A c o p i o u s  l i t e r a t u r e  on t h e  c l i n i c a l  p r o b l e m s  a s s o c i a t e d  w i t h  
h e r p e s  s i m p l e x  v i r u s  a w a i t s  t h e  d i l i g e n t  r e a d e r ,  b u t  p e r h a p s  t h e  m o s t  
c o n c i s e  d e s c r i p t i o n  o f  t h e s e  m a l a d i e s  a p p e a r s  in a  t r e a t i s e  by M u l l e r  
and  Herrmann ( 6 7 ) .
H e r p e s  s i m p l e x  v i r u s  i s  p r o b a b l y  t h e  m o s t  common v i r a l  i n ­
f e c t i o n  o f  man and  c a u s e s  a number  o f  c l i n i c a l  sy n d ro m e s  o f  
s k i n  and  mucous  membranes  t h a t  a r e  r e a d i l y  r e c o g n i z e d  c l i n i c a l l y
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and a r e  a l m o s t  a l w a y s  b e n i g n .  The s i t e  o f  p r i m a r y  I n f e c t i o n  
I s  u s u a l l y  t h e  o r o p h a r y n g e a l  t i s s u e s ,  an d  t h e  I n f e c t i o n  I s  
m a n i f e s t e d  c l i n i c a l l y  a s  an u l c e r a t i v e  g i n g i v o s t o m a t i t i s  o f  
v a r i a b l e  l o c a l  s e v e r i t y  an d  s y s t e m i c  r e a c t i v i t y .  P r o b a b l y  in 
many I n s t a n c e s ,  t h e  s t o m a t i t i s  I s  m i l d  and  p a s s e s  u n n o t i c e d .  
C h i l d r e n  a r e  u s u a l l y  a f f e c t e d ,  b u t  r e s u l t s  o f  s e r o l o g i c  
s t u d i e s  h a v e  I n d i c a t e d  an I n c r e a s i n g  number  o f  a d u l t s  In t h e  
h i g h e r  s o c i o e c o n o m i c  g r o u p s  who ha ve  n o t  been  I n f e c t e d .
A h i g h  d e g r e e  o f  c o n t a g i o u s n e s s  o f  t h e  v i r u s  I s  I n d i c a t e d  
by I n f e c t i o n s  f r e q u e n t l y  a f f e c t i n g  more  t h a n  on e  member o f  a 
f a m i l y ,  by e p i d e m i c s  o f  h e r p e t i c  s t o m a t i t i s  among c h i l d r e n  in 
o r p h a n a g e s  and  o f  e c z e m a ,  and  by r e p o r t s  o f  d i r e c t  I n o c u l a t i o n  
o f  h e r p e s  v i r u s  I n t o  t h e  s k i n  by a b i t e  o r  i n t o  an a b r a s i o n .  
E p i d e m i c s  o f  m u l t i p l e  h e r p e s  s i m p l e x  I n f e c t i o n s  o f  t h e  s k i n  
a r e  common among c o l l e g e  w r e s t l e r s .  The  d i r e c t  v e n e r e a l  
t r a n s m i s s i o n  o f  t h e  d i s e a s e  I s  a l s o  r e c o g n i z e d .  More s e r i o u s  
h e r p e t i c  I n f e c t i o n s  may o c c u r  In p r e m a t u r e  and  newborn  I n ­
f a n t s  I n o c u l a t e d  a t  b i r t h  by c o n t a c t  w i t h  h e r p e t i c  l e s i o n s  o f  
t h e  b i r t h  c a n a l .
H e r p e t i c  i n f e c t i o n s  o f  t h e  f i n g e r s  ( h e r p e t i c  w h i t l o w ) ,  
p r i m a r i l y  a f f e c t i n g  t h e  s o f t  t i s s u e s  a b o u t  t h e  f i n g e r n a i l s ,  
w ere  r e p o r t e d  a s  a form o f  h o s p i t a l  c r o s s  I n f e c t i o n  by S t e r n  
and a s s o c i a t e s  ( 9 3 ) .  The  I n f e c t i o n s  w e r e  n o t e d  In h o s p i t a l  
p e r s o n n e l  who h a n d l e d  I n f e c t e d  s a l i v a ,  p a r t i c u l a r l y  t h a t  o f  
n e u r o s u r g i c a l  p a t i e n t s  who r e q u i r e d  s u c t i o n  o f  b r o n c h i a l  
s e c r e t i o n s  a f t e r  o p e r a t i o n .  D e n t i s t s  a r e  a l s o  b e l i e v e d  t o  be 
more f r e q u e n t l y  e x p o s e d  t o  s u c h  I n f e c t i o n s .
P r i m a r y  I n f e c t i o n  I s  f o l l o w e d  by a l a t e n t  I n f e c t i o n  wh ich  may p e r s i s t  
f o r  l i f e  w i t h  t h e  p o s s i b i l i t y  o f  r e c r u d e s c e n t  l e s i o n s  b e i n g  p r o d u c e d  by 
many t y p e s  o f  s t i m u l i ,  e . g . ,  m e n s t r u a t i o n ,  s u n b u r n ,  f e v e r ,  p s y c h i c  up­
s e t ,  and  g a s t r o - I n t e s t  I n a l  d i s t r e s s .  H e r p e s  s i m p l e x  I n f e c t i o n s  g i v e  
r i s e  t o  n e u t r a l i z i n g  a n t i b o d i e s ,  w h ic h  a r e  I n e f f e c t i v e  In p r e v e n t i n g  
s e c o n d a r y  I n f e c t i o n  ( 7 8 ) .  A l t h o u g h  a n t i b o d i e s  a p p a r e n t l y  p r e v e n t  
v i r e m l a  d u r i n g  s e c o n d a r y  I n f e c t i o n  t h e  v i r u s  i s  a b l e  t o  p a s s  f rom i n ­
f e c t e d  c e l l s  t o  a d j o i n i n g  s u s c e p t i b l e  c e l l s  w i t h o u t  coming  I n t o  c o n t a c t  
w i t h  e x t r a c e l l u l a .  a n t i b o d y .  T h i s  seems t o  be t h e  way In wh ich  HSV p r o ­
d u c e s  t h e  r e c u r r e n t  f e v e r  o r  c o l d  b l i s t e r  s o  common I y s e e n  a t  t h e  
m u c o c u t a n e o u s  j u n c t u r e  o f  t h e  mouth an d  n o s e .
Plummer ( 7 7 )  d i f f e r e n t i a t e d  b e tw e e n  two t y p e s  o f  HSV, l a t e r  
known a s  t y p e  I ( o r a l )  an d  t y p e  II ( g e n i t a l )  s t r a i n s .  In I n f e c t i o n s .
3He d e m o n s t r a t e d  a n t i g e n i c  d i f f e r e n c e s  by t h e  c r o s s  n e u t r a l i z a t i o n  t e c h ­
n i q u e .  Type I HSV was shown t o  be  n e u r o t r o p i c ,  l e s s  s t a b l e  in h e p a r i n ,  
and  p r o l i f e r a t e d  b e t t e r  in r a b b i t  k i d n e y  m o n o l a y e r s  t h a n  d i d  t y p e  II 
v i r u s  ( 7 9 ) .
R e c e n t l y ,  i n t e r e s t  h a s  t u r n e d  t o  t h e  e p i d e m i o l o g y  o f  HSV in 
a s s o c i a t i o n  w i t h  c e r v i c a l  c a r c i n o m a .  J o s e y  e t  aj_. (5 0 )  f o u n d  22% c o r ­
r e l a t i o n  b e tw ee n  c e r v i c a l  c a r c i n o m a  and  h e r p e s  v i r u s  i n f e c t i o n .  Rawls  
e t  a_L" ( 8 1 )  r e p o r t e d  an 83^  c o r r e l a t i o n  b e tw e e n  c e r v i c a l  c a n c e r  and  
a n t i b o d y  t o  t y p e  II HSV, a f i n d i n g  which  s u g g e s t s  a r e l a t i o n s h i p  b e ­
tw e e n  HSV and  c a r c i n o m a  o f  t h e  c e r v i x .
HSV i n f e c t i o n  c a u s e s  a l t e r a t i o n s  o f  mammalian  ch ro m os om es .  
Hampar and E l l i s o n  (34 )  n o t e d  i n c r e a s e d  t r a n s l o c a t i o n s ,  abnormal  f o r ­
m a t i o n ,  a c c e n t u a t e d  c o n s t r i c t i o n  and  b r e a k a g e  o f  chromosomes  in HSV- 
i n f e c t e d  h a m s t e r  c e l l s .  L a t e r ,  S t i c h  e t  aj_. ( 9 4 )  r e p o r t e d  t h a t  t h e  
chromosomal  a b e r r a t i o n s  in human o r  C h i n e s e  h a m s t e r  lung  c e l l s  i n ­
f e c t e d  w i t h  HSV w ere  r e s t r i c t e d  t o  f i x e d  r e g i o n s  o f  t h e  X-chromosome 
and  chromosome I .  Such a b e r r a t i o n s  w e r e  n o t  p r o d u c e d  by n o n - i n f e c t i o u s  
HSV and  v i r a l  n u c l e i c  a c i d  s y n t h e s i s  c o u l d  n o t  be  shown t o  c a u s e  t h e  
chromosomal  a l t e r a t i o n s .
In v iew o f  t h e  p r e v a l e n c e  o f  HSV i n f e c t i o n s  in t h e  p o p u l a t i o n  
and  t h e  r e s u l t s  o f  s u r v e y s  i n d i c a t i n g  good c o r r e l a t i o n  b e tw e e n  HSV t y p e  
II i n f e c t i o n s  and  c e r v i c a l  c a n c e r ,  a more  c o m p l e t e  u n d e r s t a n d i n g  o f  t h e  
h o s t  r e s p o n s e s  t o  HSV and  t o  t h e  p r o d u c t s  o f  HSV i n f e c t i o n  seems im pe r­
a t i v e .
De la y e d  H v p e r s e n s i t i v i t v
In a d d i t i o n  t o  c i r c u l a t i n g  a n t i b o d y ,  d e l a y e d  h y p e r s e n s i t i v i t y  
t o  HSV i s  known t o  f o l l o w  p r i m a r y  i n f e c t i o n .  H y p e r s e n s i t i v e  r e a c t i o n s
4a r e  s e p a r a b l e  i n t o  tw o  c a t e g o r i e s  b a s e d  upon t h e  t i m e  r e q u i r e d  f o r  m a n i ­
f e s t a t i o n  o f  t h e  r e a c t i o n  f o l l o w i n g  a n t i g e n i c  c h a l i e n g e .  Im m e d ia te  
h y p e r s e n s i t i v e  r e a c t i o n s  u s u a l l y  b e g i n  w i t h i n  m i n u t e s  a f t e r  e x p o s u r e  t o  
a n t i g e n  and  become maximal  by 4 h r ,  w i t h  t h e  e x c e p t i o n  o f  t h e  A r t h u s  
phenomenon In w h ic h  h e m o r r h a g e  an d  n e c r o s i s  may n o t  p e a k  u n t i l  24  h r  
( 8 8 ) .  O t h e r  e x a m p l e s  o f  i m m e d i a t e  r e a c t i o n s  i n c l u d e  a t o p y ,  s e r u m  s i c k ­
n e s s ,  an d  a n a p h y l a x i s .  D e l a y e d  h y p e r s e n s i t i v e  r e a c t i o n s  u s u a l  I y do n o t  
f i r s t  become a p p a r e n t  u n t i l  3 t o  6 h r  a f t e r  c h a l l e n g e  w i t h  a n t i g e n  and 
may t a k e  f rom 24 t o  72  h r  t o  become m a x i m a l .
A s e c o n d  c r i t e r i o n  w h ic h  d i f f e r e n t i a t e s  b e t w e e n  i m m e d i a t e  and  
d e l a y e d  h y p e r s e n s i t i v i t i e s  i s  r e v e a l e d  in  p a s s i v e  t r a n s f e r  s t u d i e s .  
W h ereas  s k i n  r e a c t i v i t y  in  i m m e d i a t e  h y p e r s e n s i t i v i t y  i s  t r a n s f e r a b l e  
w i t h  s e r u m ,  lym ph o id  c e l l s  a r e  r e q u i r e d  f o r  t r a n s f e r  o f  t h e  d e l a y e d  
h y p e r s e n s i t i v e  s t a t e  ( 8 8 ) .  C h a s e  ( i l )  d e m o n s t r a t e d  t h a t  d e l a y e d  s k i n  
r e a c t i v i t y  t o  t u b e r c u l i n  c o u l d  be  s y s t e m i c a l l y  t r a n s f e r r e d  in g u i n e a  
p i g s  by ly mp ho id  c e l l s  f rom  p e r i t o n e a l  e x u d a t e s ,  s p l e e n ,  and  lymph n o d e s  
o f  d o n o r  a n i m a l s .  In a d d i t i o n  t o  i n t a c t  lymphoid  c e i l s ,  l y s a t e s  o f  
ly mphoid  c e l l s  p r e p a r e d  by s o n i c  v i b r a t i o n  h a v e  b een  shown t o  t r a n s f e r  
p a s s i v e l y  s k i n  r e a c t i v i t y  t o  2 , 4  - d i n l t r o c h l o r o b e n z e n e  ( 4 8 )  an d  t u b e r ­
c u l i n  ( 1 2 ) .  Two f r a c t i o n s  f rom s e n s i t i z e d  c e l l  l y s a t e s  w h ic h  w ere  
c a p a b l e  o f  p a s s i v e l y  t r a n s f e r r i n g  t u b e r c u l i n  h y p e r s e n s i t i v i t y  w e r e  p r e ­
p a r e d  by Dunn and  P a t n o d e  ( 1 9 ) .  The f i r s t  f r a c t i o n ,  w h ic h  was e s t i m a t e d  
by g e l  f i l t r a t i o n  t o  h a v e  a m o l e c u l a r  w e i g h t  (mol w t )  o f  5 0 , 0 0 0  o r  
l e s s  was c h a r a c t e r i z e d  a s  p r o t e i n .  A s m a l l e r  R N A - l i ke  f r a c t i o n ,  h a v i n g  
a mol wt  o f  a b o u t  1 0 , 0 0 0  was a l s o  r e p o r t e d  t o  t r a n s f e r  t u b e r c u l i n  
h y p e r s e n s i t i v i t y  p a s s i v e l y .  Local  p a s s i v e  t r a n s f e r  o f  d e l a y e d  s k i n  
h y p e r s e n s i t i v i t y  c a n  be  d e m o n s t r a t e d  by t h e  i n t r a c u t a n e o u s  i n j e c t i o n  o f
5lymphoid  c e l l s  an d  s u b s e q u e n t  c h a l l e n g e  w i t h  a n t i g e n  a t  t h e  same s i t e  
o r  by t h e  i n t r a v e n o u s  a d m i n i s t r a t i o n  o f  a n t i g e n  ( 6 5 ) .  In a r e c e n t  
s t u d y  ( 7 5 ) ,  a s  few a s  1 0 0 ,0 0 0  lymp hoi d  c e l l s  w e r e  shown t o  t r a n s f e r  
l o c a l  r e a c t i v i t y  t o  v a c c i n i a  v i r u s  in g u i n e a  p i g s .  The  a u t h o r s  u t i l ­
i z e d  p e r i t o n e a l  e x u d a t e  c e l l s  o b t a i n e d  f rom g u i n e a  p i g s  s e n s i t i z e d  by 
i n f e c t i o n  w i t h  v a c c i n i a  v i r u s .  T w e n t y - f o u r  h o u r s  a f t e r  i n t r a c u t a n e o u s  
i n j e c t i o n  o f  t h e  e x u d a t e  c e l l s  i n t o  normal  a n i m a l s ,  i n a c t i v e  v i r a l  
a n t i g e n  was a d m i n i s t e r e d  i n t r a v e n o u s l y  a n d  s u b s e q u e n t l y ,  t h e  s k i n  s i t e s  
w e re  e x a m in e d  f o r  e r y t h e m a  and  i n d u r a t i o n .  The l o c a l  p a s s i v e  t r a n s f e r  
t e c h n i q u e  h a s  be en  u s e d  t o  t r a n s f e r  d e l a y e d  a l l e r g y  t o  d i p h t h e r i a  t o x ­
o i d  ( 8 7 ) ,  s h e e p  e r y t h r o c y t e s  ( 4 2 ) ,  an d  2 , 4 - d i n i t r o c h l o r o b e n z e n e  ( 9 ) .
The  n a t u r e  o f  t h e  c e l l u l a r  i n f i l t r a t e  24 h r  a f t e r  s k i n  t e s t i n g  
a l s o  d i s t i n g u i s h e s  im m e d i a t e  f rom d e l a y e d  s k i n  r e a c t i o n s .  In t h e  
A r t h u s  r e a c t i o n  an d  o t h e r  im m e d i a t e  h y p e r s e n s i t i v i t i e s ,  t h e  p r e d o m i n a t e  
c e l l  t y p e  in t h e  i n f i l t r a t e  a t  4 and  24 h r  i s  t h e  p o l y m o r p h o n u c l e a r  
n e u t r o p h i l e .  M o n o n u c l e a r  c e l l s  a r e  s e e n  in  A r t h u s  r e a c t i o n s  a t  24 h r  
b u t  t h e y  a r e  a t t r i b u t e d  t o  t h e  s t a g e  o f  h e a l i n g  f o l l o w i n g  h e m o r r h a g e  
and  i s c h e m i a .  In c o n t r a s t ,  m o n o n u c l e a r  c e l l s  p r e d o m i n a t e  in t h e  d e l a y e d  
h y p e r s e n s i t i v e  r e a c t i o n  a t  24  h r  a f t e r  s k i n  t e s t i n g .  O c c a s i o n a l l y ,  
p o l y m o r p h o n u c l e a r  l e u k o c y t e  c o u n t s  may r e a c h  60^ a t  24 h r ,  b u t  u s u a l l y  
many more  m o n o n u c l e a r  c e l l s  a r e  p r e s e n t  ( 2 6 ,  2 7 ,  1 6 ) .  D i e n e s  and 
M a l l o r y  (16)  s u g g e s t e d  t h a t  t h e  d e g r e e  o f  n e c r o s i s  s e e n  may be  a r e s u l t  
o f  t h e  number o f  p o l y m o r p h o n u c l e a r  l e u k o c y t e s  in t h e  s k i n  t e s t  s i t e  a t  
24 h r .  F e a t u r e s  whi ch  d i s t i n g u i s h  c e l l - m e d i a t e d  h y p e r s e n s i t i v i t y  f rom 
s e r u m - m e d i a t e d  h y p e r s e n s i t i v i t y  i n c l u d e  t h e  f o l l o w i n g  in  v i t r o  r e a c t i o n s  
w h ic h  a r e  c h a r a c t e r i s t i c  o f  d e l a y e d  a l l e r g y :  I )  c y t o - t o x i c  e f f e c t  o f
6s e n s i t i z e d  lymph no de  c e l l s  upon s y n g e n e i c  f i b r o b l a s t s  in  t h e  p r e s e n c e  
o f  s p e c i f i c  a n t i g e n  ( 8 4 ) ;  2 )  i n h i b i t i o n  o f  s e n s i t i z e d  m a c r o p h a g e  m i g r a ­
t i o n  in t h e  p r e s e n c e  o f  t h e  s e n s i t i z i n g  a n t i g e n  ( 1 4 ,  19,  2 8 ) .
D e la y e d  H y p e r s e n s i t i v i t y  in V i r a l  I n f e c t i o n s
In h i s  r e v i e w  o f  v i r a l  i n f e c t i o n s  w h ic h  g i v e  r i s e  t o  d e l a y e d  
h y p e r s e n s i t i v i t y  t o  s k i n  t e s t  a n t i g e n s ,  B e v e r i d g e  ( 7 )  l i s t e d  v a c c i n i a ,  
h e r p e s ,  mumps, i n f l u e n z a ,  m e a s l e s ,  s w i n e  f e v e r ,  c o n t a g i o u s  ec th y m a  o f  
s h e e p ,  e c t r o m e l i a ,  and  lumpy s k i n  d i s e a s e  o f  c a t t l e .  He p o s t u l a t e d  
t h a t  d e l a y e d  h y p e r s e n s i t i v i t y  p r o b a b l y  o c c u r r e d  in a l l  v i r u s  i n f e c t i o n s .
A l l i s o n  ( I )  q u o t e d  f rom Edward  J e n n e r ' s  o r i g i n a l  d e s c r i p t i o n  o f  
t h e  d e l a y e d  r e a c t i o n  a p p e a r i n g  a t  t h e  s i t e  o f  v a r i o l a  i n o c u l a t i o n  in 
t h e  arm o f  Mary B a r g e ,  a f a rm  g i r l  who had cowpox.  J e n n e r ' s  d e s c r i p ­
t i o n  on  p a g e  13 o f  An I n q u i r y  i n t o  t h e  C a u s e s  a n d  E f f e c t s  o f  t h e
V a r i o l a e  V a c c i n a e ,  o r i g i n a l l y  p u b l i s h e d  in 1798 ,  i s  a s  f o l l o w s ;
An e f f l o r e s c e n c e  o f  a p a l i s h  r e d  c o l o u r  so o n  a p p e a r e d  a b o u t  
t h e  p a r t s  w h e r e  t h e  m a t t e r  was i n s e r t e d  and  s p r e a d  i t s e l f  
r a t h e r  e x t e n s i v e l y ,  b u t  d i e d  away in  a few d a y s  w i t h o u t  p r o ­
d u c i n g  any  v a r i o l o u s  s y m p to m s . . . .  11 i s  r e m a r k a b l e  t h a t  v a r i o ­
l o u s  m a t t e r ,  when t h e  s y s t e m  I s  d i s p o s e d  t o  r e j e c t  i t ,  s h o u l d  
e x c i t e  i n f l a m m a t i o n  on  t h e  p a r t  t o  wh ich  i t  i s  a p p l i e d  more  
s p e e d i l y  t h a n  when i t  p r o d u c e s  t h e  Smal l  P o x .  I nd eed  i t  b e ­
comes  a l m o s t  a  c r i t e r i o n  by w h i c h  we c a n  d e t e r m i n e  w h e t h e r  
t h e  i n f e c t i o n  w i l l  be  r e c e i v e d  o r  n o t .  I t  se em s a s  i f  a
c h a n g e ,  w h ic h  e n d u r e s  t h r o u g h  l i f e ,  had  b e e n  p r o d u c e d  in t h e
a c t i o n ,  o r  d i s p o s i t i o n  t o  a c t i o n ,  in  t h e  v e s s e l s  o f  t h e  s k i n ;  
an d  i t  i s  r e m a r k a b l e  t o o ,  t h a t  w h e t h e r  t h i s  c h a n g e  h a s  been  
e f f e c t e d  by t h e  Smal l  P o x ,  o r  t h e  Cow P o x ,  t h a t  t h e  d i s p o s i t i o n  
t o  s u d d e n  c u t i c u l a r  i n f l a m m a t i o n  i s  t h e  same on  t h e  a p p l i c a t i o n  
o f  v a r i o l o u s  m a t t e r .
The  p r i n c i p l e  o f  t h e  s k i n  t e s t  was p u t  t o  u s e  i n  1909 when von P i r q u e t
( 7 6 )  d e v e l o p e d  t h e  d i a g n o s t i c  t u b e r c u l i n  s k i n  t e s t .
In e a r l y  s t u d i e s  o f  d e l a y e d  h y p e r s e n s i t i v i t y  f o l l o w i n g  v i r a l  
i n f e c t i o n ,  c r u d e  a n t i g e n s  w e r e  o f t e n  e m p l o y e d .  Fo r  e x a m p l e .
7ly m pho granulo ma  v en ereu m (LGV) s k i n  t e s t  a n t i g e n  c o n s i s t e d  o f  h e a t -  
i n a c t i v a t e d  p u s  f rom a bubo o f  an i n f e c t e d  p e r s o n .
A n d e r v o n t  and  Rosenau  ( 4 )  d e s c r i b e d  a d e l a y e d  r e a c t i o n  in p e r ­
s o n s  immunized w i t h  v a c c i n i a  v i r u s  w hi ch  c o u l d  be e l i c i t e d  by a n t i g e n  
h e a t e d  f o r  I h r  a t  120 C. The h e a t e d  p r e p a r a t i o n  p r o d u c e d  r e a c t i o n s  
in  v a c c i n a t e d  p e r s o n s  o n l y ,  and  t h e  s k i n  t e s t  m a t e r i a l  was shown t o  be 
t h e  v a c c i n i a  v i r u s  p a r t i c l e .
In 1944,  B e v e r i d g e  and B u r n e t  ( 8 )  r e p o r t e d  t h a t  i n f l u e n z a  t y p e s  
A and  B, p r o l i f e r a t e d  in e m b r y o n a t e d  e g g s ,  p r o d u c e d  a h e a t - s t a b l e  s k i n  
t e s t  a n t i g e n  which  was n o t  i n a c t i v a t e d  by e x p o s u r e  t o  120 C f o r  30 m i n .  
I n j e c t i o n  o f  t h i s  p r e p a r a t i o n  i n t o  human a d u l t s  o f t e n  e l i c i t e d  e r y t h e ­
m a t o u s  a r e a s  w i t h  d i a m e t e r s  a s  l a r g e  a s  30 mm.
P e r s o n s  immunized w i t h  i n a c t i v a t e d  m e a s l e s  v a c c i n e s  d e v e l o p  an 
e a r l y ,  i n d u r a t e d  r e s p o n s e  t o  i n t r a d e r m a  I i n j e c t i o n  o f  m e a s l e s  a n t i g e n ,  
w h i l e  p e r s o n s  w i t h  a h i s t o r y  o f  n a t u r a l  d i s e a s e  o r  i n f e c t i v e  m e a s l e s  
i m m u n i z a t i o n  e x h i b i t  l i t t l e  o r  no r e s p o n s e  ( 4 6 ,  5 6 ) .
In a d d i t i o n  t o  i t s  u s e  a s  a s k i n  t e s t  a n t i g e n  ( 7 3 ) ,  s o l u b l e  
a n t i g e n  o f  v a c c i n i a  v i r u s  i s  a l s o  e f f e c t i v e  in  i n h i b i t i n g  m i g r a t i o n  o f  
s e n s i t i z e d  p e r i t o n e a l  e x u d a t e  c e l l s  in  v i t r o  ( 1 0 3 ) .  S t u d i e s  o f  t h e  
s p e c i f i c i t y  o f  t h e  s o l u b l e  a n t i g e n  o f  v a c c i n i a  v i r u s  a r e  n e e d e d .  
R e c e n t l y ,  s k i n  t e s t  r e a c t i v i t y  t o  v a c c i n i a  v i r u s  p a r t i c l e s  was t r a n s -
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f e r r e d  t o  normal g u i n e a  p i g s  w i t h  a s  few a s  10 p e r i t o n e a l  e x u d a t e  c e l l s  
f ro m  s e n s i t i v e  d o n o r s .  T h i s  showed t h e  h i g h  d e g r e e  o f  s e n s i t i v i t y  
a t t a i n a b l e  w i t h  w hol e  v i r u s  s e n s i t i z a t i o n  and  c h a l l e n g e  ( 7 5 ) .
E n d e r s  e t  ( 2 1 )  n o t e d  t h a t  p e r s o n s  who r e s p o n d e d  t o  mumps 
a n t i g e n  w i t h  a p o s i t i v e  s k i n  t e s t  d i d  n o t  d e v e l o p  t h e  d i s e a s e  a s  o f t e n
8a s  n o n - r e a c t o r s .  L a t e r ,  d e l a y e d  h y p e r s e n s i t i v i t y  t o  mumps was demon­
s t r a t e d  by i n h i b i t i o n  o f  m i g r a t i o n  o f  p e r i t o n e a l  e x u d a t e  c e l l s  i n  v i t r o
( 2 2 ) ,  in v i v o  s k i n  t e s t  r e a c t i v i t y  ( 1 0 2 ,  3 0 ) ,  p a s s i v e  t r a n s f e r  by c e l l s  
( 1 0 2 ) ,  and  t i s s u e  c u l t u r e  c y t o t o x i c i t y  ( 3 3 ) .
H e n i e  e t  ( 3 8 )  p r e p a r e d  a s k i n  t e s t  a n t i g e n  f o r  i n f e c t i o u s  
h e p a t i t i s  f rom a m n i o t i c  f l u i d  o f  i n f e c t e d  c h i c k  e m b r y o s .  F o l l o w i n g  
i n t r a d e r m a  I i n j e c t i o n  o f  U V - i r r a d i a t e d  a n t i g e n ,  r e a c t i o n s  o f  e r y t h e m a  
and  i n d u r a t i o n  which  m e a s u r e d  up t o  45 mm in d i a m e t e r  w e r e  o b s e r v e d  in 
100% o f  p e r s o n s  w i t h  known c o n t a c t  w i t h  i n f e c t i o u s  h e p a t i t i s ,  w h e r e a s  
o n l y  11% o f  p re su m ed n o n - e x p o s e d  p e r s o n s  showed s k i n  r e a c t i v i t y .  In 
an e p i d e m i o l o g i c a l  s t u d y ,  p e r s o n s  p r e v i o u s l y  s k i n  t e s t e d  w i t h  t h e  same 
a n t i g e n ,  had o n l y  a 1.6% a t t a c k  r a t e  o f  i n f e c t i o u s  h e p a t i t i s ,  w h i l e  no n ­
s k i n  t e s t e d  p e r s o n s  in t h e  same i n s t i t u t i o n  had an a t t a c k  r a t e  o f  13.6%. 
The a u t h o r s  s u g g e s t e d  t h a t  t h e  l o w e r  a t t a c k  r a t e  in t h e  s k i n  t e s t e d  
p e r s o n s  was due  t o  an Immuniz ing  e f f e c t  o f  t h e  s k i n  t e s t  m a t e r i a l  ( 1 8 ) .
C o n t r a r y  t o  r e s u l t s  o f  e a r l i e r  s t u d i e s .  S m i th  ( 8 9 )  r e p o r t e d  t h e  
s k i n  t e s t  a n t i g e n  o f  v a c c i n i a  v i r u s  t o  be  i n a c t i v a t e d  by a u t o c l a v i n g .
In a d d i t i o n  much o f  t h e  s k i n  t e s t  a c t i v i t y  o f  t h e  p r e p a r a t i o n  was r e ­
moved by f i l t r a t i o n  t h r o u g h  a  9 my f i l t e r  b u t  n o t  by f i l t e r s  o f  l a r g e r  
p o r e  s i z e .  V a c c i n a t e d  p e r s o n s  r e s p o n d e d  t o  t h e  a c t i v e  s k i n  t e s t  a n t i ­
g en  w i t h  a r e a s  o f  e r y t h e m a  m e a s u r i n g  2 0 - 3 0  mm in d i a m e t e r ,  w h e r e a s  un­
v a c c i n a t e d  p e r s o n s  showed no r e a c t i o n s .  The r e a c t i o n  was s p e c i f i c  f o r  
v a c c i n i a ;  HSV p r e p a r a t i o n s  d i d  n o t  e l i c i t  s k i n  r e a c t i o n s  in v a c c i n i a -  
s e n s i t i z e d  a n i m a l s .
Noren e t  ^ L '  ( 7 3 )  c o n f i r m e d  t h e  s k i n  r e a c t i v i t y  o f  a s o l u b l e  
v a c c i n i a  a n t i g e n  and  n o t e d  t h a t  t h i s  m a t e r i a l  was a b e t t e r  s k i n  t e s t
9a n t i g e n  t h a n  was t h e  p u r i f i e d ,  w h o le  v i r i o n .  The  d e g r e e  o f  r e s p o n s e  
was d o s e  d e p e n d e n t ,  s i n c e  d i a m e t e r s  o f  e r y t h e m a  in  t h e  s k i n  t e s t s  o f  
g u i n e a  p i g s  and  human v o l u n t e e r s  w e r e  d i r e c t l y  p r o p o r t i o n a l  t o  t h e  c o n ­
c e n t r a t i o n  o f  a n t i g e n  i n j e c t e d .
A l i n e a r  r e l a t i o n s h i p  b e t w e e n  i n h i b i t i o n  o f  m i g r a t i o n  o f  p e r i ­
t o n e a l  e x u d a t e  c e l l s  and  c e l l u l a r  t r a n s f e r  o f  l o c a l  c u t a n e o u s  h y p e r ­
s e n s i t i v i t y  t o  i n a c t i v e  v a c c i n i a  v i r i o n s  in g u i n e a  p i g s  was shown by 
P i l c h a r d  e t  a L  ( 7 5 ) ,  who n o t e d  t h a t  d e l a y e d  s k i n  r e a c t i o n s  f i r s t  
a p p e a r e d  on t h e  f o u r t h  day  f o l l o w i n g  i n f e c t i o n  w i t h  v a c c i n i a  v i r u s .  
Tom pki ns  e t  a l .  ( 1 0 1 )  showed a d i r e c t  r e l a t i o n s h i p  b e tw e e n  i n h i b i t i o n  
o f  m i g r a t i o n  and  s k i n  t e s t  d i a m e t e r s  t o  f i b r o m a  v i r u s  in r a b b i t s .  S k i n  
t e s t  a n t i g e n s  in t h e  p s i t t a c o s i s - l y m p h o g r a n u l o m a  v e n e re u m  g r o u p  a r e  
known t o  h a v e  a common g r o u p  a n t i g e n  ( 4 0 )  an d  c r o s s  r e a c t i o n s  o c c u r  in 
s e n s i t i z e d  a n i m a l s  ( 8 0 ) .  Lymphogranuloma v e n e r e u m  (LGV) p a t i e n t s  e x ­
h i b i t  p o s i t i v e  s k i n  r e a c t i o n s  t o  t h e  f o l l o w i n g  s k i n  t e s t  a n t i g e n s  p r e ­
p a r e d  in  y o l k  s a c s :  LGV, f e l i n e  p n e u m o n i t i s ,  m e n i n g o - p n e u m o n i t i s ,
p s i t t a c o s i s ,  o r n i t h o s i s  and  mouse p n e u m o n i t i s .  The  s k i n  t e s t  a n t i g e n s  
in p s i t t a c o s i s  an d  LGV ha v e  been  shown t o  be  r e s i s t a n t  t o  d e g r a d a t i o n  
by b o t h  t r y p s i n  an d  p o t a s s i u m  p e r i o d a t e .  Com plem en t  f i x i n g  (OF) a n t i ­
g e n s  f rom  t h e s e  a g e n t s  a r e  t r y p s i n  r e s i s t a n t ,  b u t  t h e y  a r e  i n a c t i v a t e d  
by p e r i o d a t e  ( 6 ) ,  an  i n d i c a t i o n  t h a t  t h e y  a r e  c a r b o h y d r a t e  in  n a t u r e  o r  
a c o m p l e x e d  c a r b o h y d r a t e .  J o r g e n s o n  e t  £]_. ( 4 9 )  p r e s e n t e d  e v i d e n c e  
w h ic h  i n d i c a t e d  t h a t  t h e  CF a n t i g e n  o f  o r n i t h o s i s  v i r u s  was a l i p o -  
p o l y s a c c h a r i d e .
S e n s i t i z a t i o n  t o  v a r i o u s  v i r u s e s  may f o l l o w  n a t u r a l  i n f e c t i o n ,  
s k i n  t e s t i n g ,  v a c c i n a t i o n ,  o r  i n j e c t i o n  o f  v i r a l  a n t i g e n  a l o n e  o r  in
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a d j u v a n t .  The  s k i n  t e s t  o r  c h a l l e n g e  a n t i g e n s  and  t h e i r  a n t i g e n i c  c h a r ­
a c t e r  a r e  a s  v a r i e d  a s  t h e  m e th o d s  o f  s e n s i t i z a t i o n .  B o th  w h o l e  v i r u s  
p a r t i c l e s ,  i n f e c t i v e  o r  i n a c t i v a t e d ,  and  f r a c t i o n s  t h e r e o f  h a v e  be en  
shown t o  be  good  s k i n  t e s t  a n t i g e n s .
A n t i g e n s  o f  H e r p e s  S i m p l e x  V i r u s
S p e a r  and  Roizman ( 9 1 )  r e p o r t e d  t h a t  H S V - i n f e c t e d  HEp-2 c e l l s  
s y n t h e s i z e d  a t  l e a s t  25 p r o t e i n s  a t  v a r i o u s  t i m e s  d u r i n g  t h e  g r o w t h  
c y c l e .  The a n t i g e n i c i t y  o f  t h e s e  p r o t e i n s  was n o t  s t u d i e d .  T h e i r  s i z e  
e s t i m a t e s  o f  t h e s e  d e t e c t a b l e  p r o t e i n s  r a n g e d  f rom  2 9 , 0 0 0  t o  1 2 5 ,0 0 0  
d a l t o n s .  The a p p l i c a t i o n  o f  p o l y a c r y l a m i d e  e l e c t r o p h o r e s i s  t o  h e r p e s -  
i n f e c t e d  c e l l s  r e v e a l e d  t h e  e x i s t e n c e  o f  12 s p e c i f i c  v i r a l  a n t i g e n s  
w h ic h  s t i m u l a t e d  p r o d u c t i o n  o f  p r e c i p i t a t i n g  a n t i b o d i e s  in r a b b i t s  
( 1 0 5 ) .
By g e l  I m m u n o d i f f u s i o n ,  Tokumaru  ( 1 0 0 )  d e m o n s t r a t e d  t h r e e  s o l ­
u b l e  a n t i g e n s  o f  HSV in a d d i t i o n  t o  t h e  v i r i o n .  The s o l u b l e  a n t i g e n s  
w e re  e s t i m a t e d  t o  h a v e  m o l e c u l a r  w e i g h t s  o f  9 0 , 0 0 0 ,  1 7 0 , 0 0 0 ,  and  
1 , 0 0 0 , 0 0 0 ;  w h i l e  t h e  v i r a l  a n t i g e n  was e s t i m a t e d  t o  h a v e  a  mol wt  
g r e a t e r  t h a n  3 x 10^ .
Brown ( 1 0 )  r e p o r t e d  t h a t  w a s h e d ,  w h o le  v i r u s  p a r t i c l e s  a d s o r b e d  
t h e  n e u t r a l i z i n g  c o m p o n e n t ,  b u t  n o t  t h e  CF c o m p o n e n t s  o f  a n t i s e r u m .
The  r e v e r s e  s i t u a t i o n  was a l s o  f o u n d  t o  h o l d  t r u e ,  t h a t  i s ,  a n t i  s e r a  
p r e p a r e d  t o  w h o le  v i r a l  p a r t i c l e s  l a c k e d  CF a b i l i t y  b u t  p o s s e s s e d  n e u ­
t r a l i z i n g  a b i l i t y .  H e a t  t r e a t m e n t  a t  56  C f o r  1 h r  d e s t r o y e d  t h e  CF 
a c t i v i t y  o f  t h e  s o l u b l e  a n t i g e n ,  b u t  d i d  n o t  a f f e c t  i t  a s  a s k i n  t e s t  
a n t i g e n .  Roane  an d  Roizman ( 8 3 )  f ou nd  t h a t ,  when t r e a t e d  l a t e r  w i t h  
com pl em ent  an d  HSV a n t i s e r u m ,  HEp-2 c e l l s  i n f e c t e d  24 h r  p r e v i o u s l y
11
w i t h  HSV w e r e  l y s e d ,  b u t  w e r e  n o t  a l t e r e d  m o r p h o l o g i c a l l y  by c o m p l e ­
m ent  o r  a n t i s e r u m  a l o n e .  T h e s e  d a t a  s u g g e s t  t h a t  a d i s t i n c t  s u r f a c e  
a n t i g e n ,  s p e c i f i c  f o r  HSV i s  p r o d u c e d  in H S V - i n f e c t e d  c e l l s  w i t h i n  
24 h r .
N in e  p r o t e i n s  l o c a t e d  in t h e  c ô a t  o f  HSV w ere  e s t i m a t e d  by 
O l s h e v s k y  an d  B e c k e r  ( 7 4 ) ,  t o  h av e  mol wt  r a n g i n g  from 2 4 , 0 0 0  t o  
1 4 ,0 0 0  d a l t o n s .  I t  a p p e a r e d  t h a t  a  p r o t e i n  o f  110 ,0 0 0  mol w t ,  in 
c o m b i n a t i o n  w i t h  a 3 0 , 0 0 0  mol wt p a r t i c l e ,  c o m p r i s e d  much o f  t h e  
vi  r u s  c a p s  i d .
K ap la n  (52 )  n o t e d  t h a t  H S V - i n f e c t e d  c e l l s  y i e l d e d  a s o l u b l e  
CF a n t i g e n  w h ic h  was s e p a r a b l e  f rom t h e  v i r a l  p a r t i c l e  by d i f f e r e n t i a l  
c e n t r i f u g a t i o n ,  i t  h a s  been s u g g e s t e d  t h a t  t h e  CF a n t i g e n  i s  e x c e s s  
s t r u c t u r a l  p r o t e i n  wh ich  was n o t  i n c o r p o r a t e d  i n t o  t h e  c o m p l e t e  v i r i o n s .  
More r e c e n t l y ,  S p e a r  e t  £j_. ( 92 )  d e m o n s t r a t e d  t h a t  HSV i n f e c t i o n  o f  
HEp-2 c e l l s  e l i c i t e d  t h e  p r o d u c t i o n  o f  t h r e e  o r  f o u r  v i r a l  g l y c o p r o t e i n s  
wh ic h  became i n c o r p o r a t e d  i n t o  c e l l  m e m b ra n e s .  The moi w t  o f  t h e s e  
p r o t e i n s  r a n g e d  f rom 0 . 5  t o  1 . 0  x 10^ d a l t o n s .
S k i n  T e s t  A n t i g e n s  o f  H e r p e s  S i m p l e x  V i r u s
S i n c e  90?  o f  p e r s o n s  a b o v e  f o u r  y e a r s  o f  a g e  e x h i b i t  an e r t h e -  
m a t o u s  r e a c t i o n  t o  s k i n  t e s t  m a t e r i a l  p r e p a r e d  f rom H S V - i n f e c t e d  
c h o r i o a l l a n t o i c  m em b ran es ,  HSV i n f e c t i o n s  m u s t  be  w i d e s p r e a d  in t h e  
p o p u l a t i o n  ( 6 8 ) .  In 1951,  J a w e t z  e t  aj_. ( 4 7 )  showed t h a t  h i g h  s p e e d  
c e n t r i f u g a t i o n  o f  H S V - i n f e c t e d  c h i c k  embryo  a l l a n t o i c  f l u i d  y i e l d e d  a 
s u p e r n a t a n t  f l u i d  c o n t a i n i n g  a  s o l u b l e  a n t i g e n  w h ic h  was a more  
e f f e c t i v e  s k i n  t e s t  a n t i g e n  t h a n  was t h e  v i r u s - c o n t a i n i n g  s e d i m e n t .  In
t h e s e  e a r l y  s t u d i e s  w i t h  human s u b j e c t s ,  t h e  s k i n  t e s t  a n t i g e n  was
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p r e p a r e d  f rom a m n i o t i c  o r  a l l a n t o i c  f l u i d s  h a r v e s t e d  f rom i n f e c t e d  
e m b r y o n a t e d  h e n ' s  e g g s ,  a n d  t h e  p r e p a r a t i o n s  w ere  i n a c t i v a t e d  by u l t r a ­
v i o l e t  i r r a d i a t i o n  b e f o r e  u s e .
O t h e r  w o r k e r s  h a v e  emp loyed  i n a c t i v a t e d  HSV in s k i n  t e s t i n g  
( 1 0 ,  99) b u t  a c o m p a r i s o n  o f  v i r a l  s k i n  t e s t  a n t i g e n  and  s o l u b l e  s k i n  
t e s t  a n t i g e n  showed t h e  l a t t e r  t o  be more s a t i s f a c t o r y  s i n c e  i t  
e l i c i t e d  s m a l l e r  n o n - s p e c i f i c  r e a c t i o n s  ( 3 ,  1 0) .  Brown ( 1 0 )  demon­
s t r a t e d  t h a t  HSV h y p e r  immunized g u i n e a  p i g s  r e s p o n d e d  t o  HSV s k i n  t e s t  
m a t e r i a l  w i t h  l a r g e  a r e a s  o f  i n d u r a t i o n  and  e r y t h e m a .  R e p e a t e d  i n t r a ­
p e r i t o n e a  I i n j e c t i o n s  o f  i n f e c t i v e  HSV i n d u c e d  a n i m a l s  t o  d e v e l o p  i n ­
d u r a t e d  s k i n  t e s t  r e a c t i o n s  t o  t h e  s o l u b l e  a n t i g e n .  In a s t u d v  by 
Lausch  e t  ( 5 5 )  which  c h a r a c t e r i z e d  t h e  s k i n  t e s t  r e a c t i o n  f o l l o w i n g  
l i v e  v i r u s  s e n s i t i z a t i o n ,  g u i n e a  p i g s  w ere  s k i n  t e s t e d  w i t h  s o l u b l e  
a n t i g e n  f rom h e a t - t r e a t e d  H S V - i n f e c t e d  c h i c k  embryo f i b r o b l a s t s .  The 
e r y t h e m a t o u s  r e a c t i o n  was f o u n d  t o  be maximal  a t  24 h r  a f t e r  t e s t i n g  
and h i s t o l o g i c a l  e x a m i n a t i o n  r e v e a l e d  a p r e d o m i n a n c e  o f  m o n o n u c l e a r  
c e l l s .  P a s s i v e  t r a n s f e r  o f  t h e  s k i n  r e a c t i v i t y  was a c c o m p l i s h e d  by us e  
o f  p e r i t o n e a l  e x u d a t e  c e l l s  b u t  n o t  o f  s e r u m .  From t h e s e  d a t a ,  t h e  
a u t h o r s  c o n c l u d e d  t h a t  t h i s  was a d e l a y e d  t y p e  o f  h y p e r s e n s i t i v i t y  
w i t h o u t  a c o n s i s t e n t  i n d u r a t i o n .  L a t e r  s t u d i e s  by Swye rs  e t  aj_. (97)  
r e v e a l e d  t h a t  d e l a y e d  h y p e r s e n s i t i v i t y  r e a c t i o n s  c o u l d  be p r o d u c e d  
in t h e  c o r n e a s  o f  H S V - i n f e c t e d  g u i n e a  p i g s .  They s u g g e s t e d  t h a t  a 
s i m i l a r  r e a c t i o n  may c o n t r i b u t e  t o  d i s c i f o r m  k e r a t i t i s  in man.
Whi le  t h e  a b o v e  s t u d i e s  i n d i c a t e d  t h a t  a d e l a y e d - t y p e  o f  s k i n  
r e a c t i v i t y  f o l l o w s  i n f e c t i o n  w i t h  HSV, t h e  r e l a t i o n s h i p  o f  t h e  s k i n  
t e s t  t o  a n t i b o d y  t i t e r s  was n o t  e x a m i n e d .  Good c o r r e l a t i o n  b e tw een
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e r y t h e m a ,  which  p e a k e d  a t  24 h r ,  and  t i t e r  o f  CF a n t i b o d y  in  human s u b ­
j e c t s  s k i n  t e s t e d  w i t h  u l t r a v i o l e t  l i g h t - i n a c t i v a t e d  s o l u b l e  a n t i g e n  
was r e p o r t e d  by Yamamoto ( 1 0 7 ) .  A l t h o u g h  t h i s  would  s u g g e s t  t h a t  t h e  
s k i n  t e s t  i s  m e d i a t e d  by CF a n t i b o d y ,  i t  s h o u l d  be  n o t e d  t h a t  t h e  s k i n  
t e s t  m a t e r i a l  u se d  was a c r u d e  p r e p a r a t i o n  wh ich  c o u l d  ha v e  c o n t a i n e d  
many d i f f e r e n t  a n t i g e n s  a c t i n g  c o n c o m i t a n t l y  t o  p r o d u c e  many d i f f e r e n t  
r e s p o n s e s .  However ,  t h i s  s t u d y  d i d  e m p h a s i z e  t h a t  d e l a y e d  s k i n  r e ­
a c t i v i t y  i s  a f r e q u e n t  o c c u r r e n c e  f o l l o w i n g  n a t u r a l  i n f e c t i o n  w i t h  HSV.
To d a t e ,  i t  h a s  been  shown t h a t  t h e  s k i n  t e s t  a n t i g e n  o f  HSV 
i s  h e a t  s t a b l e  ( 3 ,  10 ,  5 5 ) ,  n o n - d i a l y z a b l e  ( 5 5 ) ,  n o t  s e d i m e n t e d  by 
u l t r a c e n t r i f u g a t i o n  a t  s p e e d s  o f  7 9 , 0 0 0  x g f o r  3 h r  ( 3 )  a n d ,  m o s t  
i m p o r t a n t l y ,  d o e s  n o t  e l i c i t  s i g n i f i c a n t  r e a c t i o n s  in n o n - s e n s i t i z e d  
a n i m a l s  ( 1 0 ) .
F a c t o r s  I n v o l v e d  in R e c o v e r y  f rom V i r a l  D i s e a s e
A n t i b o d y
A c c o r d i n g  t o  F e n n e r  ( 2 3 ) ,  t h e  r o l e  o f  a n t i b o d y  in v i r a l  i n ­
f e c t i o n s  i s  t h e  p r e v e n t i o n  o f  t h e  a t t a c h m e n t  and  p e n e t r a t i o n  o f  v i r u s  
i n t o  s u s c e p t i b l e  c e l l s .  Once i n s i d e  t h e  c e l l ,  t h e  v i r u s  i s  p r o t e c t e d  
f rom n e u t r a l i z i n g  a n t i b o d y .  A p p a r e n t l y ,  t h e  mode o f  r e l e a s e  o f  v i r u s  
f rom i n f e c t e d  c e l l s ,  a s  w e l l  a s  t h e  mec hanis m o f  t r a n s f e r  o f  i n f e c t i v e  
v i r u s  t o  a d j a c e n t  c e l l s ,  d e t e r m i n e s  t h e  e f f e c t i v e n e s s  o f  n e u t r a l i z i n g  
a n t i b o d y  in  v i r u s  i n f e c t i o n s .  HSV and v a c c i n i a  v i r u s  a r e  a b l e  t o  p r o ­
du c e  l e s i o n s  in t h e  p r e s e n c e  o f  h i g h  t i t e r s  o f  n e u t r a l i z i n g  a n t i b o d y
( 2 3 ) .  P e r s o n s  s u b j e c t  t o  r e c u r r e n t  h e r p e s  l a b i a l  i s  h a v e  c i r c u l a t i n g ,  
n e u t r a l i z i n g  a n t i b o d y .  R e c u r r i n g  i n f e c t i o n s  do n o t  n e c e s s a r i l y  s t i m u ­
l a t e  d e t e c t a b l e  i n c r e a s e s  in a n t i b o d y  t i t e r  ( 1 7 ) .
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I n a c t i v a t e d  HSV v a c c i n e s  w i l l  p r o t e c t  m ic e  and  g u i n e a  p i g s  
a g a i n s t  i n t r a c e r e b r a l  c h a l l e n g e  w i t h  h i g h  d o s e s  o f  v i r u s .  H ow eve r ,  
Kapla n  (52 )  n o t e d  t h a t  t h e  a d m i n i s t r a t i o n  o f  s i m i l a r  v a c c i n e s  in man 
d i d  n o t  s t i m u l a t e  c i r c u l a t i n g  a n t i b o d y  p r o d u c t i o n  o f  t h e  m a g n i t u d e  
e l i c i t e d  in a n i m a l s .  T h e s e  v a c c i n e s  w e r e  shown t o  be  i n e f f e c t i v e  in 
p r e v e n t i n g  t h e  d i s e a s e  in man; e v e n  t h e  a d m i n i s t r a t i o n  o f  a n t i s e r u m  t o  
p a t i e n t s  w i t h  a c t i v e  d i s e a s e  h a s  been  o f  q u e s t i o n a b l e  v a l u e  ( 5 2 ) .
I n t e r f e r o n
V i r a l  i n t e r f e r e n c e  was shown by I s a a c s  an d  Lindenmann ( 4 4 )  t o  
be  m e d i a t e d  by a p r o t e i n  p r o d u c e d  by h o s t  c e l l s  in r e s p o n s e  t o  v i r a l  
i n f e c t i o n .  I s a a c s  and  Lindenmann ( 4 4 )  a n d  I s a a c s  e t  ( 4 5 )  named t h e  
p r o t e i n - c o n t a i n i n g  s u b s t a n c e  i n t e r f e r o n  and  c h a r a c t e r i z e d  i t  a s  b e i n g  
h e a t  s t a b l e  ( 5 6  C f o r  I h r ) ,  s e n s i t i v e  t o  t h e  a c t i o n  o f  t r y p s i n ,  n o t  
i n a c t i v a t e d  by a n t i - v i r a I s e r u m ,  s t a b l e  o v e r  a pH r a n g e  o f  I t o  I I ,  
h o s t  s p e c i e s  s p e c i f i c ,  n o n - d i a l y z a b l e ,  n o t  s e d i m e n t e d  by c e n t r i f u g a t i o n  
a t  1 0 0 ,0 0 0  X g f o r  I h r ,  and  e f f e c t i v e  a g a i n s t  v i r u s e s  o t h e r  t h a n  t h o s e  
i n d u c i n g  i t s  p r o d u c t i o n .
Fungi  and  b a c t e r i a ,  a s  w e l l  a s  v i r u s e s ,  i n d u c e  i n t e r f e r o n  s y n ­
t h e s i s .  In a d d i t i o n ,  c e r t a i n  n u c l e i c  a c i d s  and  s i m p l e  c o p o l y m e r s  o f  
n u c l e i c  a c i d s ,  su c h  a s  p o l y  1C, a s y n t h e t i c  c o p o l y m e r  o f  I n o s i n i c  and  
c y t i d y l i c  a c i d s ,  i n d u c e  i n t e r f e r o n  f o r m a t i o n  ( 6 4 ) .  N e i t h e r  t h e  e x a c t  
m echa n is m s  i n v o l v e d  in  i n t e r f e r o n  p r o d u c t i o n ,  n o r  i t s  mode o f  a c t i o n ,  
a r e  u n d e r s t o o d .  I t  i s  known t h a t  i n t e r f e r o n  can  a c t  by p r e v e n t i n g  
f o r m a t i o n  o f  v i r a l  c o a t  p r o t e i n ,  i n h i b i t i n g  v i r a l  DNA o r  RNA r e p l i c a ­
t i o n ,  and h a m p e r i n g  c o m p l e t e  v i r i o n  p r o d u c t i o n  ( 6 4 ) ,  p r e s u m a b l y  by 
i n t e r f e r i n g  w i t h  t r a n s l a t i o n  o f  v i r a l  m e s s e n g e r  RNA i n t o  p r o t e i n  ( 3 9 ) .
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R e c e n t l y ,  i t  h a s  been  d e m o n s t r a t e d  t h a t  t h e  same m echa n ism  i n v o l v e d  in 
d e l a y e d  h y p e r s e n s i t i v e  r e a c t i o n s  may s t i m u l a t e  i n t e r f e r o n  p r o d u c t i o n  
b o t h  in  i n t a c t  a n i m a l s  ( 9 5 )  and  in v i t r o  ( 3 3 ) .  Mice  p r e v i o u s l y  i n f e c t e d  
w i t h  M y c o b a c t e r i u m  t u b e r c u l o s i s ,  s t r a i n  BCG, p r o d u c e d  s i g n i f i c a n t  l e v e l s  
o f  i n t e r f e r o n  upon c h a l l e n g e  w i t h  p u r i f i e d  p r o t e i n  d e r i v a t i v e  ( 9 5 ) .  
Lymph ocyte s  f rom p e r s o n s  whose  s k i n  t e s t s  w e r e  p o s i t i v e  t o  PPD p r o d u c e d  
l a r g e  a m o u n ts  o f  i n t e r f e r o n  upon s t i m u l a t i o n  o f  t h e  l y m p h o c y te  c u l t u r e s  
w i t h  p u r i f i e d  p r o t e i n  d e r i v a t i v e  ( 3 3 ) .  S i m i l a r  c u l t u r e s  f rom p e r s o n s  
p r e v i o u s l y  immunized w i t h  t e t a n u s  t o x o i d  o r  d i p h t h e r i a  t o x o i d  a l s o  c o n ­
t a i n e d  s i g n i f i c a n t l y  l a r g e r  a m o u n ts  o f  i n t e r f e r o n  upon c h a l l e n g e  w i t h  
t h e s e  a n t i g e n s  t h a n  w ere  c o n t a i n e d  in c o n t r o l  l y m p h o c y t e  c u l t u r e s  ( 3 3 ) .  
T h e s e  f i n d i n g s  i l l u s t r a t e  t h e  p r o b l e m s  i n v o l v e d  in c r i t i c a l  a n a l y s i s  o f  
t h e  c o m p a r a t i v e  i m p o r t a n c e  o f  i n t e r f e r o n  an d  d e l a y e d  h y p e r s e n s i t i v i t y  
in r e c o v e r y  f rom  v i r a l  i n f e c t i o n s .  An e x c e l l e n t  r e v i e w  o f  s t u d i e s  on  
t h i s  s u b j e c t  i s  p r e s e n t e d  by Glasgow ( 2 9 ) .
Mice i n f e c t e d  w i t h  HSV e x h i b i t  maximum o f  i n t e r f e r o n  p r o d u c t i o n  
a t  t h e  s i t e  o f  t h e  v i r a l  l e s i o n  f i v e  d a y s  p o s t - i n f e c t  i o n ,  w i t h  maximal 
v i r u s  p r o d u c t i o n  o c c u r r i n g  on  t h e  s i x t h  d a y  ( 9 8 ) .  T h i s  may be i n t e r ­
p r e t e d  a s  an i n d i c a t i o n  o f  r e c o v e r y  a t t r i b u t a b l e  t o  i n t e r f e r o n  b u t  c o n ­
c l u s i v e  d a t a  in s u p p o r t  o f  t h i s  h y p o t h e s i s  a r e  l a c k i n g .  P e r s o n s  w i t h  
v a c c i n i a  g a n g r e n o s a  a r e  o f t e n  u n a b l e  t o  d e v e l o p  d e l a y e d  h y p e r s e n s i t i v i t y  
t o  t h e  v i r u s  an d  o f t e n  d i e  w i t h  t h i s  v i r a l  d i s e a s e  ( 3 7 ) .  T h e s e  d a t a  
c l e a r l y  i n d i c a t e  t h a t  w h i l e  i n t e r f e r o n  may be  a v e r y  i m p o r t a n t  f a c t o r  
in  r e c o v e r y  f rom v i r a l  i n f e c t i o n ,  t h e  r o l e  o f  o t h e r  c e l l u l a r  ph en om en a ,  
s u c h  a s  d e l a y e d  h y p e r s e n s i t i v i t y ,  m u s t  be  e l u c i d a t e d .
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Cel I u l a r  Immunity 
S t u d i e s  o f  c e r t a i n  d e f i c i e n c i e s  o f  t h e  immune s y s t e m  s u g g e s t  
t h a t  t h e  a b i l i t y  t o  m a n i f e s t  d e l a y e d  h y p e r s e n s i t i v e  r e a c t i o n s  i s  n e c ­
e s s a r y  f o r  r e c o v e r y  f rom v i r a l  i n f e c t i o n s .  M a le s  w i t h  c o n g e n i t a l ,  s e x -  
l i n k e d  a g a m m a g l o b u l i n e m i a  h a v e  few p l a s m a  c e l l s  and  do n o t  p r o d u c e  
d e t e c t a b l e  l e v e l s  o f  a n t i b o d y .  Such p e r s o n s  c a n  d e v e l o p  d e l a y e d  h y p e r ­
s e n s i t i v i t y  and  h a n d l e  many v i r a l  i n f e c t i o n s  in  a normal  f a s h i o n  ( 1 5 ,  
8 8 ) .  A s e c o n d  t y p e  o f  i m m u n e - d e f i c i e n c y  d i s e a s e ,  S w i s s - t y p e  agamma­
g l o b u l i n e m i a ,  i s  c h a r a c t e r i z e d  by t h e  a b s e n c e  o f  a n t i b o d i e s ,  p la s m a  
c e l l s ,  and  l y m p h o c y t e s .  T h e s e  p e r s o n s  a r e  e x t r e m e l y  s u s c e p t i b l e  t o  
v i r a l  an d  b a c t e r i a l  d i s e a s e s .  Ke ida n  e t ^ .  ( 5 3 )  and  l a t e r ,  Somers 
( 9 0 ) ,  r e p o r t e d  c a s e s  o f  S w i s s - t y p e  a g a m m a g l o b u l i n e m i a  in w h ic h  immuni­
z a t i o n  w i t h  v a c c i n i a  v i r u s  r e s u l t e d  in g e n e r a l i z e d  v a c c i n i a  and  d e a t h .  
P e r s o n s  w i t h  S w i s s - t y p e  a g a m m a g l o b u l i n e m i a  ha v e  a l s o  d i e d  f o l l o w i n g  
i n o c u l a t i o n  w i t h  M y c o b a c t e r i u m  t u b e r c u l o s i s , s t r a i n  BCG ( 6 1 ) .
In t h t '  W i s k o t t - A l d r i c h  s y n d r o m e ,  c h a r a c t e r i z e d  by d e f e c t s  in 
c e l l u l a r  immuni ty  in  v a r y i n g  d e g r e e s  b u t  e x h i b i t i n g  normal  l e v e l s  o f  
im m u n o g l o b u l i n s  ( 3 1 ,  9 6 ) ,  f a t a l i t i e s  due  t o  n o r m a l l y  b e n i g n  v i r a l  i n ­
f e c t i o n s  hav e  b een  r e p o r t e d .  F a t a l i t i e s  du e  t o  HSV i n f e c t i o n  h av e  
o c c u r r e d  in p e r s o n s  w i t h  t h e  W i s k o t t - A l d r i c h  s y n d r o m e ,  and  in  t h e s e  
c a s e s ,  n e u t r a l i z i n g  a n t i b o d i e s  t o  HSV w e r e  e i t h e r  a b s e n t  o r  a t  e x t r e m e l y  
low l e v e l s  ( 6 0 ,  3 2 ) .
F u l g i n i t i  e t  aj_. ( 2 4 )  d e s c r i b e d  t h r e e  c h i l d r e n  w i t h  i n a b i l i t y  
t o  d e v e l o p  s k i n  t e s t  r e a c t i o n s  t o  mumps v i r u s  o r  m o n i l i a l  a n t i g e n s .  One 
c h i l d  d i e d  o f  g e n e r a l i z e d  v a c c i n i a ,  and  in a n o t h e r ,  v a r i c e l l a  l e s i o n s  
p e r s i s t e d  f o r  e i g h t  m o n t h s .  Al l  t h r e e  c h i l d r e n  d i e d  o f  i n f e c t i o n s
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b e f o r e  16 mon th s  o f  a g e ,  e v e n  t h o u g h  some o f  them had a l m o s t  normal  
l e v e l s  o f  I m m u n o g l o b u l i n s .
T h r e e  p a t i e n t s  who w ere  u n a b l e  t o  d e v e l o p  s k i n  r e a c t i o n s  t o  
m o n i l i a l  a n t i g e n s  a n d  who s u b s e q u e n t l y  d i e d  o f  m o r b l l l l  w e re  d e s c r i b e d  
by L i p s e y  e t  aj_' ( 5 8 ) .  The p a t i e n t s '  s e r a  c o n t a i n e d  f o u r  t i m e s  t h e  
l e v e l  o f  I m m u n o g lo b u l in s  s e e n  In I n d i v i d u a l s  w i t h  S w i s s - t y p e  agamma­
g l o b u l i n e m i a .  A u to p sy  d i s c l o s e d  an a t r o p h i c  th y m u s ,  b u t  normal l e v e l s  
o f  l y m p h o c y t e s  and  p l a s m a  c e l l s  were  o b s e r v e d .  Immune g l o b u l i n  was 
a d m i n i s t e r e d  in a l l  t h r e e  c a s e s  w i t h o u t  s u c c e s s .  Nahmlas e t  aj_. (6 9 )  
d e s c r i b e d  a f o u r  m o n t h - o l d  p a t i e n t  w i t h  normal  l e v e l s  o f  I m m u n o g lo b u l i n s  
who e x p i r e d  w i t h  m e a s l e s  v i r u s  p n e u m o n i a .  At  a u t o p s y ,  no t h y m i c  t i s s u e  
c o u l d  be  d e t e c t e d .
S u r g i c a l  removal  o f  t h e  thym us  o r  t r e a t m e n t  w i t h  a n t  I - l y m p h o c y t e  
se ru m  h a s  a l s o  I n d i c a t e d  t h e  I m p o r t a n c e  o f  c e l l u l a r  immuni ty  In r e c o v e r y  
f rom v i r a l  d i s e a s e .  In m i c e  w i t h  p e r s i s t i n g  l y m p h o c y t i c  c h o r i o m e n i n ­
g i t i s  v i r u s  (LCM) I n f e c t i o n ,  a d m i n i s t r a t i o n  o f  a n t i - l y m p h o c y t e  se rum 
p r o d u c e d  a v i r e m i a  wh ich  d i s a p p e a r e d  when t h e  a n t i - l y m p h o c y t e  s e ru m  was 
d i s c o n t i n u e d  ( 1 0 4 ) .  The t i t e r  o f  CF a n t i b o d y  t o  LCM was u n a f f e c t e d  
d u r i n g  t h i s  t r e a t m e n t .
In HSV I n f e c t i o n s  o f  m i c e ,  Nahmlas  et^ aj_. ( 70 )  d e m o n s t r a t e d  
t h a t  t r e a t m e n t  w i t h  a n t  I - t h y m o c y t e  se ru m  p r o d u c e d  h i g h e r  m o r t a l i t y  r a t e s  
in  m i c e  I n f e c t e d  I n t r a p e r l t o n e a l l y  o r  I n t r a g e n i t a l l y  t h a n  In u n t r e a t e d  
a n i m a l s .  Mice c h a l l e n g e d  I n t r a c e r e b r a l l y  an d  t r e a t e d  w i t h  t h e  same 
a n t  I - t h y m o c y t e  se rum  e x h i b i t e d  an I n c r e a s e d  s u r v i v a l  r a t e .  The r o l e  o f  
I n t e r f e r o n  was n o t  m e n t i o n e d  In t h i s  s t u d y .  T r e a t m e n t  w i t h  a n t i -  
ly m p h o c y te  se rum c a u s e s  a d e c r e a s e  In t h e  I n t e r f e r o n  l e v e l s  In m ic e  
s u b s e q u e n t l y  c h a l l e n g e d  w i t h  an i n d u c e r  o f  i n t e r f e r o n  ( 5 ) .
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A f t e r  i m m u n i z a t i o n  w i t h  HSV, n e o n a t a l ! y t h y m e c t o m i z e d  m i c e  b e ­
came more  s u s c e p t i b l e  t o  c h a l l e n g e  w i t h  HSV t h a n  w e r e  normal m i c e  ( 6 6 ) .  
The p o s s i b l e  e f f e c t s  o f  i n t e r f e r o n  upon t h e  r e s u l t s  w e re  n o t  a s c e r t a i n e d  
in t h i s  s t u d y .  The r e s u l t s  w e r e  i n t e r p r e t e d  a s  s t r o n g  e v i d e n c e  in  s u p ­
p o r t  o f  t h e  r o l e  o f  c e l l u l a r  f a c t o r s  in  immuni ty  t o  HSV.
H i r s c h  e t  a_l_. ( 4 1 )  d e m o n s t r a t e d  t h a t  t r e a t m e n t  w i t h  a n t i ­
t h y m o c y t e  se rum  a l l o w e d  e s t a b l i s h m e n t  o f  p e r s i s t i n g  l y m p h o c y t i c  c h o r i o ­
m e n i n g i t i s  v i r u s  i n f e c t i o n  in  m i c e  w hich  o r d i n a r i l y  would  h a v e  d i e d  o f  
t h e  c h a l l e n g e  d o s e  o f  v i r u s .  F u r t h e r m o r e ,  h i g h  t i t e r s  o f  c i r c u l a t i n g  
a n t i b o d y  and  v i r u s  w e r e  d e t e c t e d  in  t h e  b l o o d  o f  t h e s e  a n i m a l s .  L a r g e  
r e t i c u l a r  c e l l s  i n f i l t r a t e d  k i d n e y ,  l u n g ,  and  l i v e r  o f  t h e  m i c e .
V i r a l  a n t i g e n s  w e re  d e t e c t e d  in  k i d n e y  t i s s u e  by t h e  f l u o r e s c e n t  a n t i ­
body t e c h n i q u e .
T r e a t m e n t  w i t h  a n t i - m o n o n u c l e a r  c e l l  s e r u m  a p p a r e n t l y  r e s u l t s  
in  an i n c r e a s e d  s u s c e p t i b i l i t y  t o  v i r a l  d i s e a s e s  in  e x p e r i m e n t a l  a n i m a l s .  
I n j e c t i o n  o f  young m i c e  w i t h  a n t i - l y m p h o c y t e  se ru m  p r i o r  t o  i n o c u l a t i o n  
w i t h  10^ p l a q u e  f o r m i n g  u n i t s  o f  HSV p r o d u c e d  100% m o r t a l i t y  w i t h  symp­
t o m s o f  e n c e p h a l i t i s  a nd  m e n i n g i t i s  b u t  l i t t l e  h e p a t i c  i n v o l v e m e n t  
( 1 0 8 ) .  The same d o s e  o f  HSV in  normal m i c e  p r o d u c e d  d e a t h  in  o n l y  18% 
o f  t h e  a n i m a l s .  A d m i n i s t r a t i o n  o f  a n t i - m a c r o p h a g e  s e r u m  p r i o r  t o  i n ­
j e c t i o n  o f  HSV r e s u l t e d  in  93% m o r t a l i t y  w i t h  symptoms o f  s e v e r e  h e p a ­
t i t i s .  Both  t h e  amount  and d u r a t i o n  o f  v i r e m i a  i n c r e a s e  in  HSV i n f e c ­
t i o n s  f o l l o w i n g  t r e a t m e n t  w i t h  a n t i - m o n o n u c l e a r  c e l l  s e r a  ( 7 0 ,  108 ) .
In a d d i t i o n  t o  i n c r e a s i n g  t h e  s e v e r i t y  o f  i n f e c t i o n  w i t h  HSV, po x­
v i r u s e s ,  and  o t h e r  v i r a l  a g e n t s ;  im m u n o s u p p r e s i v e  d r u g s  i n c r e a s e  mor­
t a l i t y  t o  v i r a l  i n f e c t i o n s  ( 2 9 ) .  C o r t i s o n e  h a s  be en  shown t o  i n c r e a s e
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t h e  s e v e r i t y  o f  HSV i n f e c t i o n s .  S i n c e  im m u n o s u p p r e s i v e  d r u g s  u s u a l l y  
d e c r e a s e  b o t h  d e l a y e d  h y p e r s e n s i t i v e  r e a c t i o n s  and  c i r c u l a t i n g  a n t i ­
body f o r m a t i o n ,  t h e  c o n c l u s i o n s  t h a t  c a n  be  drawn f rom r e p o r t s  o f  t h e i r  
e f f e c t s  a r e  o f  l i m i t e d  v a l u e  in a s s e s s i n g  t h e  i m p o r t a n c e  o f  d e l a y e d  
h y p e r s e n s i t i v i t y  in  v i r a l  d i s e a s e .
G o a l s  o f  t h e  R e s e a r c h  
R e c e n t  r e p o r t s  o f  a  h i g h  c o r r e l a t i o n  b e tw e e n  i n f e c t i o n  w i t h  
h e r p e s  s i m p l e x  v i r u s ,  t y p e  I I ,  a n d  c e r v i c a l  c a r c i n o m a  ( 7 9 ,  81)  i n d i c a t e  
t h e  need  f o r  f u r t h e r  s t u d y  o f  h o s t  c e l  I - v i r u s  r e l a t i o n s h i p s  in t h e  more  
common v i r a l  i n f e c t i o n s .
C u r r e n t  i n t e r e s t  in  t h e  s i g n i f i c a n c e  o f  d e l a y e d  h y p e r s e n s i t i v i t y  
in  v i r a l  d i s e a s e  h a s  n e c e s s i t a t e d  an e x a m i n a t i o n  o f  m e t h o d s  o f  i n d u c ­
t i o n  o f  s k i n  t e s t  r e a c t i v i t y  and  r e s p o n s e s  t o  a n t i g e n i c  c h a l l e n g e  o t h e r  
t h a n  a n t i b o d y  f o r m a t i o n .  To i n i t i a t e  a s t u d y  o f  t h e  s i g n i f i c a n c e  o f  
d e l a y e d  h y p e r s e n s i t i v i t y  in a v i r a l  d i s e a s e ,  t h e  r o l e  o f  d e l a / e d  h y p e r ­
s e n s i t i v i t y  m u s t  be  s e p a r a t e d  f rom  t h a t  o f  a n t i b o d y  and i n t e r f e r o n .  
A c h i e v e m e n t  o f  t h i s  g o a l  wi l l  r e q u i r e  p u r i f i c a t i o n  and  c h a r a c t e r i z a t i o n  
o f  an a n t i g e n  w h ic h  i s  c a p a b l e  o f  e l i c i t i n g  d e l a y e d  h y p e r s e n s i t i v e  
r e a c t i o n s .  Most  i m p o r t a n t l y ,  s e p a r a t i o n  o f  t h e  s k i n  r e a c t i v e  m a t e r i a l  
f rom i n t r i n s i c  i n t e r f e r o n  i n d u c i n g  m a t e r i a l s ,  s u c h  a s  h i g h  m o l e c u l a r  
w e i g h t  n u c l e i c  a c i d s  o r  e n d o t o x i n s ,  i s  e s s e n t i a l .
In t h e  p r e s e n t  i n v e s t i g a t i o n ,  t h e  p r i m a r y  g o a l  was t h e  p a r t i a l  
p u r i f i c a t i o n  and  c h e m i c a l  c h a r a c t e r i z a t i o n  o f  a s o l u b l e  s k i n  t e s t  a n t i ­
ge n  o f  h e r p e s  s i m p l e x  v i r u s .  S e c o n d a r i l y ,  c h a r a c t e r i z a t i o n  o f  t h e  
s o l u b l e  s k i n  r e a c t i v e  a n t i g e n  n e c e s s i t a t e d  a  c o m p a r i s o n  o f  v a r i o u s  
m e t h o d s  o f  s e n s i t i z a t i o n  o f  g u i n e a  p i g s  t o  h e r p e s  s i m p l e x  v i r u s .
CHAPTER I I 
MATERIALS AND METHODS 
S o l u t i o n s
W a t e r  u se d  f o r  p r e p a r a t i o n  o f  a l l  s o l u t i o n s  and  m e d ia  and  f o r  
f i n a l  r i n s i n g  o f  a l l  g l a s s w a r e  was d e m i n e r a l i z e d '  and  g l a s s  d i s t i l l e d .  
R e a g e n t  g r a d e  c h e m i c a l s  w e r e  u s e d  in t h e  p r e p a r a t i o n  o f  a l l  s o l u t i o n s  
u n l e s s  o t h e r w i s e  s t a t e d .
H a n k s '  b a l a n c e d  s a l t  s o l u t i o n  (HBSS),  u s e d  f o r  c e l l  c u l t u r e  
m e d i a ,  d i l u e n t s ,  and  t i s s u e  and  c e l l  c u l t u r e  r i n s e s ,  was p r e p a r e d  a c ­
c o r d i n g  t o  t h e  me th od  o f  Hanks a n d  W a l l a c e  ( 3 6 )  and  s t e r i l i z e d  by
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M i l l i p o r e  membrane  f i l t r a t i o n .  F o r  t h i s  p u r p o s e ,  and  in  s u b s e q u e n t  
e x p e r i m e n t s  in t h i s  s t u d y ,  a 0 . 4 5 p  p o r e  membrane f i l t e r  was u se d  f o r  
s t e r i I i  z a t i o n .
P h o s p h a t e  b u f f e r e d  s a l i n e  ( P B S ) ,  w h ic h  was c a l c i u m -  and  
m a g n e s i u m - f r e e ,  was p r e p a r e d  and  s t e r i l i z e d  by a u t o c l a v i n g  a t  121 C,
15 lb p r e s s u r e  f o r  20 min a c c o r d i n g  t o  t h e  t e c h n i q u e  o f  S c h m i d t  ( 8 6 ) .  
PBS was u s e d  f o r  t h e  p r e p a r a t i o n  o f  t r y p s i n  s o l u t i o n s  and  f o r  w a s h i n g  
o f  c e l l  c u l t u r e s .
' D e e m i n i t e  L- IO ,  C r y s t a l  R e s e a r c h  L a b o r a t o r i e s ,  H a r t f o r d ,  
C o n n e c t i c u t .
^ M i l l i p o r e  C o r p o r a t i o n ,  B e d f o r d ,  M a s s a c h u s e t t e s .
2 0
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B i 0 1oq i c a I  s
P e n i c i l l i n ^  an d  S t r e p t o m y c i n ^  w e r e  p r e p a r e d  in  s t e r i l e  w a t e r  
a s  s t o c k  s o l u t i o n s  and  s t o r e d  in 1 ml a m o u n t s  a t  - 2 5  C u n t i l  a d d e d  t o  
c u l t u r e  m e d ia  o r  s o l u t i o n s .  F i n a l  c o n c e n t r a t i o n s  w e r e  100 u n i t s  o f  
P e n i c i l l i n  and  100 yg  o f  S t r e p t o m y c i n  p e r  m i l l i l i t e r  o f  g r o w t h  
medium.
H o r s e  se ru m ^  an d  newborn  c a l f  s e r u m ^  w e re  h e a t - i n a c t i v a t e d  a t  
56 C f o r  30 min and  s t o r e d  a t  - 2 5  C. F o r  u s e ,  t h e y  w e r e  t h a w e d  and  
a d d e d  t o  c e l l  c u l t u r e  m e d i a  in '  a p p r o p r i a t e  c o n c e n t r a t i o n s  and  t h e  com­
p l e t e  m e d i a  w ere  s t e r i l i z e d  by membrane f i l t r a t i o n .
A 10/È s t o c k  s o l u t i o n  o f  t r y p s i n ^  was p r e p a r e d  in PBS, c e n t r i ­
f u g e d  a t  700 X g ,  s t e r i l i z e d  by membrane  f i l t r a t i o n ,  and  s t o r e d  a t
- 2 5  C. F o r  d i s p e r s i n g  c e l l s  in  c u l t u r e  an d  p r e p a r i n g  p r i m a r y  c e l l  
c u l t u r e s ,  0.1% o r  0.2% t r y p s i n  s o l u t i o n s  w e r e  p r e p a r e d  in PBS f rom t h e  
c o n c e n t r a t e d  s t o c k  s o l u t i o n .  In a d d i t i o n ,  a 1% s o l u t i o n  o f  s t o c k  
t r y p s i n  was p r e p a r e d  in 0 .1  M p h o s p h a t e  b u f f e r ,  pH 7 . 6 ,  an d  u s e d  t o  
t r e a t  s o l u b l e  a n t i g e n  p r e p a r a t i o n s  in t h e  c h a r a c t e r i z a t i o n  p r o c e d u r e .
A 50% c h i c k  embryo  e x t r a c t  (CEE) in HBSS was p r e p a r e d  f rom 
n i n e - d a y  i n c u b a t e d  H o n e g g e r  w h i t e  Leghor n  e g g s  a c c o r d i n g  t o  t h e  me th od  
o f  S c h m i d t  ( 8 6 ) ,  and  s t o r e d  a t  - 2 5  C. P r i o r  t o  u s e ,  t h e  p r e p a r a t i o n
^ P o t a s s i u m  P s n i c i i l i n  G, E .R.  S q u i b b  & S o n s ,  New Y o r k ,  N. Y.
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S t r e p t o m y c i n  s u l f a t e ,  C h a s .  P f i z e r  & C o . ,  I n c . ,  New Y o rk ,  N. Y.
^ M i c r o b i o l o g i c a l  A s s o c i a t e s ,  B e t h e s d a ,  Md. ,  L ot  71 6 3 2 1 4 4 0 3 .
^Newborn c a l f  s e r u m ,  H y l a n d ,  01v .  o f  T r a v a n o l  L a b o r a t o r i e s ,  In c .  
Los A n g e l e s ,  C a l i f . ,  C o n t r o l  3102H007A1.
^ T r y p s i n  1 : 2 5 0 ,  D i f c o  C o . ,  I n c . ,  D e t r o i t ,  Mi ch .
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was t h a w e d  and  c e n t r i f u g e d  10 min a t  700 x g f o r  c l a r i f i c a t i o n .  A 4% 
c o n c e n t r a t i o n  o f  CEE was a d d e d  t o  t h e  o u t g r o w t h  medium f o r  c u l t i v a t i o n  
o f  c h i c k  embryo  f i b r o b i a s t s .
C u l t u r e  Media
E a g l e ' s  Minimum E s s e n t i a l  Medium (MEM) u s e d  a s  g r o w t h  medium 
f o r  c e l l  c u l t u r e s  was p r e p a r e d  by d i s s o l v i n g  a d e h y d r a t e d  com m erc ia l  
p r e p a r a t i o n ®  in  w a t e r  ( 2 0 ) .  U n l e s s  o t h e r w i s e  s p e c i f i e d ,  t h i s  medium 
was s u p p l e m e n t e d  w i t h  9^ h o r s e  s e ru m  (MEMg^ Hg) o r  9% c a l f  se rum 
(MEMgj Cg) and  s t e r i l i z e d  by membrane  f i l t r a t i o n .
In o r d e r  t o  u s e  a  c o l o r i m e t r i c  p r o t e i n  d e t e r m i n a t i o n  p r o c e d u r e ,  
a g r o w t h  medium was n e e d e d  wh ich  d i d  n o t  c o n t a i n  an i n d i c a t o r .  Minimum 
E s s e n t i a l  Medium, IX c o n c e n t r a t i o n  whic h  l a c k e d  p he no l  r e d ,  was p r e ­
p a r e d  by a d d i n g  t o  HBSS a p p r o p r i a t e  a m ou nt s  o f  t h e  f o l l o w i n g  c o n c e n ­
t r a t e s ^ :  1) MEM v i t a m i n  s o l u t i o n ,  lOOX; 2)  s o l u t i o n  o f  MEM ami no  a c i d
m i x t u r e ,  50X; an d  3) s o l u t i o n  o f  MEM n o n - e s s e n t i a l  ami no  a c i d  m i x t u r e ,
lOOX. L - G lu ta m in e^®  was a d d e d  t o  a f i n a l  c o n c e n t r a t i o n  o f  0 . 2 9 2  g p e r
l i t e r  an d  t h e  medium was t h e n  f i l t e r  s t e r i l i z e d .  T h i s  medium i s  h e r e ­
a f t e r  r e f e r r e d  t o  a s  MEM-PR.
A s e c o n d  g r o w t h  medium u s e d  t o  p r o l i f e r a t e  L c e l l s  f o r  v i r a l  
t i t r a t i o n  and  r o u t i n e  c e l l  m a i n t e n a n c e  c o n s i s t e d  o f  HBSS s u p p l e m e n t e d  
w i t h  0.5/È l a c t a l b u m i n  h y d r o l y s a t e ^ ^ , 0.1% y e a s t  e x t r a c t ^ ^ ,  0.45%
®Grand I s l a n d  B i o l o g i c a l  C o . ,  Grand  I s l a n d ,  N . Y . ,  C o n t r o l  67 45 5 1 .
^ M i c r o b i o l o g i c a l  A s s o c i a t e s ,  B e t h e s d a ,  Md.
^^Sigma Chemica l  C o . ,  S t .  L o u i s ,  Mo.
^ ^ N u t r i t i o n a l  B i o c h e m i c a i s  C o . ,  C l e v e l a n d ,  O h i o .
T^Di fco  L a b o r a t o r i e s ,  D e t r o i t  1 ,  Mich .
2 3
d e x + r o s e ' ^ ,  and  8.0% i n a c t i v a t e d  newborn c a l f  s e r u m .  T h i s  medium was 
s t e r i l i z e d  by membrane f i l t r a t i o n .  I t  was d e s i g n a t e d  a s  LHYE C.
Growth  medium f o r  c h i c k  embryo  f i b r o b l a s t s  (CEF) was a m o d i f i e d  
LHYE and was d e s i g n a t e d  a s  I HYE f o r  CEF. I t  was p r e p a r e d  by s u p ­
p l e m e n t i n g  p h e n o l - r e d - f r e e  HBSS w i t h  0.25% l a c t a l b u m i n  h y d r o l y s a t e ,
2% c h i c k  embryo e x t r a c t ,  0 .07% NaHCOj, and  2% i n a c t i v a t e d ,  newborn c a l f  
se r u m .
C e l l  L i n e s  an d  C u l t u r e  T e c h n i q u e s
P r i m a r y  C e l l  C u l t u r e  P r e p a r a t i o n
CEF c u l t u r e s  w ere  p r e p a r e d  a c c o r d i n g  t o  t h e  m e th od  o f  S c h m i d t  
( 8 6 ) .  E l e v e n - d a y - o l d  H o n e g g e r  w h i t e  Leghorn  e m b ry o s  w e r e  h a r v e s t e d  
a s e p t i c a l l y ;  e y e s ,  w i n g s ,  l e g s  and  b e a k s  w e re  removed an d  d i s c a r d e d .  
A f t e r  t h e y  w e re  r i n s e d  t h r e e  t i m e s  in HBSS, t h e  t o r s o s  w e r e  f i n e l y  
m i n c e d  and  p l a c e d  in a 250  ml t r y p s i n i z i n g  f l a s k .  The m in ced  t i s s u e  
was washed  o n c e  in HBSS, a l l o w e d  t o  s e d i m e n t ,  an d  t h e  s u p e r n a t a n t  f l u i d  
was d e c a n t e d .  Two h u n d r e d  m i l l i l i t e r s  o f  0.25% t r y p s i n  w e re  add ed  p e r  
10 em bryos  and t h e  m i x t u r e  was s t i r r e d  w i t h  a m a g n e t i c  s t i r r e r  f o r  
1 h r  a t  room t e m p e r a t u r e .  A f t e r  t r y p s i n i z a t i o n ,  t h e  s u p e r n a t a n t  f l u i d  
was d e c a n t e d  t h r o u g h  s i x  l a y e r s  o f  s t e r i l e  g a u z e  i n t o  a 250 ml c e n t r i ­
f u g e  b o t t l e  and c e n t r i f u g e d  a t  80 x g f o r  10 min in a g r a d u a t e d  50 ml 
c e n t r i f u g e  t u b e .  The s u p e r n a t a n t  f l u i d  was d e c a n t e d  and  LHYE f o r  CEF 
was a d d e d  t o  b r i n g  t h e  c e l l  c o n c e n t r a t i o n  t o  0 .5 % .  T h i s  c e l l  s u s p e n s i o n  
was d i s p e n s e d  in 10 ml v o lu m es  p e r  150 ml b o t t l e  and  t h e  b o t t l e s  were
I ^ F I s h e r  S c i e n t i f i c  C o . ,  F a i r  Lawn, New J e r s e y ,  Lot  77 43 83 .
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i n c u b a t e d  a t  36 C f o r  48  h r .  LHYE f o r  CEF was t h e n  removed and  10 ml 
MEM-PR was a d d e d .  C u l t u r e s  w e r e  i n c u b a t e d  a t  36 C u n t i l  u s e d .
C o n t i n u o u s  C e l l  C u l t u r e  P r o p a g a t i o n  
To p r o v i d e  a c e l l  c u l t u r e  whi ch  wou ld  be  l e s s  l i k e l y  t o  c r o s s  
r e a c t  w i t h  c h i c k  embryo a n t i g e n s ,  a s t r a i n  o f  mouse  f i b r o b l a s t s ,  L-929  
( 8 5 ) ,  was u s e d  t o  p r o l i f e r a t e  p o o l s  o f  HSV. T h i s  c e l l  l i n e  was o b t a i n e d  
f rom M i c r o b i o l o g i c a l  A s s o c i a t e s ,  B e t h e s d a ,  Md. ,  and was m a i n t a i n e d  in 
t h i s  l a b o r a t o r y  e i t h e r  by r o u t i n e  p a s s a g e  a t  w e e k ly  i n t e r v a l s  o r  by 
s t o r a g e  a t  - 7 0  C in 5% g l y c e r o l  in MEMqq C^ ^ ,  a c c o r d i n g  t o  t h e  p r o c e d u r e  
o f  S c h m i d t  ( 8 6 ) .  The c e l l  c u l t u r e s  w e r e  t r e a t e d  p e r i o d i c a l l y  w i t h  
Kanamycin s u l f a t e ' ^  (2 0 0  p g / m i )  f o r  a  7 - d a y  p e r i o d  t o  c o n t r o l  p o s s i b l e  
c o n t a m i n a t i o n  w i t h  p l e u r o p n e u m o n i a - l i k e  o r g a n i s m s .
VI r u s e s
H e r p e s  S i m p l e x  V i r u s  
The HP s t r a i n  o f  h e r p e s  s i m p l e x  v i r u s  (HSV),  w hi ch  was o r i g i n a l l y  
o b t a i n e d  f rom t h e  N a t i o n a l  Communicable  D i s e a s e  C e n t e r ,  A t l a n t a ,  G a . ,  
was u se d  in t h e s e  s t u d i e s .  The v i r u s  had  been  p r o p a g a t e d  p r e v i o u s l y  in 
t h i s  l a b o r a t o r y  t h r o u g h  s e v e r a l  p a s s a g e s  in H e l a  c e l l s  an d  in e m b r y -  
o n a t e d  e g g s .  To p r e v e n t  c a r r y - o v e r  o f  s p e c i f i c  a n t i g e n s  o f  H e l a  o r  
c h i c k  embryo c e l l s  in wh ich  t h e  v i r u s  had  been  p r o p a g a t e d ,  v i r u s  was 
p a s s e d  t w i c e  in L c e l l s  b e f o r e  p r e p a r a t i o n  o f  s e e d  i n o c u l u m .  C e r t a i n  
o f  t h e s e  v i r a l  p r e p a r a t i o n s  w e r e  u se d  t o  s e n s i t i z e  e x p e r i m e n t a l  a n i m a l s .  
S i m i l a r l y ,  v i r u s  was p a s s e d  t h r e e  t i m e s  in  CEF b e f o r e  p r e p a r a t i o n  o f  
s o l u b l e  a n t i g e n .
^ ^ B r i s t o l  L a b o r a t o r i e s ,  S y r a c u s e ,  N. Y . , C o n t r o l  6 1 L 1135.
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V a c c i n i a  V i r u s
V a c c i n i a  v i r u s  was o b t a i n e d  o r i g i n a l l y  f rom t h e  Am er ic an  Type  
C u l t u r e  C o l l e c t i o n  (#VR325) .  I t  had  been  m a i n t a i n e d  in t h i s  l a b o r a t o r y  
by p a s s a g e  on  t h e  c h o r i o a l l a n t o i c  membrane  o f  e m b r y o n a t e d  e g g s  a n d ,  
j u s t  p r i o r  t o  u s e ,  was p a s s e d  o n c e  in CEF m o n o l a y e r s  grown in LHYE f o r  
CEF. F o r t y - e i g h t  h o u r s  a f t e r  i n o c u l a t i o n ,  t h e  i n f e c t e d  m o n o l a y e r s  
w e r e  s u b j e c t e d  t o  t h r e e  f r e e z e - t h a w  c y c l e s  an d  t h e  c e l  I l y s a t e s  w e re  
c e n t r i f u g e d  a t  700 x g f o r  30 m i n .  The  s u p e r n a t a n t  f l u i d  was t h e  
s e e d  i n o c u lu m  f o r  g r o w t h  o f  v a c c i n i a  v i r a l  p o o l s  w h ic h  w e r e  u s e d  f o r  
t h e  p r e p a r a t i o n  o f  s o l u b l e  a n t i g e n .
V i r u s  T i t r a t i o n
F i f t y  P e r  C e n t  I n f e c t i v i t y  
Mouse f i b r o b l a s t  m o n o l a y e r s ,  m a i n t a i n e d  in  LHYE C, in  r o l l e r  
t u b e s  ( 1 6  X 150 mm) w e r e  i n f e c t e d  w i t h  0 . 1  ml o f  a HSV s u s p e n s i o n .  
Q u a d r u p l i c a t e  m o n o l a y e r s  w e r e  u s e d  f o r  e a c h  lo g ^ g  d i l u t i o n  o f  v i r u s .  
A f t e r  a 1 h r  a d s o r p t i o n  p e r i o d  a t  36 C, 1 ml o f  g r o w t h  medium was 
a d d e d  and  t h e  t u b e s  w e r e  i n c u b a t e d  on a  r o l l e r  drum a t  36 C f o r  6 d a y s  
b e f o r e  f i n a l  i n f e c t i v i t y  r e a d i n g s  w e r e  r e c o r d e d  and  v i r a l  t i t e r s  w er e  
d e t e r m i n e d .  T i t e r s  w e r e  c a l c u l a t e d  by t h e  me th od  o f  Reed and  Meunch 
( 8 2 )  and  w e r e  e x p r e s s e d  a s  t h e  r e c i p r o c a l  lo g ^ ^  o f  t h e  h i g h e s t  d i l u t i o n  
o f  HSV g i v i n g  50^  i n f e c t i o n  o f  t h e  m o n o l a y e r s  (TCID^q ) .
P l a q u e  Forming  U n i t  
As sa y  o f  HSV by t h e  p l a q u e  f o r m i n g  u n i t  (PFU) me th od  was p e r ­
fo rm ed  a c c o r d i n g  t o  t h e  t e c h n i q u e  o f  G a r a b e d i a n  and  S c o t t  ( 2 5 ) .  Mono­
l a y e r s  o f  L c e l l s  m a i n t a i n e d  in  MEMg  ^ Cg w ere  i n o c u l a t e d  w i t h  lo g ^ g
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d i l u t i o n s  o f  v i r u s  an d  o v e r l a i d  w i t h  MEMg^ Cg p l u s  1.5% m e th y l  c e l l u ­
l o s e .  Fo u r  f l a s k s  w e r e  u se d  f o r  e a c h  log^Q d i l u t i o n .  Fo r  t h e  v i r a l  
d i l u t i o n  g i v i n g  3 0 - 3 0 0  p l a q u e s  p e r  m o n o l a y e r ,  t h e  a v e r a g e  number  o f  
p l a q u e s  was c a l c u l a t e d  and  e x p r e s s e d  a s  PFU p e r  ml o f  u n d i l u t e d  i n o c ­
u lum.
A n i m a l s
Young a d u l t ,  m a l e ,  a l b i n o  g u i n e a  p i g s ,  o f  t h e  H a r t l e y  s t r a i n ,  
w e i g h i n g  4 0 0 - 5 5 0  g e a c h ,  w e r e  o b t a i n e d  f rom Camm R e s e a r c h  I n s t i t u t e  and  
m a i n t a i n e d  on a  d i e t  o f  w a t e r ,  l a b o r a t o r y  f o o d  b l o c k s ,  and  l e a f y  g r e e n  
v e g e t a b l e s .  A f t e r  a s h o r t  p e r i o d  o f - a c c i i m a t i z a t i o n ,  t h e  a n i m a l s  w e re  
u se d  in  t h e  s k i n  t e s t  e x p e r i m e n t s  t o  be d e s c r i b e d .
Em b r y o n a te d  H o n e g g e r  w h i t e  Leghorn  e g g s  w h ic h  had been  i n c u r  
b a t e d  a t  39  C f o r  9 t o  11 d a y s  w e r e  o b t a i n e d  f rom a l o c a l  h a t c h e r y  
and w e re  u s e d  f o r  p r e p a r i n g  c h i c k  e m br yo  f i b r o b l a s t  c e l l  c u l t u r e s  and 
f o r  p r o l i f e r a t i o n  o f  HSV in  p r e p a r a t i o n  o f  s o l u b l e  a n t i g e n  (S A) .
S k i n  T e s t i n g  P r o c e d u r e s
S e n s i t i z a t i o n  t o  V i r a l  A n t i g e n
G u i n e a  p i g s  w e r e  s e n s i t i z e d  by t h e  i n t r a c u t a n e o u s  i n j e c t i o n  o f  
0 .1  ml o f  a n t i g e n  ( e i t h e r  a c t i v e  v i r u s ,  i n a c t i v e  v i r u s ,  o r  SA) i n t o  a 
s i n g l e  s i t e  on t h e  d o r s a l  t h o r a x .  V i r u s  was  i n a c t i v a t e d  by h e a t i n g  t h e  
HSV p r e p a r a t i o n  ( 1 0 ^ * ^  TCID^g/ml p r i o r  t o  i n a c t i v a t i o n )  a t  56 C f o r  
1 h r .  A f t e r  i n a c t i v a t i o n ,  no i n f e c t i v i t y  c o u l d  be  d e m o n s t r a t e d  by 
i n o c u l a t i o n  o f  t h e  p r e p a r a t i o n  i n t o  L c e l l  m o n o l a y e r  c u l t u r e s .  In 
c e r t a i n  e x p e r i m e n t s ,  a s e c o n d  i n j e c t i o n  o f  a n t i g e n  was a d m i n i s t e r e d  14 
d a y s  a f t e r  t h e  p r i m a r y  i n j e c t i o n  t o  d e t e r m i n e  i t s  e f f e c t i v e n e s s  in
27
15
s e n s i t i z i n g  a n i m a i s  t o  HSV SA. When F r e u n d ' s  c o m p l e t e  a d j u v a n t  
was e m p l o y e d ,  t h e  a n t i g e n  was mixed w i t h  a d j u v a n t  in a I : I r a t i o  and  
i n j e c t e d  in 0 . 1  mi v o lu m e s  in  two s e p a r a t e  s i t e s  on  t h e  d o r s a l  
t h o r a x .
D e t e c t i o n  o f  S e n s i t i v i t y  t o  V i r a l  A n t i g e n s  
F o u r t e e n  d a y s  a f t e r  s e n s i t i z a t i o n s ,  a n i m a l s  w e r e  s k i n  t e s t e d  
by i n j e c t i o n  o f  0 . 1  mi o f  a n t i g e n  i n t r a c u t a n e o u s i y i n t o  t h e  s h a v e d  
d or su m .  C o n t r o l  and  t e s t  a n t i g e n  i n j e c t i o n s  w e r e  p l a c e d  in t r a n s ­
v e r s e  s i t e s  on o p p o s i n g  s i d e s  o f  t h e  b a c k .  S k i n  t e s t  d i a m e t e r s  we re  
r e c o r d e d  in m i l l i m e t e r s  a s  t h e  a v e r a g e  o f  two r e a d i n g s  t a k e n  a t  r i g h t  
a n g l e s  t o  o n e  a n o t h e r .  In p i l o t  s t u d i e s  whic h  w i l l  n o t  be d e s c r i b e d  
in d e t a i l ,  t y p i c a l  e r y t h e m a  was e v i d e n t  a s  e a r l y  a s  4 t o  8 h r  and p r o ­
g r e s s e d  t o  maximal  i n t e n s i t y  by 16 h r .  When i n d u r a t i o n  was p r e s e n t ,  
t h e  t i m e  o f  maximal i n t e n s i t y  c l o s e l y  p a r a l l e l l e d  t h a t  o f  t h e  e r y t h e ­
m a t o u s  r e s p o n s e .  Ba sed  upon t h e s e  f i n d i n g s ,  o b s e r v a t i o n  t i m e s  o f  0 . 5 ,  
4 ,  16, 2 4 ,  48 ,  and  72 h r  w e r e  s e l e c t e d .  In s t u d i e s  w h e r e  i n d u r a t i o n  
was n o t  m a r k e d ,  o n l y  t h e  d i a m e t e r s  o f  e r y t h e m a  w e r e  r e c o r d e d .  C o l o r  
p h o t o g r a p h s  w e r e  made o f  s k i n  t e s t  s i t e s  0 . 5  h r  and 24 h r  a f t e r  i n ­
j e c t i o n  o f  a n t i g e n s .
M i c r o s c o p i c  s e c t i o n s  o f  b i o p s i e d  s k i n  t e s t  s i t e s  w ere  f i x e d  in 
b u f f e r e d  f o r m a l i n ,  s t a i n e d  w i t h  h e m a t o x y l i n  and  e o s i n ,  and  ex am in ed  
f o r  c e l l u l a r  i n f i l t r a t i o n .  The r e s u l t s  o f  m i c r o s c o p i c  e x a m i n a t i o n  we re  
r e c o r d e d  in c o l o r  p h o t o m i c r o g r a p h s .  P h o t o m i c r o g r a p h s  o f  h e m a t o x y l i n  
a nd  e o s i n  s t a i n e d  s e c t i o n s  o f  s k i n  t e s t  s i t e s  w e r e  made w i t h  a L e i t z
*^ D i fco  L a b o r a t o r i e s ,  D e t r o i t  1 ,  Mich .
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m i c r o s c o p e  f i t t e d  w i t h  a 35 mm L e i c a  cam e ra  and  a M i c r o - l b s o  a t t a c h ­
m en t  Kodachrome II p r o f e s s i o n a l  f i l m  (Type  was u se d  f o r  t h e  
p h o t o m i c r o g r a p h y .
P h o t o g r a p h s  o f  t h e  g r o s s  s k i n  t e s t  s i t e s  w e r e  t a k e n  w i t h  a 
18
35 mm Y a s h i c a  cam e ra  u t i l i z i n g  Kodachrome II d a y l i g h t  t y p e  f i l m .
S t a t i s t i c a l  A n a l y s i s  o f  S k i n  T e s t  D ata  
In e x p e r i m e n t s  i n v o l v i n g  t h r e e  o r  mo re  s k i n  t e s t  s i t e s  p e r  
a n i m a l ,  c o m p a r i s o n s  o f  e r y t h e m a t o u s  a n d / o r  i n d u r a t i v e  r e s p o n s e s  f o r  
e a c h  t i m e  i n t e r v a l  w e r e  made by D u n c a n ' s  new m u l t i p l e  r a n g e  t e s t  ( 5 7 ) .  
D a t a  f rom c e r t a i n  e x p e r i m e n t s  d i d  n o t  f u l f i l l  a l l  c r i t e r i a  f o r  
a p p l i c a t i o n  o f  t h i s  s t a t i s t i c a l  t e s t  s i n c e  a l a r g e  number  o f  z e r o  r e ­
a c t i o n s  p r o h i b i t s  u s e  o f  normal  t h e o r y  a n a l y s i s .  In c o m p a r i s o n s  o f  
o n l y  two t e s t  s i t e s  and  when t h e  d a t a  q u a l i f i e d ,  S t u d e n t ' s  " t "  t e s t
was a p p l i e d  and  s i g n i f i c a n c e  a t  t h e  o r  5% l e v e l s  was r e c o r d e d  In
e a c h  i n s t a n c e  ( 5 7 ) .
H e r p e s  S i m p l e x  V i r u s  S o l u b l e  A n t i g e n  P r e p a r a t i o n
T r e a t m e n t  o f  L y s a t e s  
S o n i c a t i o n  o f  v i r u s - i n f e c t e d  c e i l s . To d i s r u p t  c e l l  m emb ranes ,  
t h u s  r e l e a s i n g  i n t r a c e l l u l a r  p r o d u c t s ,  an d  t o  d e t e r m i n e  t h e  e f f e c t  on 
HSV SA, p o o l s  o f  i n f e c t e d  c e l l s  w e r e  s o n i c a t e d  f o r  15 min a t  10 kc in
IGg. L e i t z ,  I n c . ,  New Y o rk ,  N. Y.
' ^ E a s t m a n  Kodak C o . ,  R o c h e s t e r ,  N. Y.
^®Yashica C o . ,  LTD.,  Tok y o ,  J a p a n .
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a s o n i c  o s c i l l a t o r J ^  U n i n f e c t e d  c o n t r o l  c e l l s  w e r e  t r e a t e d  in  a s i m i ­
l a r  f a s h i o n .  A f t e r  s o n i c a t i o n ,  t h e  m a t e r i a l s  w e r e  c e n t r i f u g e d  a t  
600 X 9 f o r  to m i n .  The s e d i m e n t  was d i s c a r d e d  and  t h e  s u p e r n a t a n t  
f l u i d  was s t o r e d  a t  - 7 0  C.
U l t r a c e n t r i f u g a t i o n  p r o c e d u r e s . Bo th  H S V - i n f e c t e d  an d  c o n t r o l
20p r e p a r a t i o n s  w e r e  c e n t r i f u g e d  a t  6 6 , 0 0 0  x  g f o r  0 . 5  h r  a t  10 C. The 
s u p e r n a t a n t  f l u i d s  w e r e  removed by d é c a n t a t i o n  a n d  s t o r e d  a t  - 7 0  C.
The p e l l e t  f rom H S V - l n f e c t e d  m o n o l a y e r s  was r e s u s p e n d e d  In f r e s h  g r o w t h  
medium and  s t o r e d  a t  - 7 0  C u n t i l  u s e d  a s  v i r a l  a n t i g e n .
P r o t e i n  d e t e r m i n a t i o n . The  p r o t e i n  c o n t e n t  o f  a n t i g e n s  p r e ­
p a r e d  In m e d i a  c o n t a i n i n g  p h e n o l  r e d  was d e t e r m i n e d  by t h e  m e th o d  o f  
Lowry e t  aj_. ( 5 9 ) .  When a n t i g e n s  w e re  p r e p a r e d  In p h e n o l - r e d - f r e e  
m e d i a ,  t h e i r  p r o t e i n  c o n t e n t  was d e t e r m i n e d  s p e c t r o p h o t o m e t r i c a I l y  by 
t h e  me th od  o f  K a l c k a r  ( 5 1 ) .  P r o t e i n  l e v e l s  d e t e r m i n e d  by b o t h  m e t h o d s  
w e r e  e x p r e s s e d  a s  mg/ml o f  a n t i g e n  p r e p a r a t i o n .
L y o p h I I I z a t l o n  p r o c e d u r e . M a t e r i a l s  t o  b e  s t o r e d  o r  c o n c e n ­
t r a t e d  w ere  f r o z e n  In an e t h a n o l - d r y  I c e  b a t h  p r i o r  t o  l y o p h i I I z a t l o n
21on a V I r t i s  l y o p h i I I z e r .  F o l l o w i n g  l y o p h i I I z a t l o n ,  a n t i g e n  p r e p a r ­
a t i o n s  w e re  s t o r e d  a t  5 C u n t i l  u s e d .  A n t i g e n s  w e r e  r e c o n s t i t u t e d  w i t h  
e i t h e r  d i s t i l l e d  w a t e r  o r  PBS a s  r e q u i r e d .
1 9
R a y t h e o n  M a n u f a c t u r i n g  C o . ,  W a l th am ,  M a s s .
20
Type  30 r o t o r .  Mode! L2-65B c e n t r i f u g e ,  Beckman I n s t r u m e n t s ,  
I n c . ,  S p l n c o  D i v . ,  P a l o  A l t o ,  C a l i f o r n i a .
71 V i r t i s  R e s e a r c h  E q u i p m e n t ,  G a r d i n e r ,  N. Y.
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L C e l l - P r e p a r e d  H e r p e s  S i m p l e x  V i r u s  S o l u b l e  A n t i g e n  
C o m p l e t e  m o n o l a y e r s  o f  L c e l l s  w e r e  p r e p a r e d  in  250 ml b o t t l e s  
e m p l o y i n g  MEM^ ^ Hg w hi ch  c o n t a i n e d  a n t i b i o t i c s .  M o n o l a y e r s  w e r e  washed 
o n c e  w i t h  HBSS t o  remove  c o n t a m i n a t i n g  s e r a  o r  o t h e r  p r o t e i n s  and w ere  
i n f e c t e d  w i t h  m e m b r a n e - f i l t e r e d  l y s a t e  f rom H S V - i n f e c t e d  c e l l s  w h ic h  had 
a t i t e r  o f  1 x  10^ T C ID ^g /m l .  To r i d  t h e  s e e d  in o c u l u m  o f  c o n t a m i n a t i n g  
p r o t e i n s ,  t h e  v i r u s  was p r o p a g a t e d  t h r o u g h  t h r e e  s e r i a l  p a s s a g e s  in L 
c e l l s  p r o l i f e r a t e d  in MEMg^ Hg p r i o r  t o  t h e  ma ki ng  o f  t h e  v i r a l  p o o l .
The c u l t u r e  medium f o r  L c e l l s  was s u p p l e m e n t e d  w i t h  h o r s e  se ru m  in  an 
a t t e m p t  t o  o b v i a t e  c r o s s  r e a c t i o n s  in  s k i n  t e s t s  due  t o  common se ru m  
o r  c e l l  c o m p o n e n t s  in  b o t h  s e n s i t i z i n g  and  s k i n  t e s t  a n t i g e n s .  One 
m i l l i l i t e r  o f  v i r a l  i n o c u lu m  was p l a c e d  on  e a c h  c u l t u r e  and  a l l o w e d  t o  
a d s o r b  f o r  i h r  a t  36 C b e f o r e  a d d i t i o n  o f  10 ml o f  MEMg^ Hg. T h e s e  
i n f e c t e d  m o n o l a y e r s  w e re  i n c u b a t e d  f o r  72 h r  a t  36 C an d  w er e  t h e n  s u b ­
j e c t e d  t o  f i v e  f r e e z e - t h a w  c y c l e s  u s i n g  t e m p e r a t u r e s  o f  37 C and  - 7 0  C 
t o  r e l e a s e  i n t r a c e l l u l a r  v i r u s .  A f t e r  l y s i s ,  t h e  pH o f  t h e  l y s a t e  was 
a d j u s t e d  t o  7 . 0  by a d d i t i o n  o f  IN NaOH an d  t h e  p r e p a r a t i o n  was c e n t r i ­
f u g e d  a t  700  X g a t  4 C f o r  30 min t o  remove  c e l  I u l a r  d e b r i s .  The 
r e s u l t i n g  s u p e r n a t a n t  l i q u i d  was c e n t r i f u g e d  f u r t h e r  a t  6 6 , 0 0 0  x g f o r  
30 m i n .  The s o l u b l e  a n t i g e n  (SA) f r a c t i o n  r e m a i n e d  in t h e  l i q u i d  p o r ­
t i o n  and  was c o n c e n t r a t e d  f i v e - f o l d  by l y o p h i I i z a t l o n .  The l y o p h i I i z e d  
SA was r e s u s p e n d e d  in 80 ml o f  d i s t i l l e d  w a t e r  and  d i a l y z e d  a g a i n s t  PBS 
a t  pH 7 . 0  f o r  24 h r  a t  4 C. T h i s  p a r t i a l l y  p u r i f i e d  and  c o n c e n t r a t e d  
SA was s t o r e d  a t  - 7 0  u n t i l  u s e d .  The s e d i m e n t  f rom t h e  u l t r a c e n t r i f u ­
g a t i o n  p r o c e d u r e  was  r e s u s p e n d e d  in 1 / 8  t h e  o r i g i n a l  vo lume o f  MEMg^ Hg,
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d e s i g n a t e d  v i r a l  a n t i g e n  (VA) , a n d  s t o r e d  a t  - 7 0  C In 1 ml a m o u n t s  f o r  
l a t e r  u s e .
C h i c k  Embryo F i b r o b l a s t - P r e p a r e d  H e r p e s  S i m p l e x
V i r u s  S o l u b l e  A n t i g e n
C o m p le te  m o n o l a y e r  c u l t u r e s  o f  c h i c k  embryo  f i b r o b l a s t s  w e r e
p r o l i f e r a t e d  In LHYE f o r  CEF in  250  ml b o t t l e s  ( 8 6 ) .  The  g r o w t h  medium
22
e m p lo y e d  c o n t a i n e d  2^ c a l f  s e ru m  , b u t  I t  l a c k e d  p h e n o l  r e d .  The  CEF
m o n o l a y e r s  were  m a i n t a i n e d  48  h r  on  MEM-PR b e f o r e  I n o c u l a t i o n  w i t h  0 . 5
ml o f  C E F - p r o l I f e r a t e d  HSV w h ic h  had  a t i t e r  o f  10^*^  T C ID ^ ^ /m l .  Ad­
s o r p t i o n  f o r  1 h r  a t  35 C was a l l o w e d  b e f o r e  10 ml o f  MEM-PR was a d d e d  
t o  e a c h  m o n o l a y e r .  An e q u a l  number o f  u n i n f e c t e d  m o n o l a y e r s  w e r e  k e p t  
a s  c o n t r o l s  f o r  l a t e r  s t u d i e s .  The  a n t i g e n  t r e a t m e n t s  a r e  d e s c r i b e d  
In f lo w  d i a g r a m  fo rm  In F i g u r e  I .  U n i n f e c t e d  m o n o l a y e r s  w e r e  s u b j e c t e d  
t o  a s i m i l a r  t r e a t m e n t  t o  o b t a i n  c o n t r o l  a n t i g e n .
C h i c k  E m b r y o - P r e p a r e d  H e r p e s  S i m p l e x  V i r u s  S o l u b l e  A n t i g e n  
H e r p e s  s i m p l e x  v i r u s  SA was  p r e p a r e d  In c h i c k  em b r y o s  (CE) a c ­
c o r d i n g  t o  t h e  m e th o d  o f  J a w e t z  e t  aj_' ( 4 7 ) .  E m b r y o n a t e d  e g g s ,  I n c u ­
b a t e d  10 d a y s ,  w e r e  I n f e c t e d  w i t h  HSV v i a  t h e  c h o r i o a l l a n t o i c  membrane  
a n d  I n c u b a t e d  f o u r  d a y s  b e f o r e  t h e  a l l a n t o i c  f l u i d  was h a r v e s t e d .
P o o l s  o f  H S V - l n f e c t e d  CE a l l a n t o i c  f l u i d  and  c o n t r o l  CE a l l a n t o i c  f l u i d  
w e r e  c e n t r i f u g e d  a t  1 7 ,0 0 0  x  g f o r  1 h r  a t  5 C b e f o r e  s u p e r n a t a n t  
f l u i d s  w e re  c o l l e c t e d  and  s t o r e d  a t  - 7 0  C. The s e d i m e n t  o f  H S V - i n f e c t e d
CE was l a b e l l e d  HSV CE and  r e t a i n e d  a t  - 7 0  C f o r  l a t e r  u s e .  P r i o r  t o
22
Newborn c a l f  s e r u m ,  H y l a n d ,  0 1 v .  o f  T r a v a n o l  L a b o r a t o r i e s ,  I n c .  
Los  A n g e s e s ,  C a l i f . ,  C o n t r o l  3102H007A1.
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H e r p e s  S i m p l e x  V i r u s  I n f e c t e d  
C h i c k  embryo  f i b r o b l a s t s  o r  L c e l l s *
S t e p  1 
VIRUS RELEASE
L y s a t e
S t e p  2 
CENTRIFUGATION
r
S e d i m e n t
i
V i r a l  A n t i g e n  (HSV)
F r e e z e - t h a w  5X 
o r
S o n i c a t i o n  lOKC, 10 m i n .
6 6 , 0 0 0  X g ;  30 m in .  
S p l n c o ,  Model L
%
S u p e r n a t e
L y o p h i 1 1 z a t i o n  
and  D i a l y s i s ,  
0 ,0 1  M PBS, 
pH 7 . 0
S o l u b l e  A n t i g e n  (SA)
♦ U n i n f e c t e d  c e l l s  r e c e i v e d  i d e n t i c a l  t r e a t m e n t  t o  o b t a i n  c o n t r o l  
a n t i g e n s .
F i g u r e  I .  Summary o f  p r e p a r a t i o n  m e t h o d s  f o r  a n t i g e n s  
f rom e i t h e r  v i r a l - i n f e c t e d  o r  u n i n f e c t e d  c e l l s .
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u s e  a s  s k i n  t e s t  a n t i g e n s ,  a l l a n t o i c  f l u i d  a n t i g e n  p o o l s  w e r e  h e a t e d  
a t  56 C f o r  1 h r .
V a c c i n i a  S o l u b l e  A n t i g e n  P r e p a r a t i o n
C h i c k  embryo f i b r o b l a s t  m o n o l a y e r s  in 250  ml b o t t l e s  w e r e  I n -
5 5
f e c t e d  w i t h  1 . 0  ml vo lume c o n t a i n i n g  10 * TCID^q o f  CEF p r o l i f e r a t e d  
v a c c i n i a  v i r u s .  A t w o - h o u r  a d s o r p t i o n  p e r i o d  a t  36 C was a l l o w e d  b e ­
f o r e  a d d i t i o n  o f  9 ml o f  MEM-PR p e r  c u l t u r e  b o t t l e .  M o n o l a y e r s  w ere  
i n c u b a t e d  a t  36 C f o r  48  h r  an d  t h e  v i r u s  was t h e n  r e l e a s e d  by t h r e e  
f r e e z e - t h a w  c y c l e s .  The r e s u l t i n g  l y s a t e  was c e n t r i f u g e d  a t  700 x  g 
t o  remove  c e l l u l a r  d e b r i s ,  an d  t h e  s u p e r n a t a n t  f l u i d  r e s u l t i n g  f rom 
c e n t r i f u g a t i o n  a t  6 6 , 0 0 0  x g f o r  30 min a t  10 C was d e s i g n a t e d  t h e  
v a c c i n i a  s o l u b l e  a n t i g e n  (VSA).
T r e a t m e n t  o f  H e r p e s  S i m p l e x  V i r u s  S o l u b l e  A n t i g e n
In o r d e r  t o  c h a r a c t e r i z e  f u r t h e r  t h e  SA, i t  was s u b j e c t e d  t o  
enzyme a c t i o n ,  e t h e r  e x t r a c t i o n ,  d i a l y s i s ,  and  u l t r a f i l t r a t i o n  p r o c e ­
d u r e s  b e f o r e  b e i n g  u se d  a s  s k i n  t e s t  a n t i g e n .
T r y p s i n
A 1^ s o l u t i o n  o f  t r y p s i n ^ ^  was p r e p a r e d  in 0 . 1  M so d iu m  p h o s ­
p h a t e  b u f f e r ,  pH 7 . 6  a s  d e s c r i b e d  e a r l i e r .  The p r o t e o l y t i c  a c t i v i t y  o f  
t r y p s i n  was  d e t e r m i n e d  by m e a s u r i n g  t h e  i n c r e a s e  in  u l t r a v i o l e t  l i g h t  
a b s o r b a n c e  a t  a w a v e l e n g t h  o f  280  mp a f t e r  t r e a t m e n t  o f  c a s e i n  w i t h  
u n h e a t e d  a n d  h e a t e d  (1 0 0  C, 10 m in )  t r y p s i n  ( 5 4 ) .  A u n i t  o f  t r y p s i n  
i s  d e f i n e d  a s  t h a t  amount  o f  a c t i v i t y  which  p r o d u c e s  an i n c r e a s e ,  u n d e r
^ ^ T r y p s i n  1 : 2 5 0 ,  D i f c o  C o . ,  I n c . ,  D e t r o i t ,  Mich .
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t h e  c o n d i t i o n s  d e s c r i b e d ,  o f  o n e  un i t / m i n  in  t h e  a b s o r b a n c e  a t  280  my. 
The u n h e a t e d  t r y p s i n  p r e p a r a t i o n  u se d  in t h i s  s t u d y  had  an  a c t i v i t y  o f  
0 . 0 1 2  un I t s / m  I /m in  an d  a s p e c i f i c  a c t i v i t y  o f  0 . 0 0 1  u n i t s / m g .  H e a t e d  
t r y p s i n  showed no  p r o t e o l y t i c  a c t i v i t y  u n d e r  t h e s e  c o n d i t i o n s .  One 
m i l l i l i t e r  a m o u n ts  o f  CE p r o l i f e r a t e d  s o l u b l e  a n t i g e n  w e r e  i n c u b a t e d  
f o r  2 h r  a t  37 C w i t h  e q u a l  v o lu m e s  o f  h e a t e d  and  u n h e a t e d  t r y p s i n .  
C o n t r o l  a l l a n t o i c  f l u i d  was i n c u b a t e d  w i t h  u n h e a t e d  t r y p s i n  u n d e r  t h e  
a b o v e  c o n d i t i o n s .  F o l l o w i n g  t r y p s i n  t r e a t m e n t ,  c o n t r o l  an d  s o l u b l e  
a n t i g e n  p r e p a r a t i o n s  w e r e  s t o r e d  a t  - 7 0  C u n t i l  u s e d  a s  s k i n  t e s t  a n t i ­
g e n s .  B e f o r e  t e s t i n g ,  t h e  a n t i g e n s  w e r e  h e a t e d  a t  70 C f o r  2 h r  t o  
r e d u c e  t r y p s i n  a c t i v i t y .  F o l l o w i n g  t r e a t m e n t  a t  70  C f o r  2 h r ,  t h e  
a c t i v i t y  o f  t h e  t r y p s i n  p r e p a r a t i o n  was t o o  low t o  m e a s u r e  by t h i s  
t e c h n i q u e .
P r o n a s e
A 0.5/5 s o l u t i o n  o f  p r o n a s e ^ ^  was p r e p a r e d  in  0 .1  M so d iu m  p h o s ­
p h a t e  b u f f e r ,  pH 7 . 4 .  The  p r o t e o l y t i c  a c t i v i t y  o f  u n h e a t e d  and  h e a t e d  
(1 0 0  C, 10 mi n )  p r o n a s e  was d e t e r m i n e d  by t h e  same me th od  a s  u s e d  f o r  
t r y p s i n ,  e x c e p t  t h a t  t h e  a s s a y  was do ne  a t  pH 7 . 4 .  The  a c t i v i t y  o f  un­
h e a t e d  p r o n a s e  was 0 . 0 0 4 6  u n i t s / m l / m i n .  H e a t e d  p r o n a s e  showed no a c ­
t i v i t y  u n d e r  t h e s e  c o n d i t i o n s .  The s p e c i f i c  a c t i v i t y  o f  t h e  u n h e a t e d  
p r o n a s e  was 2 . 4  X 10” ^ u n i t s / m g .  The r e m a i n d e r  o f  t h e  p r o c e d u r e  was 
t h e  same a s  t h a t  u s e d  in t h e  t r y p s i n  t r e a t m e n t .
24
P r o n a s e  B g r a d e ,  C a l b i o c h e m ,  4 5 , 0 0 0  PUK u n i t s / g r a m .  Lot
80 19 2 9 .
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D eoxyr î  b o n u c l e a s e
25
A s t o c k  s o l u t i o n  o f  d e o x y r i b o n u c l e a s e  (DNase)  was p r e p a r e d  
in  0 . 2  M s o d iu m  p h o s p h a t e  b u f f e r ,  pH 7 . 0 ,  a t  a c o n c e n t r a t i o n  o f  i 2 . 5  
m g /m l .  DNase a c t i v i t y  was m e a s u r e d  by d e t e r m i n i n g  t h e  i n c r e a s e  in  
a b s o r b a n c e  a t  a  w a v e l e n g t h  o f  260  mu a f t e r  t r e a t m e n t  o f  d e o x y r i b o ­
n u c l e i c  a c i d  w i t h  u n h e a t e d  and  h e a t e d  ( 7 0  C, 2 h r )  s t o c k  DNase ( 6 3 ) .  
The  a c t i v i t y  o f  DNase i s  d e f i n e d  a s  t h a t  am ou n t  o f  a c t i v i t y  w hic h  
g i v e s  an  i n c r e a s e  in a b s o r b a n c e  a t  260 my o f  o n e  un i t / m i n .  The a c ­
t i v i t i e s  o f  t h e  h e a t e d  and  u n h e a t e d  DNase p r e p a r a t i o n s  w e r e  0 . 0 1 8  
u n i t s / m l / m i n  a n d  2 2 . 5  u n i t s / m i / m i n ,  r e s p e c t i v e i y . S p e c i f i c  a c t i v i t i e s  
w e r e  1 . 5  X 10” ^ u n i t s / m g  f o r  h e a t e d  DNase and  1 . 8  u n i t s / m g  f o r  un­
h e a t e d  DNase.  One m i l i i l i t e r  o f  t h e  s t o c k  DNase s o i u t i o n  was ad d e d  t o  
4 mi o f  SA a n d  L c e i i  c o n t r o l  p r e p a r a t i o n s ,  r e s p e c t i v e i y ,  a nd  b o t h  w e re  
i n c u b a t e d  a t  37  C f o r  16 h r .  in a d d i t i o n ,  a 4 ml a l i q u o t  o f  SA was 
i n c u b a t e d  w i t h  1 ml o f  i n a c t i v e  DNase ( h e a t e d  70 C, 2 h r )  u n d e r  t h e  
same e x p é r i m e n t a i  c o n d i t i o n s  a s  a b o v e .  B o t h  SA and  L c e l i  c o n t r o l  
p r e p a r a t i o n s  c o n t a i n e d  290  yg o f  p r o t e i n  p e r  m l .  F o l l o w i n g  t h e  i n c u ­
b a t i o n  p e r i o d ,  t h e  p r e p a r a t i o n s  w e r e  h e a t e d  a t  70 C f o r  2 h r  t o  i n ­
a c t i v a t e  r e m a i n i n g  enzyme b e f o r e  l y o p h i I i z a t i o n  t o  c o n c e n t r a t e  
t h e  a n t i g e n  p r e p a r a t i o n s  f o r  s k i n  t e s t i n g .  A n t i g e n  p r e p a r a t i o n s  w e r e  
a d j u s t e d  t o  1 . 5  mg o f  SA o r  c o n t r o l  p r o t e i n / m l  p r i o r  t o  a n i m a i  c h a i -  
i e n g e .
^ ^ D e o x y r i b o n u c l e a s e ,  b e e f  p a n c r e a s ,  G r a d e  1 ,  M i l e s  L a b o r a ­
t o r i e s ,  I n c . ,  E l k h a r t ,  I n d . ,  C o n t r o l  #1 3 0 7 0 .
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A 155 s t o c k  s o l u t i o n  o f  R I b o n u c l e a s e  ( R N a s e ) ^ ^  was p r e p a r e d  in 
0 .1  M s o d iu m  a c e t a t e  b u f f e r ,  pH 5 . 0 .  R I b o n u c l e a s e  a c t i v i t y  was a s s a y e d  
by d e t e r m i n a t i o n  o f  t h e  i n c r e a s e  in a b s o r b a n c e  a t  260  my a f t e r  t r e a t ­
m en t  o f  r i b o n u c l e i c  a c i d  w i t h  u n h e a t e d  and  h e a t e d  ( 7 0  C, 2 h r )  RNase 
( 6 2 ) .  A u n i t  o f  RNase i s  t h a t  amount  o f  a c t i v i t y  w h ic h  c a u s e s  an i n ­
c r e a s e  in a b s o r b a n c e  o f  o n e  un i t / m  in  u n d e r  s t a n d a r d  c o n d i t i o n s .
U n h e a t e d  RNase had an a c t i v i t y  o f  0 . 0 0 4 8  u n i t s / m l / m i n .  The  s p e c i f i c  
a c t i v i t y  o f  t h e  p r e p a r a t i o n s  was 0 . 4 8  u n i t s / m g  f o r  u n h e a t e d  RNase and  
2 . 4  X 10” ^ u n i t s / m g  f o r  h e a t e d  RNase .  Wi th  t h e  e x c e p t i o n s  o f  enzyme 
and  b u f f e r s  u s e d ,  t h e  r e m a i n d e r  o f  t h e  RNase t r e a t m e n t  was t h e  same a s  
t h e  a b o v e  f o r  DNase.
F o l l o w i n g  i n c u b a t i o n  and  c o n c e n t r a t i o n  a s  a b o v e ,  t h e  p r o t e i n  
c o n t e n t s  o f  t h e  t r e a t e d  p r e p a r a t i o n s  w e r e  a d j u s t e d  t o  2 . 5  mg/ml f o r  
u s e  in  s k i n  t e s t i n g  o f  s e n s i t i z e d  a n i m a l s .
E t h e r  E x t r a c t i o n  o f  S o l u b l e  A n t i g e n  
F i f t y  m i l l i l i t e r  p o r t i o n s  o f  HSV SA o r  CEF c o n t r o l  p r e p a r a t i o n s  
w e r e  e a c h  e x t r a c t e d  t h r e e  t i m e s  w i t h  50 ml v o lu m e s  o f  e t h y l  e t h e r .  
F o l l o w i n g  e t h e r  e x t r a c t i o n ,  t h e  p r e p a r a t i o n s  w e re  h e a t e d  a t  37 C u n d e r  
f l o w i n g  n i t r o g e n  t o  remove  r e s i d u a l  e t h e r  b e f o r e  b e i n g  s u b j e c t e d  t o  
u l t r a f i l t r a t i o n  and u s e d  a s  s k i n  t e s t  a n t i g e n s .
D i a l y s i s  o f  S o l u b l e  A n t i g e n  
CEF SA and  c o n t r o l  CEF p r e p a r a t i o n s  w er e  d i a l y z e d  a g a i n s t  d i s ­
t i l l e d  w a t e r  f o r  48 h r  a t  5 C. When p r e c i p i t a t e s  w e r e  n o t e d  in  t h e
R i b o n u c l e a s e ,  RNase-A,  P r o t e a s e  f r e e ,  Type  X l l - A ,  B o v i n e  P a n -  
c r e a s e ,  Sigma C hemica l  C o . ,  S t .  L o u i s ,  Mo . ,  Lot  2 7 8 - 8 5 5 0 .
37
d i a l y s i s  b a g s ,  t h e  c o n t e n t s  w e r e  c e n t r i f u g e d  a t  5 C f o r  15 min a t  
700 X g .  The s u p e r n a t a n t  f l u i d s  w e r e  s a v e d  and u s e d  a s  s k i n  t e s t  a n t i ­
g e n s  f o l l o w i n g  a d j u s t m e n t  o f  p r o t e i n  c o n c e n t r a t i o n s  t o  150 y g / m l .  
S e d i m e n t s  w e r e  r e s u s p e n d e d  In PBS, pH 7 . 0 ,  a nd  t h e  p r o t e i n  c o n c e n t r a ­
t i o n  was a d j u s t e d  t o  150 y g / m l .  T h i s  m a t e r i a l  was u s e d  a s  a s k i n  t e s t  
a n t i g e n .
When a n t i g e n  p r e p a r a t i o n s  w e r e  d i a l y z e d  a g a i n s t  PBS, t r e a t m e n t  
was c a r r i e d  o u t  a t  5 C f o r  48 h r .
U l t r a f i l t r a t i o n  o f  S o l u b l e  A n t i g e n
S i z e  e s t i m a t e s  o f  t h e  SA f r a c t i o n  r e s p o n s i b l e  f o r  e l i c i t i n g
s k i n  t e s t  r e a c t i o n s  w e r e  made by f i l t r a t i o n  o f  CEF SA t h r o u g h  XM-100
27
and XM-50 u l t r a f i l t r a t i o n  m e m b r a n e s .  F o l l o w i n g  f i l t r a t i o n  t h r o u g h  
t h e  m emb rane ,  HSV SA p r e p a r a t i o n s  w e r e  c o n c e n t r a t e d  by l y o p h i I I z a t l o n  
and  t h e  p r o t e i n  c o n t e n t s  w e r e  a d j u s t e d  t o  1 . 5  mg/ml by s p e c t r o p h o t o -  
m e t r l c  m e t h o d s  b e f o r e  u s e .  T h e s e  a n t i g e n s  w e r e  u s e d  in  t e s t i n g  o f  
b o t h  HSV s e n s i t i z e d  and  L c e l l  s e n s i t i z e d  g u i n e a  p i g s .
27 Am I con  C o r p o r a t i o n ,  L e x i n g t o n ,  M ass .
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RESULTS
A n t i g e n  P r e p a r a t i o n s  
F o r  t h e  p u r p o s e  o f  c l a r i t y  in p r e s e n t a t i o n ,  a c a t a l o g u e  o f  
a n t i g e n s  u s e d  in t h i s  s t u d y ,  i n c l u d i n g  i n f o r m a t i o n  on t h e  n a t u r e  of  
v i r a l ,  s o l u b l e  and  c o n t r o l  a n t i g e n s  and  c e l l  c u l t u r e s ,  l i s t i n g  c e l l s ,  
m e d i a ,  a n d  s e r a  u s e d  in t h e  p r o d u c t i o n  o f  a n t i g e n  p o o l s  i s  p r e s e n t e d  
in  T a b l e  1 .  H e r p e s  s i m p l e x  v i r u s  (HSV) a n t i g e n s  were  a l s o  p r e p a r e d  
f rom i n f e c t e d  c h i c k  embryo a l l a n t o i c  f l u i d .  In o r d e r  t o  p r e v e n t  un­
d e s i r a b l e  c r o s s  r e a c t i o n s  s e v e r a l  v i r a l  p r e p a r a t i o n s  f rom L and c h i c k  
embryo  f i b r o b l a s t  c e l l  c u l t u r e s  w e r e  p r e p a r e d .  L i k e w i s e ,  t h e  s e r a  
u s e d  t o  s u p p l e m e n t  g r o w t h  m e d ia  w e r e  v a r i e d  t o  o b v i a t e  c r o s s  r e a c t i v i t y  
d ue  t o  u s e  o f  t h e  same s e ru m  in  b o t h  s e n s i t i z i n g  and  c h a l l e n g e  a n t i ­
g e n  p r e p a r a t i o n s .  The HSV s e n s i t i z i n g  a n t i g e n  p r e p a r e d  in L c e l l s  and 
t h e  v a c c i n i a  v i r u s  s e n s i t i z i n g  a n t i g e n  p r e p a r e d  in  CEF had i n f e c t i v i t y  
t i t e r s  o f  1 0 ^ ' ^  and  5 X 1 0 ^ ' ^  TCID^Q/ml,  r e s p e c t i v e l y .  S i n c e  t h e  
amoun t  o f  p r o t e i n  in t h e s e  a n t i g e n s  v a r i e d  from 1 . 5  t o  11 m g /m l ,  t h e  
p r o t e i n  c o n c e n t r a t i o n s  w e re  a d j u s t e d  t o  a p p r o x i m a t e l y  150 y g / O . 1 ml 




ANTIGENS USED IN SKIN TEST STUDIES
A n t i g e n S o u r c e
TC'OSO*
P r o t e i n
(mg/m l)
N a t u r e Use C e l l Med Ium Serum
Lowry 
e t  a l . 
( 59)
K a l c k a r
(51)
HSV S^ L-929 MEM91 Hg H o r s e Iq6 . 5 - -
HSV SA S L-929 MEMg, Hg H o r s e - 11 . 0 -
HSV SA c" CE Embryo None - - 3 . 9 8
C o n t r o l S / C L-929 MEM9 I Hg H o r s e - 10 . 0 -
C o n t r o l c CE Embryo None - - 5 . 5 7
VV s CEF LHYE C a l f 5 X l o f ' S - -
VSA c CEF LHYE C a l f - - 2 . 0
HSV SA c CEF LHYE C a l f - - 1 .5
CEF C o n t r o l c CEF LHYE C a l f - - 1 .5
®AII a b b r e v i a t i o n s  e x p l a i n e d  in C h a p t e r  I I .  
^ A n t i g e n  u se d  t o  s e n s i t i z e  a n i m a l s .
' A n t i g e n  u se d  t o  c h a l l e n g e  a n i m a l s .
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S e n s i t i z a t i o n  o f  G u i n e a  P i g s  t o  H e r p e s  S i m p l e x  V i r u s  A n t i g e n s
I n f e c t i v e  H e r p e s  S i m p l e x  V i r u s  
One i n j e c t i o n . The  s k i n  t e s t  r e a c t i o n s  in f i v e  g u i n e a  p i g s  
w hi ch  w e r e  s e n s i t i z e d  by t h e  i n t r a d e r m a l  i n j e c t i o n  o f  0 . 1  ml o f  HSV 
(1 0 ^ * ^  TCIDj q ) an d  c h a l l e n g e d  14 d a y s  l a t e r  w i t h  CE p r e p a r e d  SA, wh ich  
had be e n  d i a l y z e d  a g a i n s t  PBS, a r e  p r e s e n t e d  in  T a b l e  2 .  N e i t h e r  
e r y t h e m a  n o r  i n d u r a t i o n  w e r e  s e e n  in t h e  s k i n  r e a c t i o n s  t o  SA a t  2 h r  
( F i g u r e  2 ) .  S l i g h t  e r y t h e m a  was n o t e d  by 4 h r ,  b u t  d i s c e r n a b l e  i n d u r ­
a t i o n  was n o t  p r e s e n t  ( T a b l e  2 ) .  Maximal e r y t h e m a  o c c u r r e d  a t  16 h r ,  
b u t  i n d u r a t i o n  n o t e d  a t  t h i s  t i m e  was o f  b o r d e r l i n e  i n t e n s i t y  a n d ,  
t h e r e f o r e ,  n o t  r e a d i l y  m e a s u r a b l e .  T h u s ,  o n l y  a v e r a g e  d i a m e t e r s  o f  
e r y t h e m a  a r e  r e p o r t e d .  B o th  e r y t h e m a t o u s  and  i n d u r a t i v e  r e a c t i o n s  
( F i g u r e  3)  w e r e  somew hat  s m a l l e r  a t  24 h r  t h a n  a t  16 h r ,  had d i m i n i s h e d  
g r e a t l y  by 48  h r ,  a n d  had  d i s a p p e a r e d  by 72 h r .  E r y th e m a  and  i n d u r a ­
t i o n  in t h e  CE c o n t r o l  a n t i g e n  s i t e  w e r e  n e g l i g i b l e .  The  r e s p o n s e  t o  
CE c o n t r o l  a n t i g e n  a t  2 h r  was z e r o  ( F i g u r e  2 ) .  A s l i g h t  r e a c t i o n  
became e v i d e n t  by 4 h r  a n d  was maximal  a t  16 h r .  The  c o n t r o l  r e a c t i o n  
d i s a p p e a r e d  c o m p l e t e l y  by 24 h r  an d  n e v e r  a t t a i n e d  t h e  i n t e n s i t y  o f  
e r y t h e m a  n o t e d  a t  t h e  SA s i t e  in t h e s e  a n i m a l s .  I n d u r a t i o n  was n e v e r  
o b s e r v e d  a t  t h e  CE c o n t r o l  a n t i g e n  s i t e s .
Two i n j e c t i o n s . S i x  a n i m a l s  w h ic h  had  r e c e i v e d  two s e n s i t i z i n g
5 5
i n j e c t i o n s  o f  i n f e c t i o u s  HSV ( 1 0  * TCID^q/ G . I  ml )  on d a y s  0 and  14 
w e r e  c h a l l e n g e d  on  day  26 w i t h  SA and  CE c o n t r o l  a n t i g e n s .  The l a r g e s t  
r e s p o n s e s  a t  t h e  SA c h a l l e n g e  s i t e s  in  t h e s e  a n i m a l s  o c c u r r e d  a t  16 h r  
( T a b l e  3 ) .  E r y t h e m a  a n d  i n d u r a t i o n  w e r e  o f  c o m p a r a b l e  s i z e  a t  16 and  
24 h r  and  w e r e  s t i l l  e v i d e n t  a t  48  h r .  No r e a c t i o n s  w e r e  s e e n  a t  72 h r .
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TABLE 2
SKIN TEST REACTIONS IN GUINEA PIGS SENSITIZED® WITH ONE INJECTION 
OF HSV AND CHALLENGED WITH SOLUBLE ANTIGEN
Time
A n t i g e n
( H o u r s )
SA^ C on t r o l *-
0 . 5 Qd Qd
4 3 . 6 0 . 9
16 12.1 1 . 1
24 7 . 5 0
48 3 . 3 0
72 0 0
^ A n i m a l s  s e n s i t i z e d  by s i n g l e  i n j e c t i o n  HSV, 10^*^ TCIDc q ; 
c h a l l e n g e d  14 d a y s  l a t e r .
S o l u b l e  a n t i g e n  p r e p a r e d  f rom  HSV i n f e c t e d  CE a l l a n t o i c  f l u i d .  
^ C o n t r o l  a n t i g e n  p r e p a r e d  f rom u n i n f e c t e d  CE a l l a n t o i c  f l u i d .
^Average  d i a m e t e r  o f  e r y t h e m a  in  mm; 5 a n i m a l s .
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m
F i g u r e  2 .  S k i n  r e a c t i o n s  o f  an  I n f e c t i v e  HSV s e n s i t i z e d  
g u i n e a  p i g  2 h r  a f t e r  c h a l l e n g e  w i t h  CE c o n t r o l  a n t i g e n  ( l e f t  s i d e )  
a n d  HSV SA ( r i g h t  s i d e ) ,  1 / 3  normal  s i z e .
F i g u r e  3 .  S k i n  r e a c t i o n s  o f  an  I n f e c t i v e  HSV s e n s i t i z e d  
g u i n e a  p i g  24 h r  a f t e r  c h a l l e n g e  w i t h  CE c o n t r o l  a n t i g e n  ( l e f t  
s i d e )  an d  HSV SA ( r i g h t  s i d e ) ,  1 / 3  nor ma l  s i z e .
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TABLE 3
SKIN TEST REACTIONS IN GUINEA PIGS SENSITIZED^ WITH TWO INJECTIONS 
OF HSV AND CHALLENGED WITH SOLUBLE ANTIGEN
Time
( H o u r s )
E ry th em a 1n d u r a t l o n
SA^ C o n t r o l SAd C o n t r o l
0 . 5 Od Od Od od
4 11 .3 7 . 6 5 . 7 3 . 7
16 15 .4 2 . 8 11 . 2 0
24 14 .5 2 . 5 8 . 4 0
48 10.4 0 . 5 5 . 0 0
72 0 0 0 0
^A n i m a l s  s e n s i t i z e d  by tw o  I n j e c t i o n s  HSV, 10^"^  TCIDrQ on d a y s  
0 and  14; c h a l l e n g e d  on day  28 .
^ S o l u b l e  a n t i g e n  p r e p a r e d  f rom HSV i n f e c t e d  CE a l l a n t o i c  f l u i d .
("Cont ro l  a n t i g e n  p r e p a r e d  f rom u n i n f e c t e d  CE a l l a n t o i c  f l u i d .
^Average d i a m e t e r  In mm; 6 a n i m a l s .
4 4
W h il e  c e n t r a l  b l a n c h i n g  o f  t h e  l e s i o n s  o c c a s i o n a l l y  o c c u r r e d ,  n e c r o s i s  
was n o t  o b s e r v e d  w i t h  t h e  c o n c e n t r a t i o n  o f  a n t i g e n  e m p l o y e d .  The r e ­
a c t i o n s  t o  CE c o n t r o l  a n t i g e n  In t h e s e  a n i m a l s  w e r e  t r a n s i e n t .  E ry th em a  
was maximal a t  4 h r  an d  d e c r e a s e d  t o  l e s s  t h a n  o n e - h a l f  I t s  f o r m e r  
l e v e l  by 16 h r .  I n d u r a t i o n  was d e t e c t a b l e  o n l y  a t  4 h r  and  d i s a p p e a r e d  
by 16 h r .  The a r e a  o f  e r y t h e m a  was s m a l l e r  and  t h e  I n t e n s i t y  o f  I n d u r ­
a t i o n  was l e s s  a t  t h e  CE c o n t r o l  s i t e s  t h a n  a t  SA s i t e s .  The d i a m e t e r s  
o f  b o t h  e r y t h e m a  and  I n d u r a t i o n  w ere  l a r g e r  a t  t h e  SA s i t e s  t h a n  a t  t h e  
CE c o n t r o l  a n t i g e n  s i t e s  a t  4 ,  16,  2 4 ,  and  48  h r  a f t e r  c h a l l e n g e .  Re­
a c t i o n s  t o  b o t h  a n t i g e n s  w e r e  z e r o  a t  0 . 5  an d  72 h r .
H e a t e d  H e r p e s  S i m p l e x  V i r u s  
G u i n e a  p i g s  I n o c u l a t e d  w i t h  h e a t e d  HSV p r e p a r a t i o n s  ( 1 0 ^ * ^  TCIDg^ 
p r i o r  t o  I n a c t i v a t i o n ) ,  wh ich  c o n t a i n e d  no d e t e c t a b l e  I n f e c t i v e  v i r u s ,  
r e c e i v e d  0 .1  ml o f  m a t e r i a l  on  d a y s  0 and  14 and  w ere  c h a l l e n g e d  w i t h  
SA and  CE c o n t r o l  a n t i g e n s  on  day  2 8 .  D i a m e t e r s  o f  e r y t h e m a  a t  SA 
s i t e s  w e r e  l a r g e r  t h a n  t h o s e  a t  CE c o n t r o l  a n t i g e n  s i t e s  a t  24 an d  48 
h r  ( T a b l e  4 ) .  SA s k i n  t e s t  s i t e s  d e v e l o p e d  l a r g e r  d i a m e t e r s  o f  I n d u r a ­
t i o n  t h a n  CE c o n t r o l  a n t i g e n  c h a l l e n g e  s i t e s  a t  16,  2 4 ,  and  48  h r .
T h e s e  r e s u l t s  d e m o n s t r a t e  t h e  a b i l i t y  o f  n o n - I n f e c t i v e  HSV t o  s e n s i t i z e  
a n i m a l s  t o  a s k i n  t e s t  a n t i g e n  o f  HSV.
H e r p e s  S i m p l e x  V i r u s  S o l u b l e  A n t i g e n  
A s i n g l e  I n j e c t i o n  o f  HSV SA p r e p a r e d  In L c e l l s  ( 1 .1  mg o f  
p r o t e l n / 0 . 1  m l)  s e n s i t i z e d  g u i n e a  p i g s  t o  HSV SA (4 0 0  y g / 0 . 1  m l)  p r e ­
p a r e d  from I n f e c t i o u s  a l l a n t o i c  f l u i d  ( T a b l e  5 ) .  A n im a ls  s o  s e n s i t i z e d  
showed maximal  e r y t h e m a t o u s  r e s p o n s e s  t o  b o t h  CE c o n t r o l  and s o l u b l e
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TABLE 4
SKIN TEST REACTIONS IN GUINEA PIGS SENSITIZED^ WITH 
HEATED HSV AND CHALLENGED WITH SOLUBLE ANTIGEN
Time
E ry th em a I n d u r a t i o n
( H o u r s )
SA^ C o n t r o l * ' SA^ C o n t r o l ^
0 . 5 od Qd od od
4 9 . 9 7 . 9 5 . 2 4 . 3
16 8 . 4 4 . 3 4 . 6 1 . e
24 9 . 8 0 5 . 5 1 . 0
48 7 . 5 0 2 . 5 0
72 0 0 0 0
^ A n im a ls  s e n s i t i z e d  by two i n j e c t i o n s  h e a t e d  HSV ( p r i o r  t o  i n ­
a c t i v a t i o n ,  I 0 5 ' 5  TCID5 0 ) on  d a y s  0  and  14; c h a l l e n g e d  on day  28 ,
^ S o l u b l e  a n t i g e n  p r e p a r e d  f rom HSV i n f e c t e d  CE a l l a n t o i c  f l u i d .
^ C o n t r o l  a n t i g e n  p r e p a r e d  f rom u n i n f e c t e d  CE a l l a n t o i c  f l u i d .
^ A v e r a g e  d i a m e t e r  in  mm; 6  a n i m a l s .
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TABLE 5
SKIN TEST REACTIONS IN SOLUBLE ANTIGEN SENSITIZED 
GUINEA PIGS® CHALLENGED WITH SOLUBLE ANTIGEN
Time
A n t i g e n
( H o u r s )
SA^ C o n t r o l ^
0 . 5 O'^ O'^
4 1 .4 0 . 6
16 7 . 9 1 .4
24 4 . 2 0 . 5
48 2 . 2 1.1
72 0 0
^ A n i m a l s  s e n s i t i z e d  by s i n g l e  I n j e c t i o n  o f  HSV SA, I . I  mg; 
c h a l l e n g e d  14 d a y s  l a t e r .
^ S o l u b l e  a n t i g e n  p r e p a r e d  f rom HSV I n f e c t e d  CE a l l a n t o i c  f l u i d .
‘' C o n t r o l  a n t i g e n  p r e p a r e d  f rom u n i n f e c t e d  CE a l l a n t o i c  f l u i d .
^ A v e r a g e  d i a m e t e r  o f  e r y t h e m a  In mm; 21 a n i m a l s .
47
a n t i g e n s  a t  16 h r .  D i a m e t e r s  o f  e r y t h e m a  a t  t h e  SA s i t e s  w ere  l a r g e r  
t h a n  a t  CE c o n t r o l  a n t i g e n  s i t e s  a t  16 ,  2 4 ,  and  48 h r  a f t e r  c h a l l e n g e .  
No e r y t h e m a  was s e e n  0 . 5  h r  a f t e r  s k i n  t e s t i n g ,  b u t  by 2 h r ,  a f a i n t  
r e d n e s s  was o b s e r v e d  o c c a s i o n a l l y  ( F i g u r e  4 ) .  A c o m p a r i s o n  o f  t h e  
r e s p o n s e  t o  SA a t  24 h r  in  SA s e n s i t i z e d  a n i m a l s  ( F i g u r e  5)  w i t h  t h a t  
in  HSV s e n s i t i z e d  a n i m a l s  ( F i g u r e  3)  r e v e a l s  a more  i n t e n s e  r e a c t i o n  
in  t h e  l a t t e r  a n i m a l s .
C o m p a r i s o n  o f  S e n s i t i z a t i o n  Methods
One i n j e c t i o n  o f  s o l u b l e  a n t i g e n  and  i n f e c t i o u s  h e r p e s  s i m p l e x  
v i r u s . S i n c e  in t h e  s t u d i e s  d e s c r i b e d  a b o v e ,  t h e  r e s u l t s  o f  w h ic h  a r e  
p r e s e n t e d  in T a b l e s  2 and  5 ,  t h e  a n i m a l s  had  be en  s k i n  t e s t e d  w i t h  t h e  
same SA p r e p a r a t i o n ,  i t  was o f  i n t e r e s t  t o  co m p a re  t h e  r e s u l t i n g  r e ­
a c t i o n s .  The r e s u l t s  o f  t h i s  c o m p a r i s o n  c a n  be  s e e n  In T a b l e  6 .
A v e r a g e  d i a m e t e r s  o f  e r y t h e m a  w e r e  l a r g e r  in  HSV i n f e c t e d  a n i m a l s  f rom 
4 t h r o u g h  46  h r  o f  e x a m i n a t i o n .  No r e a c t i o n s  w e r e  d e t e c t e d  a t  0 . 5  and  
72  h r .  The r e a c t i o n s  in  b o t h  g r o u p s  w e r e  maximal a t  16 h r  and  d i m i n ­
i s h e d  s l i g h t l y  by 24  h r .  The o n l y  t i m e  a t  w hi ch  HSV s e n s i t i z e d  a n i m a l s  
r e s p o n d e d  w i t h  s i g n i f i c a n t l y  g r e a t e r  s k i n  r e a c t i o n s  t h a n  SA s e n s i t i z e d  
a n i m a l s  was a t  16 h r .  No i n d u r a t i o n  was n o t e d  in  any  o f  t h e  a n i m a l s .  
From t h e s e  r e s u l t s  i t  may be c o n c l u d e d  t h a t  i n f e c t i v e  HSV i s  a  b e t t e r  
s e n s i t i z i n g  a g e n t  t h a n  SA. T h e s e  d a t a  and  e a r l i e r  r e s u l t s  w i t h  a n i ­
m a l s  immunized w i t h  S e a t e d  HSV ( T a b l e  4)  d e m o n s t r a t e  t h a t  I n f e c t i v e  HSV 
i s  n o t  r e q u i r e d  t o  p r o d u c e  d e l a y e d  h y p e r s e n s i t i v i t y  t o  SA.
Two i n j e c t i o n s  o f  a c t i v e  h e r p e s  s i m p l e x  v i r u s  and  h e a t e d  h e r p e s  
s i m p l e x  v i r u s . When g u i n e a  p i g s  w e r e  s e n s i t i z e d  w i t h  two i n j e c t i o n s  
o f  e i t h e r  i n f e c t i o u s  ( T a b l e  3)  o r  h e a t e d  ( T a b l e  4)  HSV and  s k i n  t e s t e d
4 8
i l
F i g u r e  4 .  S k i n  r e a c t i o n s  o f  an HSV SA s e n s i t i z e d  g u i n e a  
p i g  2 h r  a f t e r  c h a l l e n g e  w i t h  CE c o n t r o l  a n t i g e n  ( l e f t  s i d e )  and  
HSV SA ( r i g h t  s i d e ) ,  1 / 3  normal  s i z e .
F i g u r e  5 .  S k i n  r e a c t i o n s  o f  an  HSV SA s e n s i t i z e d  g u i n e a  
p i g  24 h r  a f t e r  c h a l l e n g e  w i t h  CE c o n t r o l  a n t i g e n  ( l e f t  s i d e )  and  
HSV SA ( r i g h t  s i d e ) ,  1 / 3  normal  s i z e .
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TABLE 6
AVERAGE DIAMETERS OF ERYTHEMA IN GUINEA PIGS SENSITIZED WITH HSV 
SOLUBLE ANTIGEN® OR ACTIVE HSV° AND CHALLENGED 
WITH HSV SOLUBLE ANTIGEN
Time
A n t i g e n
(H o u r s )
SA^ HSV S i g n i f i c a n c e
0 . 5 od 0®
4 1.4 3 . 6
16 7 . 9 12.1
24 4 . 2 7 . 5
48 2 . 2 3 . 3
72 0 0
^ A n i m a l s  s e n s i t i z e d  by s i n g l e  i n j e c t i o n  o f  HSV SA, I . I  mg p r o t e i n ,  
c h a l l e n g e d  14 d a y s  l a t e r .
^ A n im a ls  s e n s i t i z e d  by s i n g l e  i n j e c t i o n  HSV, 10^*^ TCID ; c h a l ­
le n g e d  14 d a y s  l a t e r .
^ S o l u b l e  a n t i g e n  p r e p a r e d  from HSV i n f e c t e d  CE a l l a n t o i c  f l u i d .
^ A v e r a g e  d i a m e t e r  o f  e r y t h e m a  in mm; 21 a n i m a l s .
^ A v e r a g e  d i a m e t e r  o f  e r y t h e m a  in mm; 5 a n i m a l s .
^ S t a t i s t i c a l l y  s i g n i f i c a n t  (p < 0 . 0 5 )  d i f f e r e n c e .  S t u d e n t ' s  " t "
t e s t .
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l a t e r  w i t h  SA, l a r g e r  r e a c t i o n s  w e r e  p r o d u c e d  w i t h  SA t h a n  w i t h  CE c o n ­
t r o l  a n t i g e n .  Bo th  s e n s i t i z i n g  a n t i g e n s  w e r e  p r e p a r e d  In L c e l l  f i b r o ­
b l a s t s  p r o l i f e r a t e d  In MEM^j Hg. The  c h a l l e n g e  p r e p a r a t i o n  was p r e p a r e d  
f rom H S V - l n f e c t e d  CE a l l a n t o i c  f l u i d .  D a t a  f rom t h e  two s t u d i e s  ha v e  
be e n  c o m b in e d  In T a b l e  7 .  E x c e p t  f o r  z e r o  r e a d i n g s  a t  0 . 5  an d  72 h r ,  
l a r g e r  d i a m e t e r s  o f  e r y t h e m a  and  I n d u r a t i o n  w e r e  o b s e r v e d  In g u i n e a  
p i g s  s e n s i t i z e d  w i t h  I n f e c t i v e  v i r u s  t h a n  In a n i m a l s  I n j e c t e d  w i t h  t h e  
same m a t e r i a l  w h i c h  h a d  b een  h e a t e d  f o r  2  h r  a t  56  C. At  16 h r ,  d ia m­
e t e r s  o f  b o t h  e r y t h e m a  an d  I n d u r a t i o n  In H S V - l n f e c t e d  a n i m a l s  w e r e  s i g ­
n i f i c a n t l y  l a r g e r  t h a n  t h o s e  In a n i m a l s  Immunized w i t h  h e a t e d  HSV. At  
24  h r  t h e  d i a m e t e r s  o f  e r y t h e m a  w e r e  s i g n i f i c a n t l y  d i f f e r e n t  w h i l e  t h e  
d i a m e t e r s  o f  I n d u r a t i o n  w e r e  n o t .  T h e s e  r e s u l t s  I n d i c a t e  t h a t  I n f e c ­
t i v e  HSV I s  a b e t t e r  s e n s i t i z i n g  a n t i g e n  t h a n  h e a t e d  HSV.
C o m p a r i s o n  o f  v a r i o u s  m e t h o d s  o f  s e n s i t i z a t i o n . In t h e  p r e ­
v i o u s  s t u d i e s .  I n f e c t i v e  HSV ( T a b l e  3 ) ,  h e a t - I n a c t I v a t e d  HSV ( T a b l e  4 ) ,  
and  t h e  SA ( T a b l e  5)  w e r e  f o u n d  t o  b e  c a p a b l e  o f  s p e c i f i c a l l y  s e n s i ­
t i z i n g  a n i m a l s  t o  HSV. The a v e r a g e  d i a m e t e r s  o f  e r y t h e m a  an d  I n d u r a ­
t i o n  p r o d u c e d  f o l l o w i n g  c h a l l e n g e  w i t h  SA In a n i m a l s  s e n s i t i z e d  by 
I n f e c t i v e  HSV, h e a t e d  HSV and  HSV SA a r e  shown In T a b l e  8 . A v e r a g e  
d i a m e t e r s  o f  I n d u r a t i o n  an d  e r y t h e m a  w e r e  a t  maximum by 16 h r .  The 
a v e r a g e  d i a m e t e r s  o f  e r y t h e m a  and I n d u r a t i o n  c a n  be  r a n k e d  a c c o r d i n g  
t o  t h e  me th od  o f  s e n s i t i z a t i o n .  R e a c t i o n s  w e r e  l a r g e s t  In a n i m a l s  
s e n s i t i z e d  w i t h  two I n j e c t i o n s  o f  I n f e c t i v e  HSV. The s e c o n d  l a r g e s t  
r e a c t i o n s  w e r e  o b s e r v e d  In a n i m a l s  s e n s i t i z e d  w i t h  two I n j e c t i o n s  o f  
I n a c t l v a t e d - H S V .  S m a l l e s t  r e a c t i o n s  t o  SA w e r e  n o t e d  In a n i m a l s  
s e n s i t i z e d  w i t h  a s i n g l e  I n j e c t i o n  o f  SA. The  SA s e n s i t i z e d  a n i m a l s
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TABLE 7
SKIN TEST REACTIONS IN ANIMALS SENSITIZED WITH ACTIVE® OR HEATED^ 
HSV AND CHALLENGED WITH SOLUBLE ANTIGEN^
Time
E ry th e m a I n d u r a t i o n
( H o u r s )
Ac t  i ve  
HSV
H e a t e d
HSV
S i g n i f i ­
c a n c e
A c t  i v e  
HSV
H e a t e d
HSV
S i g n i f i ­
c a n c e
0 . 5 od od Qd od
4 11 .3 9 . 9 5 . 7 5 . 2
16 1 5 . 4 8 . 4 11 . 2 4 . 6 +
24 14 .5 9 . 8 + 8 . 4 5 . 5
48 1 0 .4 7 . 5 5 . 0 2 . 5
72 0 0 0 0
^ A n i m a l s  s e n s i t i z e d  by two i n j e c t i o n s  HSV, 10^*^ TCID5Q, on  d a y s  
0 and  14; c h a l l e n g e d  on  day  28 .
^A n i m a l s  s e n s i t i z e d  by two i n j e c t i o n s  h e a t e d  HSV on  d a y s  0 and  
14; c h a l l e n g e d  on  day  28 .
^ S o l u b l e  a n t i g e n  p r e p a r e d  f rom HSV i n f e c t e d  CE a l l a n t o i c  f l u i d .
^ A v e r a g e  d i a m e t e r  in  mm; 6  a n i m a l s .
^ S t a t i s t i c a l l y  s i g n i f i c a n t  (p < 0 . 0 1 )  d i f f e r e n c e ,  S t u d e n t ' s  " t "
t e s t .
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TABLE 8
SKIN TEST REACTIONS TO SOLUBLE ANTIGEN IN GUINEA PIGS 
SENSITIZED BY THREE METHODS
Time
------------------
E ry th e m a I n d u r a t i o n
( H o u r s )
A c t  i ve 
HSV®




A ct  i ve  
HSV®




4 11 . 3 d 9 . g d l . 4 d 5 . 7 d 5 . 2 d od
16 15.4 8 . 4 7 . 9 11 . 2 4 . 6 0
24 14.5 9 . 8 4 . 2 8 . 4 5 . 5 0
48 10.4 7 . 5 2 . 2 5 . 0 2 . 5 0
^ S i x  a n i m a l s  in g r o u p ,  s e n s i t i z e d  by two i n j e c t i o n s  HSV, 
l O ^ ' S  TCID5 0 ,  c h a l l e n g e d  w i t h  CE HSV SA.
*^Six a n i m a l s  in g r o u p ,  s e n s i t i z e d  by two i n j e c t i o n s  o f  h e a t e d  
HSV, c h a l l e n g e d  w i t h  CE HSV SA.
^ T w e n t y - o n e  a n i m a l s  in g r o u p ,  s e n s i t i z e d  by s i n g l e  i n j e c t i o n  
s o l u b l e  a n t i g e n ,  1.1 mg p r o t e i n ,  c h a l l e n g e d  w i t h  CE HSV SA.
^ A v e r a g e  d i a m e t e r  in mm.
53
d i d  n o t  r e s p o n d  w i t h  i n d u r a t i o n  ( T a b l e  3 ) .  The l a r g e s t  s k i n  r e a c t i o n s ,  
in  which  c o n s i d e r a b l e  i n d u r a t i o n  was c o n s i s t e n t l y  p r o d u c e d ,  w e re  o b ­
s e r v e d  in t h e  a n i m a l s  r e c e i v i n g  two i n j e c t i o n s  o f  i n f e c t i v e  HSV.
S p e c i f i c i t y  o f  t h e  S k i n  T e s t  R e a c t i o n
When s i x  g u i n e a  p i g s  w e r e  s e n s i t i z e d  w i t h  5 X 1 0 ^ ’ ^ TCID^g o f
v a c c i n i a  v i r u s  and s k i n  t e s t e d  14 d a y s  l a t e r  w i t h  v a c c i n i a  s o l u b l e
a n t i g e n  (VSA) and  L c e l l  p r e p a r e d  HSV SA, n e i t h e r  e r y t h e m a  n o r  i n d u r ­
a t i o n  was n o t e d  in any  o f  t h e  a n i m a l s .  In a d d i t i o n ,  one  g r o u p  o f  
s i x  a n i m a l s  was s e n s i t i z e d  w i t h  L c e i l  c o n t r o l  a n t i g e n  p l u s  50% FCA; 
a n o t h e r  g r o u p  was s e n s i t i z e d  w i t h  i n f e c t i v e  HSV p l u s  50% FCA. When 
t h e s e  a n i m a l s  w e re  s k i n  t e s t e d  w i t h  VSA, r e a c t i o n s  o f  e q u a l  s i z e  w e re  
s e e n  in t h e  tw o g r o u p s .  When HSV SA was u se d  a s  t h e  s k i n  t e s t  a n t i g e n ,  
much l a r g e r  r e a c t i o n s  w e r e  s e e n  in t h e  HSV s e n s i t i z e d  a n i m a l s  t h a n  in  
a n i m a l s  s e n s i t i z e d  w i t h  L c e l l  c o n t r o l .  No e r y t h e m a  was n o t e d  a t  2 o r  
24 h r  in L c e l l  c o n t r o l  a n t i g e n - s e n s i t i z e d  a n i m a l s  c h a l l e n g e d  w i t h  
HSV SA ( F i g u r e s  6  and  7 ) .
N a t u r e  o f  C e l l u l a r  I n f i l t r a t e  in  S k i n  T e s t  S i t e s  
L c e l l  c o n t r o l  s e n s i t i z e d  a n i m a l s . Very l i t t l e  l e u c o c y t i c  
i n f i l t r a t i o n  was n o t e d  in h i s t o l o g i c  s e c t i o n s  f rom L c e l l  c o n t r o l  
s e n s i t i z e d  a n i m a l s  a t  e i t h e r  CE c o n t r o l  ( F i g u r e  8 ) o r  SA ( F i g u r e  9) 
t e s t  s i t e s  0 . 5  h r  a f t e r  c h a l l e n g e .  CE c o n t r o l  s i t e s  ex am in ed  24 h r  
a f t e r  c h a l l e n g e  c o n t a i n e d  a few m o n o n u c l e a r  and  p o l y m o r p h o n u c l e a r  
l e u c o c y t e s ,  b u t  had  no p e r i v a s c u l a r  i n f i l t r a t i o n  ( F i g u r e  1 0 ) .  However ,  
HSV SA s k i n  t e s t  s i t e s  showed f o c a l  m o n o n u c l e a r  c e l l  i n f i l t r a t i o n s  
w i t h  l a r g e  numbers  o f  l y m p h o c y t e s  a t  24 h r  ( F i g u r e  1 1 ) .
i n f e c t i v e  h e r p e s  s i m p l e x  v i r u s  s e n s i t i z e d  a n i m a l s . In p h o t o ­
m i c r o g r a p h s  o f  h i s t o l o g i c  s e c t i o n s  o f  s k i n  t e s t  s i t e s  f rom i n f e c t i v e
54
F i g u r e  6 . S k i n  r e a c t i o n s  o f  an  L c e l l  c o n t r o l  a n t i g e n  
s e n s i t i z e d  g u i n e a  p i g  2 h r  a f t e r  c h a l l e n g e  w i t h  CE c o n t r o l  a n t i g e n  
( l e f t  s i d e )  and HSV SA ( r i g h t  s i d e ) ,  1 / 3  norm al  s i z e .
F i g u r e  7 .  S k i n  r e a c t i o n s  o f  an  L c e l l  c o n t r o l  a n t i g e n  
s e n s i t i z e d  g u i n e a  p i g  24 h r  a f t e r  c h a l l e n g e  w i t h  CE c o n t r o l  a n t i g e n  
( l e f t  s i d e )  and HSV SA ( r i g h t  s i d e ) ,  1 /3  normal  s i z e .
55
F i g u r e  8 . H e m a t o x y l i n  an d  e c s i n  s t a i n e d  s e c t i o n  o f  t i s s u e  
f rom s k i n  t e s t  s i t e  o f  L c e l l  c o n t r o l  s e n s i t i z e d  g u i n e a  p i g  0 . 5  
h r  a f t e r  c h a l l e n g e  w i t h  CE c o n t r o l  a n t i g e n ,  200X.
F i g u r e  9 .  H e m a t o x y l i n  and e o s i n  s t a i n e d  s e c t i o n  o f  t i s s u e
from s k i n  t e s t  s i t e  o f  L c e l l  c o n t r o l  s e n s i t i z e d  g u i n e a  p i g  0 . 5  hr
a f t e r  c h a l l e n g e  w i t h  HSV SA , 200X.
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F i g u r e  10.  Hem a+ o x y l i n  a n d  e o s i n  s t a i n e d  s e c t i o n  o f  t i s s u e  
f rom  s k i n  t e s t  s i t e  o f  L c e l l  c o n t r o l  s e n s i t i z e d  g u i n e a  p i g  24 h r  
a f t e r  c h a l l e n g e  w i t h  CE c o n t r o l  a n t i g e n ,  200X.
F i g u r e  1 1 .  H e m a t o x y l i n  and e o s i n  s t a i n e d  s e c t i o n  o f  t i s s u e
from s k i n  t e s t  s i t e  o f  L c e l l  c o n t r o l  s e n s i t i z e d  g u i n e a  p i g  24 hr
a f t e r  c h a l l e n g e  w i t h  HSV SA, 200 X.
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HSV s e n s i t i z e d  g u i n e a  p i g s  t a k e n  0 . 5  h r  a f t e r  c h a l l e n g e  w i t h  CE c o n t r o l  
a n t i g e n  ( F i g u r e  12) and HSV SA ( F i g u r e  1 3 ) ,  a  m in im a l  c e l l u l a r  i n f i l ­
t r a t e  c o n s i s t i n g  o f  a few m o n o n u c l e a r  and  p o l y m o r p h o n u c l e a r  l e u c o c y t e s  
was o b s e r v e d .  By 24 h r ,  t h e  CE c o n t r o l  s i t e s  ( F i g u r e  14) had more  
c e l l u l a r  i n f i l t r a t e  t h a n  a t  0 . 5  h r ,  b u t  when c o m p a r e d  w i t h  t h e  SA s i t e s  
( F i g u r e  15) t h e  amo un t  o f  i n f i l t r a t i o n  was n e g l i g i b l e .  The SA s k i n  
t e s t  s i t e s  c o n t a i n e d  p r e d o m i n a n t l y  m o n o n u c l e a r  c e l l s  a t  24 h r .  The 
h i g h  d e g r e e  o f  m o n o n u c l e a r  c e l l  i n f i l t r a t i o n  a t  24  h r  in  t h e  SA s i t e  
p a r a l l e l s  t h e  am ou nt  o f  e r y t h e m a  n o t e d  in  t h e s e  a n i m a l s  ( F i g u r e  3 and 
T a b l e  2 ) .
H e r p e s  s i m p l e x  v i r u s  s o l u b l e  a n t i g e n  s e n s i t i z e d  a n i m a l s . No 
c e l l u l a r  i n f i l t r a t i o n  was n o t e d  in  c o n t r o l  a n t i g e n  s i t e s  f rom HSV SA 
s e n s i t i z e d  g u i n e a  p i g s  e x a m i n e d  0 . 5  h r  a f t e r  c h a l l e n g e  ( F i g u r e  16) .
The SA t e s t  s i t e  ( F i g u r e  17) c o n t a i n e d  a s m a l l  number  o f  p o l y m o r p h o ­
n u c l e a r  l e u c o c y t e s .  At  24 h r  t h e  c o n t r o l  a n t i g e n  s i t e  r e m a i n e d  
e s s e n t i a l l y  u n c h a n g e d ,  w i t h  o n l y  an o c c a s i o n a l  m o n o n u c l e a r  o r  p o l y ­
m o r p h o n u c l e a r  l e u c o c y t e  ( F i g u r e  1 8 ) .  P e r i v a s c u l a r  i n f i l t r a t i o n  o f  
p o l y m o r p h o n u c l e a r  l e u c o c y t e s  w i t h  a p r e d o m i n a t i n g  m o n o n u c l e a r  c e l l  
i n f i l t r a t e  was s e e n  in SA t e s t  s i t e s  a t  24 h r  ( F i g u r e s  19 an d  2 0 ) .
T h i s  i n f i l t r a t e  c l o s e l y  r e s e m b l e d  t h a t  s e e n  in SA s i t e s  a t  24 h r  in 
HSV i n f e c t e d  a n i m a l s  ( F i g u r e  1 5 ) .  On t h e  b a s i s  o f  t h e  c e l l  t y p e  o b ­
s e r v e d  a t  24 h r  in SA s e n s i t i z e d  a n i m a l s ,  t h e  r e s p o n s e  t o  SA in g u i n e a  
p i g s  s o  s e n s i t i z e d  a p p e a r s  t o  b e  a  d e l a y e d  h y p e r s e n s i t i v i t y  r e a c t i o n .
C h a r a c t e r i z a t i o n  o f  H e r p e s  S i m p l e x  V i r u s  S o l u b l e  A n t i g e n
D i a l y s i s
The  p r e c i p i t a t e  fo rm ed  when SA was d i a l y z e d  a g a i n s t  d i s t i l l e d  
w a t e r  a t  5 C f o r  48 h r  and  t h e  s u p e r n a t a n t  f l u i d  l e f t  when t h i s
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F i g u r e  12. H e m a t o x y l i n  and  e o s i n  s t a i n e d  s e c t i o n  o f  t i s s u e  
f rom s k i n  t e s t  s i t e  o f  I n f e c t i v e  HSV s e n s i t i z e d  g u i n e a  p i g  0 . 5  h r  
a f t e r  c h a l l e n g e  w i t h  CE c o n t r o l  a n t i g e n ,  200X.
F i g u r e  13 .  H e m a t o x y l i n  and e o s i n  s t a i n e d  s e c t i o n  o f  t i s s u e
from s k i n  t e s t  s i t e  o f  I n f e c t i v e  HSV s e n s i t i z e d  g u i n e a  p i g  0 . 5  hr
a f t e r  c h a l l e n g e  w i t h  HSV SA, 200X.
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F i g u r e  14. H e m a t o x y l i n  and  e o s i n  s t a i n e d  s e c t i o n  o f  t i s s u e  
f rom s k i n  t e s t  s i t e  o f  I n f e c t i v e  HSV s e n s i t i z e d  g u i n e a  p i g  24 h r  
a f t e r  c h a l l e n g e  w i t h  CE c o n t r o l  a n t i g e n ,  200X.
F i g u r e  15 .  H e m a t o x y l i n  and e o s i n  s t a i n e d  s e c t i o n  o f  t i s s u e
from s k i n  t e s t  s i t e  o f  i n f e c t i v e  HSV s e n s i t i z e d  g u i n e a  p i g  24 hr
a f t e r  c h a l l e n g e  w i t h  HSV SA, 200 X.
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F i g u r e  16.  H e m a t o x y l i n  a n d  e o s i n  s t a i n e d  s e c t i o n  o f  t i s s u e  
f rom s k i n  t e s t  s i t e  o f  HSV SA s e n s i t i z e d  g u i n e a  p i g  0 . 5  h r  a f t e r  
c h a l l e n g e  w i t h  CE c o n t r o l  a n t i g e n ,  200X.
F i g u r e  17.  H e m a t o x y l i n  and e o s i n  s t a i n e d  s e c t i o n  o f  t i s s u e
from s k i n  t e s t  s i t e  o f  HSV SA s e n s i t i z e d  g u i n e a  p i g  0 . 5  hr  a f t e r
c h a l l e n g e  w i t h  HSV SA, 200X.
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F i g u r e  18. H e m a t o x y l i n  an d  e o s i n  s t a i n e d  s e c t i o n  o f  t i s s u e  
f rom s k i n  t e s t  s i t e  o f  HSV SA s e n s i t i z e d  g u i n e a  p i g  24 h r  a f t e r  
c h a l l e n g e  w i t h  c o n t r o l  a n t i g e n ,  200X.
F i g u r e  19.  H e m a t o x y l i n  and e o s i n  s t a i n e d  s e c t i o n  o f  t i s s u e
from s k i n  t e s t  s i t e  o f  HSV SA s e n s i t i z e d  g u i n e a  p i g  2 4  h r  a f t e r
c h a l l e n g e  w i t h  HSV SA, 200X.
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F i g u r e  2 0 .  H e m a t o x y l i n  a n d  e o s i n  s t a i n e d  s e c t i o n  o f  t i s s u e  
f rom  s k i n  t e s t  s i t e  o f  HSV SA s e n s i t i z e d  g u i n e a  p i g  24 h r  a f t e r  
c h a l l e n g e  w i t h  HSV SA, I OCX.
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p r e c i p i t a t e  was removed w e re  b o t h  u s e d  a s  c h a l l e n g e  a n t i g e n s  t o  d e t e r ­
m in e  w hic h  f r a c t i o n  c o n t a i n e d  s k i n  t e s t  a c t i v i t y .
S u p e r n a t a n t  f l u i d . S i n c e  o t h e r  i n v e s t i g a t o r s  ( 9 9 ,  22)  u s e d  a d ­
j u v a n t s  s u c c e s s f u l l y  w i t h  v i r a i  s e n s i t i z i n g  a n t i g e n s ,  a n i m a l s  w e re  
s e n s i t i z e d  w i t h  50^ i n f e c t i v e  HSV in F r e u n d ' s  c o m p l e t e  a d j u v a n t  (FCA).  
When t h e  s u p e r n a t a n t  f l u i d  was u s e d  t o  s k i n  t e s t  t h e s e  g u i n e a  p i g s ,  
l a r g e r  d i a m e t e r s  o f  e r y t h e m a  w e re  s e e n  w i t h  HSV SA m a t e r i a l  a t  16 ,  24 
and  48 h r  t h a n  w e re  n o t e d  w i t h  CEF c o n t r o l  m a t e r i a l  d i a l y z e d  In t h e  
same m ann e r  ( T a b l e  9 and F i g u r e  2 1 ) .  L i k e w i s e ,  a t  16 and 24 h r  l a r g e r  
a r e a s  o f  I n d u r a t i o n  w e r e  o b s e r v e d  In r e s p o n s e  t o  SA t h a n  c o n t r o l  a n t i ­
g e n .
The  r e a c t i o n s  e l i c i t e d  In r e s p o n s e  t o  t h e  SA and  CEF c o n t r o l  
s u p e r n a t a n t  f l u i d  In L c e l l  c o n t r o l  s e n s i t i z e d  g u i n e a  p i g s  can  be s e e n  
In T a b l e  10.  SA d i d  n o t  e l i c i t  a p p r e c i a b l y  l a r g e r  s k i n  t e s t  r e a c t i o n s  
t h a n  t h e  CEF p r e p a r a t i o n .  I t  c a n  be c o n c l u d e d  t h a t  t h e  a c t i v e  p o r t i o n  
o f  t h e  s k i n  t e s t  a n t i g e n  I s  n o t  c o m p l e t e l y  p r e c i p i t a t e d  by d i a l y s i s  In 
low I o n i c  s t r e n g t h  s o l u t i o n s .  S i n c e  a n i m a l s  s e n s i t i z e d  w i t h  I n f e c t i v e  
HSV p l u s  FCA showed somewhat  c o m p a r a b l e  d i a m e t e r s  a t  t h e  SA t e s t  s i t e  
t o  t h o s e  o b s e r v e d  w i t h  a  d i f f e r e n t  SA in  a n i m a l s  s e n s i t i z e d  w i t h  two 
I n j e c t i o n s  o f  I n f e c t i v e  HSV ( T a b l e  8 ) ,  t h i s  s e n s i t i z a t i o n  m ethod  was 
u s e d  f o r  s u b s e q u e n t  s t u d i e s .
P r e c i p i t a t e d  m a t e r i a l . When t h e  p r e c i p i t a t e d  f r a c t i o n  o f  d i ­
a l y z e d  HSV s o l u b l e  a n t i g e n  was r e s u s p e n d e d  in PBS and  u s e d  a s  t h e  s k i n  
t e s t  a n t i g e n  in HSV s e n s i t i z e d  g u i n e a  p i g s ,  t h e  a r e a s  o f  e r y t h e m a  s e e n  
a t  16 and 24 h r  we re  much l a r g e r  t h a n  t h o s e  o b s e r v e d  in r e s p o n s e  t o  CEF 
c o n t r o l  a n t i g e n  ( T a b l e  11 a nd  F i g u r e  2 1 ) .  Only  min im al  I n d u r a t i o n  was
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TABLE 9
SKIN TEST REACTIONS IN HSV SENSITIZED GUINEA PIGS^ 
CHALLENGED WITH DIALYZED HSV SOLUBLE ANTIGEN
Time
(H o u r s )








C o n t r o l ^
0 . 5 od od od od
4 9 . 4 6 . 8 2 . 5 2 , 5
16 13 .4 4 . 0 6 . 0 0
24 13 .0 3 . 6 4 . 5 0
48 11.5 0 0 0
^ A n im a ls  s e n s i t i z e d  by s i n g l e  i n j e c t i o n  HSV, 10^°^  TCID5Q, in 
50? FCA; c h a l l e n g e d  14 d a y s  l a t e r .
^ ^ S u p e r n a t a n t  f l u i d  f rom s o l u b l e  a n t i g e n  d i a l y z e d  a g a i n s t  d i s ­
t i l l e d  w a t e r ;  p r e p a r e d  f rom HSV i n f e c t e d  CEP; p r o t e i n  c o n t e n t  was 150 ug 
p e r  0 . I m l .
^ C o n t r o l  a n t i g e n  s u p e r n a t a n t  f l u i d  p r e p a r e d  f rom u n i n f e c t e d  CEP.











CEF C o n t r o l  
D i a l y s i s  S u p e r n a t a n t





0 . 5 16
TIME ( h r )
24 48
F i g u r e  2 1 .  A v e r a g e  d i a m e t e r s  o f  e r y t h e m a  in  g u i n e a  p i g s  
s e n s i t i z e d  w i t h  a c t i v e  h e r p e s  s i m p l e x  v i r u s  (HSV) p l u s  F r e u n d ' s  
c o m p l e t e  a d j u v a n t  and  c h a l l e n g e d  w i t h  f r a c t i o n s  ( p r e c i p i t a t e  and  
s u p e r n a t a n t )  o f  d i a l y z e d  s o l u b l e  a n t i g e n .
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TABLE 10
SKIN TEST REACTIONS IN L CELL CONTROL SENSITIZED GUINEA PIGS'  
CHALLENGED WITH DIALYZED HSV SOLUBLE ANTIGEN
Time
( H o u r s )








C o n t r o l c
0 . 5 0 ^ Od Od od
4 5 . 0 9 . 0 1 . 2 1 . 2
16 6 . 1 5 . 5 1 .7 1 .7
24 5 .1 5 . 5 1 . 5 1 .7
48 0 0 0 0
^ A n im a ls  s e n s i t i z e d  by s i n g l e  i n j e c t i o n  L C e l l  c o n t r o l  a n t i g e n  
in  50^  FCA; c h a l l e n g e d  14 d a y s  l a t e r .
^ S u p e r n a t a n t  f l u i d  f rom s o l u b l e  a n t i g e n  d i a l y z e d  a g a i n s t  d i s ­
t i l l e d  w a t e r ;  p r e p a r e d  f rom HSV i n f e c t e d  CEF; p r o t e i n  c o n t e n t  a d j u s t e d  
t o  150 yg p e r  0 . 1  m l .
‘' C o n t r o l  a n t i g e n  s u p e r n a t a n t  f l u i d  p r e p a r e d  f rom u n i n f e c t e d  CEF.
^ A v e r a g e  d i a m e t e r  In mm; 4 a n i m a l s .
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TABLE 11
SKIN TEST REACTIONS IN HSV SENSITIZED GUINEA PIGS^ 
CHALLENGED WITH DIALYSIS PRECIPITATE
Time
( H o u r s )








C o n t r o l ^
0 . 5 0 ^ od od od
4 8 . 0 5 . 9 1 . 0 0
16 8 . 4 1 . 3 2 . 0 0
24 8 . 5 1 . 0 2 . 5 0
48 2 . 6 0 0 0
^A n i m a l s  s e n s i t i z e d  by s i n g l e  i n j e c t i o n  HSV, 10^*^ TCÎD5Q, in 
50y5 FCA; c h a l l e n g e d  14 d a y s  l a t e r .
^ P r e c i p i t a t e  f rom s o l u b l e  a n t i g e n  d i a l y z e d  a g a i n s t  d i s t i l l e d  
w a t e r ;  p r e p a r e d  f rom HSV i n f e c t e d  CEF; p r o t e i n  c o n t e n t  was 150 yg p e r  
0 . I m i .
^ C o n t r o l  a n t i g e n  p r e c i p i t a t e  p r e p a r e d  f rom u n i n f e c t e d  CEF.
A v e r a g e  d i a m e t e r  in mm; 4 a n i m a l s .
68
e l i c i t e d  by t h e  p r e c i p i t a t e d  a n t i g e n .  A l t h o u g h  a c t i v i t y  r e m a i n e d  in 
t h e  p r e c i p i t a t e d  SA, t h e  amount  o f  i n s o l u b l e  m a t e r i a l  in t h e  p r e c i p i ­
t a t e  o f  b o t h  SA an d  CEF c o n t r o l  p r e p a r a t i o n s  I n d i c a t e s  p a r t i a l  removal  
o f  CEF m a t e r i a l  f rom SA. S k in  t e s t i n g  o f  HSV-FCA s e n s i t i z e d  g u i n e a  
p i g s  w i t h  SA s u p e r n a t a n t  f l u i d  e v o k e d  much l a r g e r  e r y t h e m a t o u s  and i n ­
d u r a t e d  r e a c t i o n s  t h a n  d i d  c h a l l e n g e  w i t h  SA p r e c i p i t a t e d  m a t e r i a l  
( F i g u r e  2 1 ) .  N e i t h e r  t h e  d i a l y s i s - p r e c i p i t a t e d  SA n o r  t h e  CEF c o n t r o l  
a n t i g e n  i n d u c e d  e r y t h e m a  o r  i n d u r a t i o n  in L c e l l  c o n t r o l  s e n s i t i z e d  
g u i n e a  p i g s .  W h i l e  t r e a t m e n t  o f  SA by d i a l y s i s  a g a i n s t  d i s t i l l e d  w a t e r  
s e r v e d  t o  p r e c i p i t a t e  some o f  t h e  s k i n  t e s t  a n t i g e n ,  m o s t  o f  t h e  a c ­
t i v i t y  r e m a i n e d  in t h e  s u p e r n a t a n t  f l u i d .
U l t r a f i l t r a t i o n  o f  H e r p e s  S i m p l e x  V i r u s  S o l u b l e  A n t i g e n
XM-100 u l t r a f i l t r a t i o n  and  e t h e r  e x t r a c t i o n . S o l u b l e  a n t i g e n  
wh ich  had been  t h r i c e  e x t r a c t e d  w i t h  e t h e r  and  f i l t e r e d  t h r o u g h  an 
XM-100 u l t r a f i l t r a t i o n  membrane  r e t a i n e d  i t s  s k i n  t e s t  a c t i v i t y  ( T a b l e  
12 and  f i g u r e  2 2 ) .  I t  e l i c i t e d  l a r g e r  d i a m e t e r s  o f  e r y t h e m a  t h a n  i t s  
c o r r e s p o n d i n g  c o n t r o l  a n t i g e n  in  HSV s e n s i t i z e d  a n i m a l s  a t  16 ,  2 4 , and 
48  h r .  I n d u r a t i o n  was n o t  s e e n  w i t h  e i t h e r  s k i n  t e s t  m a t e r i a l  and 
n e g l i g i b l e  d e g r e e s  o f  e r y t h e m a  and  i n d u r a t i o n  w ere  o b s e r v e d  in L c e l l  
c o n t r o l  s e n s i t i z e d  a n i m a l s  upon c h a l l e n g e  w i t h  t h e  XM-100 f i l t r a t e s .  
D e t e r m i n a t i o n  o f  t h e  p r o t e i n  c o n t e n t  o f  t h e  SA p r e p a r a t i o n  b e f o r e  and  
a f t e r  XM-100 u l t r a f i l t r a t i o n  r e v e a l e d  t h a t  98$ o f  t h e  p r o t e i n  p a s s e d  
t h e  f i I t e r .
XM-50 u l t r a f i l t r a t i o n . Most  o f  t h e  s k i n  t e s t  a c t i v e  f r a c t i o n  
o f  t h e  SA p r e p a r a t i o n  was removed by t h e  XM-50 u l t r a f i l t r a t i o n  membrane 
( T a b l e  13 and  F i g u r e  2 2 ) .  Only  t r a c e s  o f  e r y t h e m a  and  i n d u r a t i o n  were
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TABLE 12
SKIN TEST REACTIONS IN HSV SENSITIZED GUINEA PIGS^ CHALLENGED WITH 
ETHER EXTRACTED AND XM-100 ULTRAFILTERED SOLUBLE ANTIGEN
Time
( H o u r s )








C o n t r o l ' -
0 . 5 od od od od
4 4 . 6 6 . 0 0 0
16 7.1 3 . 8 0 0
24 7 . 6 2 . 6 0 0
48 5 . 4 0 0 0
^A n im a ls  s e n s i t i z e d  by s i n g l e  i n j e c t i o n  HSV, 10^* 5  TCID5Q, in 
50^ FCA; c h a l l e n g e d  14 d a y s  l a t e r .
b w a t e r  s o l u b l e  f r a c t i o n  o f  e t h e r  e x t r a c t e d ,  XM-100 f i l t e r e d  SA; 
p r e p a r e d  f rom HSV i n f e c t e d  CEF; p r o t e i n  c o n t e n t  was 150 yg p e r  0 .1  m l .
' ' C o n t r o l  a n t i g e n  e t h e r  e x t r a c t e d ,  XM-100 f i l t e r e d  m a t e r i a l ;  p r e ­
p a r e d  f rom u n i n f e c t e d  CEF.















•  CEF C o n t r o l  
■ HSV SA
—  XM-100 U l t r a f I I t r a t e  





48244 160 . 5
TIME ( h r )
F i g u r e  2 2 .  A v e r a g e  d i a m e t e r s  o f  e r y t h e m a  i n  g u i n e a  p i g s  
s e n s i t i z e d  w i t h  a c t i v e  h e r p e s  s i m p l e x  v i r u s  (HSV) p l u s  F r e u n d ' s  
c o m p l e t e  a d j u v a n t  a nd  c h a l l e n g e d  w i t h  SA and  CEF c o n t r o l  a n t i g e n s  
which  had  be en  e t h e r  e x t r a c t e d  and  f i l t e r e d  t h r o u g h  Am i c o n  XM-50 
and  SM-lOO u l t r a f i l t r a t i o n  m em branes .
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TABLE 13
SKIN TEST REACTIONS IN HSV SENSITIZED GUINEA PIGS® CHALLENGED WITH 
XM-50 ULTRAFILTERED SOLUBLE ANTIGEN
Time
( H o u r s )
--------- .............. ....... ....... ....








C o n t r o l c
0 . 5 Qd od od Od
4 1 .3 0 0 . 9 0
i 6 L I 0 0 . 9 0
24 0 0 0 0
48 0 0 0 0
^ A n im a ls  s e n s i t i z e d  by s i n g l e  i n j e c t i o n  HSV, 10^*^ TCID^Q, in 
50^ FCA; c h a l l e n g e d  14 d a y s  l a t e r ,
^ S o l u b l e  a n t i g e n  p r e p a r e d  f rom  HSV i n f e c t e d  CEF m o n o i a y e r s  and  
f i l t e r e d  t h r o u g h  XM-50 m em brane ;  p r o t e i n  c o n t e n t  was 150 pg p e r  i n ­
j e c t i o n ,
^ C o n t r o l  a n t i g e n  XM-50 f i l t e r e d  m a t e r i a l ;  p r e p a r e d  f rom un­
i n f e c t e d  CEF.
^ A v er ag e  d i a m e t e r  in mm; 4 a n i m a l s .
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o b s e r v e d  a t  t h e  SA s k i n  t e s t  s i t e s  in HSV-FCA s e n s i t i z e d  a n i m a l s  and  
L c e l l - F C A  s e n s i t i z e d  a n i m a l s  d e v e l o p e d  no e r y t h e m a  o r  i n d u r a t i o n  t o  
t h e  f i l t e r e d  p r e p a r a t i o n .
Enzyme T r e a t m e n t  o f  S o l u b l e  A n t i g e n  
To c h a r a c t e r i z e  f u r t h e r  t h e  SA p r e p a r a t i o n ,  i t  was t r e a t e d  w i t h  
two p e p t i d a s e s  ( t r y p s i n  a n d  p r o n a s e )  t o  d e t e r m i n e  i f  i t  c o n t a i n e d  p r o ­
t e i n .  T r e a t m e n t  o f  t h e  SA w i t h  two n u c l e a s e s  (DNase and  RNase) was 
p e r f o r m e d  t o  d e t e r m i n e  DMA o r  RNA c o n t e n t .
T r v p s i n  t r e a t m e n t . When HSV s e n s i t i z e d  g u i n e a  p i g s  w e r e  s k i n  
t e s t e d  w i t h  t h e  t r y p s i n - t r e a t e d  a n t i g e n  and  c o n t r o l  p r e p a r a t i o n s ,  l a r g e r  
e r y t h e m a t o u s  r e a c t i o n s  w e r e  s e e n  a t  4 ,  16,  2 4 , and  48 h r  in r e s p o n s e  t o  
i n a c t i v e  t r y p s i n - t r e a t e d  SA t h a n  t o  a c t i v e  t r y p s i n - t r e a t e d  SA ( T a b l e  
14 and  F i g u r e  2 3 ) .  D i a m e t e r s  o f  i n d u r a t i o n  w ere  l a r g e r  a t  t h e  i n a c t i v e  
t r y p s i n - t r e a t e d  SA s i t e  t h a n  a t  t h e  a c t i v e  t r y p s i n - t r e a t e d  SA s i t e  a t  
16,  2 4 , and  48 h r .  L a r g e r  r e a c t i o n s  w ere  s e e n  in I n a c t i v e  t r y p s i n -  
t r e a t e d  SA s i t e s  t h a n  in a c t i v e  t r y p s i n - t r e a t e d  c o n t r o l  a n t i g e n  s i t e s  
t h r o u g h o u t  t h e  e x p e r i m e n t a l  p e r i o d .  T e s t i n g  o f  L c e l l  s e n s i t i z e d  a n i ­
m a l s  w i t h  t h e  t h r e e  t r y p s i n  t r e a t e d  m a t e r i a l s  r e s u l t e d  in e r y t h e m a t o u s  
o r  i n d u r a t e d  r e a c t i o n s  w h i c h  w ere  n o t a b l y  d i f f e r e n t  o n l y  a t  t h e  4 h r  
p e r i o d  ( T a b l e  15 and  F i g u r e  2 4 ) .  At  a l l  o t h e r  t i m e  i n t e r v a l s  t h e  r e ­
a c t i o n s  w ere  o f  c o m p a r a b l e  s i z e .  T h e s e  r e s u l t s  d e m o n s t r a t e  t h a t  t h e  
r e a c t i o n s  s e e n  in  t h e  HSV s e n s i t i z e d  g u i n e a  p i g s  w e r e  s p e c i f i c .
P r o n a s e  t r e a t m e n t . In HSV s e n s i t i z e d  g u i n e a  p i g s ,  somewhat  
l a r g e r  e r y t h e m a t o u s  r e a c t i o n s  w e r e  ev o k ed  a t  24 and  48  h r  in r e s p o n s e  
t o  i n a c t i v e  p r o n a s e - t r e a t e d  SA t h a n  t o  a c t i v e  p r o n a s e - t r e a t e d  SA 
( T a b l e  16 and F i g u r e  2 5 ) .  D i a m e t e r s  o f  i n d u r a t i o n  w e r e  l a r g e r  in
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TABLE 14
SKIN TEST REACTIONS IN HSV SENSITIZED GUINEA PIGS® CHALLENGED 
WITH TRYPSIN TREATED SOLUBLE ANTIGEN^
A n t i g e n  
T r e a t m e n t
E ry th e m a  (mm) 
( H o u r s )
0 . 5 16 24 48
I n d u r a t i o n  (mm) 
(H o u r s )
0 . 5  4 16 24 48
A c t  Ive  
( u n h e a t e d )  
t r y p s i n  
+ SA
I n a c t i v e  
( h e a t e d )  
t r y p s i n  
+ SA
A ct  Ive  
t r y p s i n  + 
c o n t r o I  
a n t i g e n ^
7 . 6  8 .1 8 . 2  4 . 3 0"  5 . 0  3 . 5  4 . 3  0
9 . 2  1 0 .3  12 .4  6 . 3 0 5 . 0  5 . 8  5 . 8  4 . 0
5 . 0  0 0 0 0 0 0 0 0
^A n im a ls  s e n s i t i z e d  by s i n g l e  I n j e c t i o n  o f  HSV, 10^*^ TCIDcn,
In 50^ FCA; c h a l l e n g e d  14 d a y s  l a t e r .
^ S o l u b l e  a n t i g e n  p r e p a r e d  f rom HSV I n f e c t e d  CE a l l a n t o i c  f l u i d .
^ C o n t r o l  a n t i g e n  p r e p a r e d  f rom u n i n f e c t e d  CE a l l a n t o i c  f l u i d .














* T r y p s i n - T r e a t e d  SA
 ........ .. T r y p s i n  ( I n a c t i v e ) - T r e a t e d  SA









4 160 . 5 24 48 72
TIME ( h r )
F i g u r e  2 3 .  A v e r a g e  d i a m e t e r s  o f  e r y t h e m a  in  g u i n e a  p i g s  
s e n s i t i z e d  w i t h  a c t i v e  h e r p e s  s i m p l e x  v i r u s  (HSV) p l u s  F r e u n d ' s  
c o m p l e t e  a d j u v a n t  and c h a l l e n g e d  w i t h  t r y p s i n  t r e a t e d  s o l u b l e  
a n t i g e n .
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TABLE 15
SKIN TEST REACTIONS IN L CELL SENSITIZED GUINEA PIGS'  
CHALLENGED WITH TRYPSIN TREATED SOLUBLE ANTIGEN^
A n t i g e n
T r e a t m e n t
A c t  Ive  
( u n h e a t e d  
t r y p s i n  
+ SA
I n a c t I v e  
( h e a t e d )  
t r y p s i n  
+ SA
A c t  Ive  
t r y p s i n  + 
c o n t r o l  
a n t i g e n ^
E r y th e m a  (mm) 
( H o u r s )
7 . 0  2 . 3 0 0
5 . 5  0 0 0
0 0 0  0
I n d u r a t i o n  (mm) 
( H o u r s )
0 °  4 . 9  0 0 0
0 0 0 0 0
0 0 0 0 0
^ A n i m a l s  s e n s i t i z e d  by s i n g l e  i n j e c t i o n  o f  L c e l l  c o n t r o l  in 
50^ FCA; c h a i l e n g e d  14 d a y s  l a t e r .
^ S o l u b l e  a n t i g e n  p r e p a r e d  f rom HSV i n f e c t e d  CE a l l a n t o i c  f l u i d ,
^ C o n t r o l  a n t i g e n  p r e p a r e d  f rom  u n i n f e c t e d  CE a l l a n t o i c  f l u i d .
A v e r a g e  d i a m e t e r  in  mm; 4 a n i m a l s .
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0----------0 T r y p s i n - T r e a t e d  SA
T r y p s i n  ( I n a c t  i va  t e d  ) - T r e a t e d  SA 







484 720 . 5
TIME ( h r )
F i g u r e  24 .  A v e r a g e  d i a m e t e r s  o f  e r y t h e m a  in  g u i n e a  p i g s  
s e n s i t i z e d  w i t h  L c e l l  c o n t r o l  a n t i g e n s  p l u s  F r e u n d ' s  c o m p l e t e  
a d j u v a n t  and  c h a l l e n g e d  w i t h  t r y p s i n  t r e a t e d  s o l u b l e  a n t i g e n .
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TABLE 16
SKIN TEST REACTIONS IN HSV SENSITIZED GUINEA PIGS^ CHALLENGED 
WITH PRONASE TREATED SOLUBLE ANTIGEN®
A n t i g e n  
T r e a t m e n t
0 . 5  4
A c t  Ive  
( u n h e a t e d )  
p r o n a s e  
+ SA
I n a c t i v e  
( H e a t e d )  
P r o n a s e  
+ SA
A c t  Iv e  
P r o n a s e  + 
c o n t r o l  
a n t i g e n
E r y th e m a  (mm) 
( H o u r s )
8 . 0  9 . 5  8 . 8  2 . 7
9 . 8  1 0 . 8  11 .5  8 . 2
6 . 6  8 . 2  6 . 0  1 . 4
I n d u r a t i o n  (mm) 
( H o u r s )
0 °  6 . 7  5 . 3  5 . 3  4 .1
0 3 . 0  5 . 3  5 . 6  4 . 5
0 7 . 0  5 .1  4 . 9  0
^ A n i m a l s  s e n s i t i z e d  by s i n g l e  i n j e c t i o n  o f  HSV, 1 0 ^ ' ^  TCID^q , 
in  50$ FCA; c h a l l e n g e d  14 d a y s  l a t e r .
^ S o l u b l e  a n t i g e n  p r e p a r e d  f rom HSV i n f e c t e d  CE a l l a n t o i c  f l u i d .
^ C o n t r o l  a n t i g e n  p r e p a r e d  f rom u n i n f e c t e d  CE a l l a n t o i c  f l u i d .
^ A v e r a g e  d i a m e t e r  in  mm; 4 a n i m a l s .
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HSV SENSITIZED ANIMALS 











a  ------- 0  P r o n a s e  ( I n a c t i v e ) - T r e a t e d  SA
B Z T Z ’b  P r o n a s e - T r e a t e d  SA
C m rrrc P r o n a s e - T r e a t e d  C o n t r o l  A l l a n t o i c  F l u i d
0 . 5 16 24 48 72
TIME ( h r )
F i g u r e  2 5 .  A v e r a g e  d i a m e t e r s  o f  e r y t h e m a  in  g u i n e a  p i g s  
s e n s i t i z e d  w i t h  a c t i v e  h e r p e s  s i m p l e x  v i r u s  (HSV) p l u s  F r e u n d ' s  
c o m p l e t e  a d j u v a n t  o r  L c e l l  c o n t r o l  a n t i g e n  p l u s  F r e u n d ' s  c o m p l e t e  
a d j u v a n t  and  c h a l l e n g e d  w i t h  p r o n a s e  t r e a t e d  s o l u b l e  a n t i g e n .
79
r e s p o n s e  t o  a c t i v e  p r o n a s e - t r e a t e d  SA t h a n  t o  I n a c t i v e  p r o n a s e - t r e a t e d  
SA a t  4 h r  b u t  t h e  r e a c t i o n s  w e r e  n o t  g r e a t l y  d i f f e r e n t  a t  t h e  o t h e r  
t i m e  p e r i o d s .  C o n t r o l  CE a n t i g e n  p l u s  p r o n a s e  e l i c i t e d  s m a l l e r  s k i n  
r e a c t i o n s  a t  24 and  48 h r  t h a n  e i t h e r  o f  t h e  SA p r e p a r a t i o n s .  T h i s  
d e m o n s t r a t e s  t h a t  t h e  r e a c t i v i t y  s e e n  In t h e s e  a n i m a l s  i s  d i r e c t e d  t o ­
ward  a comp on ent  in t h e  SA p r e p a r a t i o n .  In L c e l l  c o n t r o l  s e n s i t i z e d  
g u i n e a  p i g s  r e a c t i o n s  t o  i n a c t i v e  p r o n a s e - t r e a t e d  SA w e r e  s m a l l e r  
t h a n  r e a c t i o n s  t o  e i t h e r  a c t i v e  p r o n a s e - t r e a t e d  SA o r  p c t i v e  p r o n a s e  
p l u s  c o n t r o l  a n t i g e n ,  i n d i c a t i n g  t h a t  SA d i d  n o t  e l  i c i i  an HSV s p e ­
c i f i c  s k i n  r e a c t i v i t y  in L c e l l  c o n t r o l  s e n s i t i z e d  a n i m a l s  ( T a b l e  17 
and  F i g u r e  2 5 ) .
D e o x y r i b o n u c l e a s e  t r e a t m e n t . HSV s e n s i t i z e d  g u i n e a  p i g s  
r e s p o n d e d  t o  s k i n  t e s t i n g  w i t h  i n a c t i v e  D N a s e - t r e a t e d  SA w i t h  
e r y t h e m a t o u s  r e s p o n s e s  wh ich  w e r e  c o n s i d e r a b l y  l a r g e r  a t  16 h r  t h a n  
t h o s e  o b s e r v e d  w i t h  a c t i v e ,  D N a s e - t r e a t e d  SA ( T a b l e  1 8 ) .  A v e ra g e  
d i a m e t e r s  o f  i n d u r a t i o n  in t h e  f o r m e r  g r o u p  w ere  c o m p a r a b l e  in s i z e  t o  
t h o s e  w i t h  t h e  l a t t e r  a n t i g e n  t r e a t m e n t  ( T a b l e  1 8 ) .  S k in  t e s t  r e a c t i o n s  
t o  SA i n j e c t e d  s i t e s  w e re  l a r g e r  t h a n  t h o s e  t o  c o n t r o l  a n t i g e n  a t  16,
24 and  48  h r .  L c e l l  s e n s i t i z e d  a n i m a l s  r e s p o n d e d  t o  a l l  t h r e e  s k i n  
t e s t  m a t e r i a l s  t o  e s s e n t i a l l y  t h e  same d e g r e e  ( T a b l e  1 9 ) .  The o n l y  
e x c e p t i o n  was i n  t h e  d i a m e t e r s  o f  i n d u r a t i o n  s e e n  a t  48 h r .  T h e s e  
r e s u l t s  r e v e a l  t h e  s p e c i f i c i t y  o f  t h e  SA p r e p a r a t i o n  f o r  HSV a n t i g e n s  
and  s u g g e s t  t h a t  a c t i v e  DNase d e g r a d e d  t h e  SA.
R i b o n u c l e a s e  t r e a t m e n t . S k i n  t e s t  r e a c t i o n s  t o  b o t h  a c t i v e  
R N a s e - t r e a t e d  SA and i n a c t i v e  R N a s e - t r e a t e d  SA w ere  s i m i l a r  a t  a l l  
t i m e  i n t e r v a l s  in HSV s e n s i t i z e d  g u i n e a  p i g s  ( T a b l e  2 0 ) .  At 16 and
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TABLE 17
SKIN TEST REACTIONS IN L CELL SENSITIZED GUINEA PIGS^
CHALLENGED WITH PRONASE TREATED SOLUBLE ANTIGEN
A n t i g e n
T r e a t m e n t
0 . 5  4
A c t i v e  
( u n h e a t e d )  
p r o n a s e  
+ SA
I n a c t i v e  
( h e a t e d )  
p r o n a s e  
+ SA
Act  i ve  
p r o n a s e  + 
c o n t r o l  
a n t i g e n ^
E r y th e m a  (mm) 
(H o u r s )
0 °  6 . 0  4 . 6 5 . 0
0 7 . 0  2 . 5 3.3
0 8 . 1  7 . 4  7 .1 1 . 7
I n d u r a t i o n  (mm) 
( H o u r s )
0 5 . 5  4 .1  4 . 0  0
0 1.0 1.0 0 0
0 6 . 2  4 . 4  4 . 2  0 . 7
^ A nim a ls  s e n s i t i z e d  by s i n g l e  i n j e c t i o n  o f  L c e l l  c o n t r o l  in 
50/5 FCA; c h a l l e n g e d  14 d a y s  l a t e r .
^ S o l u b l e  a n t i g e n  p r e p a r e d  f rom HSV i n f e c t e d  CE a l l a n t o i c  f l u i d .
^ C o n t r o l  a n t i g e n  p r e p a r e d  f rom u n i n f e c t e d  CE a l l a n t o i c  f l u i d .
^Av er a g e  d i a m e t e r  in  mm; 4 a n i m a l s .
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TABLE 18
SKIN TEST REACTIONS IN HSV SENSITIZED GUINEA PIGS® CHALLENGED 
WITH DNASE TREATED SOLUBLE ANTIGEN*^
A n t i g e n  
T r e a t m e n t
E r y t h e m a  (mm) 
( H o u r s )
I n d u r a t i o n  (mm) 
( H o u r s )
0 . 5 4 15 24 48 0 . 5  4 16 24 48
A c t  i ve  
( u n h e a t e d )  
DNase 
+ SA 0 ^ 4 . 0  7 . 3 6 . 7 0 0^ 3 . 7 4 . 5  4 . 4 3 . 9
1n a c t i v e  
( h e a t e d )  
DNase 
+ SA 0 4 . 6  I I . 0 8 . 6 0 0 3 . 9 4 . 7  4 . 7 4 . 4
A c t  i ve  
DNase + 
c o n t r o l  
a n t i g e n ^ 0 4 . 2  6 . 7 4 . 7 0 0 3 . 8 3 . 8  3 . 6 0
^ A n i m a l s  s e n s i t i z e d  by s i n g l e  i n j e c t i o n  o f  HSV, 1 0 ^ ' ^  TCID^q , 
In 50/È FCA; c h a l l e n g e d  14 d a y s  l a t e r .
^ S o l u b l e  a n t i g e n  p r e p a r e d  f rom HSV i n f e c t e d  CEF.
^ C o n t r o l  a n t i g e n  p r e p a r e d  f rom u n i n f e c t e d  CEF.
^ A v e r a g e  d i a m e t e r  in  mm; 6  a n i m a l s .
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TABLE 19
SKIN TEST REACTIONS IN L CELL SENSITIZED GUINEA PIGS^ 
CHALLENGED WITH DNASE TREATED SOLUBLE ANTIGEN^
A n t i g e n
T r e a t m e n t
0 . 5  4
Ac t  Iv e  
( u n h e a t e d )  
DNase 
+ SA
I n a c t i v e  
( h e a t e d )  
DNase 
+ SA
Act i ve  
DNase + 
c o n t r o l  
a n t i g e n ^
E r y t h e m a  (mm) 
( H o u r s )
0 °  3 . 3  7 . 4 0 0
0 1 . 4  4 . 8  2 . 9
0 1 . 9  4 . 5 . 4  0
I n d u r a t i o n  (mm) 
( H o u r s )
0°  4 . 5  4 . 8  4 . 5  3 . 8
0 4 . 4  4 . 7  4 . 8  4 . 2
0 4 . 5  4 . 4  4 . 3  0
^ A n i m a l s  s e n s i t i z e d  by s i n g l e  i n j e c t i o n  o f  L c e l l  c o n t r o l  in 
50/6 FCA; c h a l l e n g e d  14 d a y s  l a t e r .
b S o l u b l e  a n t i g e n  p r e p a r e d  f rom HSV i n f e c t e d  CEF.
^ C o n t r o l  a n t i g e n  p r e p a r e d  f rom u n i n f e c t e d  CEF.
^ A v e r a g e  d i a m e t e r  in  mm; 6  a n i m a l s .
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TABLE 20
SKIN TEST REACTIONS IN HSV SENSITIZED GUINEA PIGS^ CHALLENGED 
WITH RNASE TREATED SOLUBLE ANTIGEN^
A n t i g e n
T r e a t m e n t
E r y th e m a  (mm) 
( H o u r s )
0 . 5  4 16 24  48
I n d u r a t i o n  (mm) 
(H o u r s )
0 . 5  4 16 24 48
A c t  i v e  
( u n h e a t e d )  
RNase 
+ SA
I n a c t i v e  
( h e a t e d )  
RNase 
+ SA
A c t  i v e  
RNase + 
c o n t r o l  
a n t i g e n ^
4 . 6  1 1 . 6  1 0 . 4  0 od 4 . 5  5 . 0  4 . 8  0
3 . 9  I I . I  1 0 . 0  0 0 4 .1  4 . 7  4 . 6  0
4 .1  7 . 8  6 . 9  0 0 3 . 9  4 . 3  4 . 6  0
^ A n i m a l s  s e n s i t i z e d  by s i n g l e  i n j e c t i o n  o f  HSV, 10 ^’ ^ TCIDcq,  
in  50% FCA; c h a i l e n g e d  14 d a y s  l a t e r .
^ S o l u b l e  a n t i g e n  p r e p a r e d  f rom HSV i n f e c t e d  CEF.
^ C o n t r o l  a n t i g e n  p r e p a r e d  f rom u n i n f e c t e d  CEF.
A v e r a g e  d i a m e t e r  in  mm; 6 a n i m a l s .
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24 h r ,  e r y t h e m a t o u s  r e a c t i o n s  w e r e  l a r g e r  In b o t h  o f  t h e s e  g r o u p s  t h a n  
In a n i m a l s  s k i n  t e s t e d  w i t h  R N a s e - t r e a t e d  c o n t r o l  a n t i g e n .  D i a m e t e r s  
o f  I n d u r a t i o n  w e r e  e s s e n t i a l l y  t h e  same In a l l  t h r e e  g r o u p s  o f  a n i m a l s  
a t  a l l  t i m e  I n t e r v a l s .  L c e l l  s e n s i t i z e d  g u i n e a  p i g s  r e s p o n d e d  t o  a l l  
t h r e e  s k i n  t e s t  m a t e r i a l s  t o  e s s e n t i a l l y  t h e  same d e g r e e  a t  a l l  t i m e  
I n t e r v a l s  ( T a b l e  2 1 ) .
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TABLE 21
SKIN TEST REACTIONS IN L CELL SENSITIZED GUINEA PIGS^ 
CHALLENGED WITH RNASE TREATED SOLUBLE ANTIGEN^
A n t i g e n
E r y t h e m a  (mm) 
( H o u r s )
I n d u r a t i o n  (mm) 
( H o u r s )
T r e a t m e n t
0 . 5 4 16 24 48 0 . 5 4 16 24 48
Ac t  i ve  
( u n h e a t e d )  
RNase 
+ SA o ' 1 . 8  5 . 9  3 .1 0 o ' 4 . 9  5 . 2  5 . 3 4 . 5
1n a c t  i ve  
( h e a t e d )  
RNase 
+ SA 0 1 .7  6 . 4  3 . 5 0 0 4 . 7  5 . 2  5 . 0 4 . 3
A c t i v e  
RNase + 
c o n t r o l  
a n t i g e n ^ 0 1 . 5  4 . 9  2 . 4 0 0 4 . 1  5 . 0  4 . 9 4 . 0
^ A n im a ls  s e n s i t i z e d  by s i n g l e  i n j e c t i o n  o f  L c e l l  c o n t r o l  in 
50$ FCA; c h a l l e n g e d  14 d a y s  l a t e r .
^ S o l u b l e  a n t i g e n  p r e p a r e d  f rom HSV i n f e c t e d  CEF.
^ C o n t r o l  a n t i g e n  p r e p a r e d  f rom u n i n f e c t e d  CEF.
^ A v er a g e  d i a m e t e r  In mm; 6 a n i m a l s .
CHAPTER IV 
DISCUSSION
A n t i g e n s  and  Media 
A s e n s i t i z i n g  h e r p e s  s i m p l e x  v i r u s  (HSV) a n t i g e n  was p r e p a r e d  
in  L c e l l s  p r o l i f e r a t e d  in E a g l e ' s  Minimum E s s e n t i a l  Medium (MEM) p l u s  
h o r s e  s e r u m .  The s k i n  t e s t  a n t i g e n s  w e r e  p r e p a r e d  in  c h i c k  em bryo s  
(CE) o r  in  c h i c k  embryo f i b r o b l a s t s  (CEF) grown in  a c a l f  s e ru m  s u p ­
p l e m e n t e d  medium (LHYE C ) .  D i f f e r e n t  c e l l  l i n e s ,  m e d i a ,  and s e r a  w e re  
u s e d  in an  a t t e m p t  t o  m i n i m i z e  c r o s s  r e a c t i o n s  w h ic h  m i g h t  make  i t  
d i f f i c u l t  t o  i n t e r p r e t  s k i n  t e s t  r e s u l t s  ( 4 5 ) .  La usc h  e t  aj_" ( 5 5 )  
w e r e  a b l e  t o  a v o i d  c r o s s  r e a c t i o n s  by u s i n g  mouse  b r a i n  p r o l i f e r a t e d  
HSV f o r  s e n s i t i z a t i o n  o f  g u i n e a  p i g s  and  by e m p l o y i n g  C E F - p r e p a r e d  
HSV a n t i g e n  a s  s k i n  t e s t  m a t e r i a l .  In t h e  p r e s e n t  s t u d i e s ,  HSV s k i n  
t e s t  a n t i g e n  p r e p a r e d  in  CE was c a p a b l e  o f  e l i c i t i n g  r e a c t i o n s  in HSV 
s e n s i t i z e d  g u i n e a  p i g s ,  a s  c a n  be  s e e n  in T a b l e s  2 ,  3 an d  4 .  In t h e s e  
t h r e e  e x p e r i m e n t s ,  s k i n  r e a c t i o n s  t o  c o n t r o l  a l l a n t o i c  f l u i d  w e re  
l a r g e s t  a t  4 h r  and d e c l i n e d  t o  low l e v e l s  by 16 a n d  24 h r ,  w h i l e  r e ­
a c t i o n s  t o  s o l u b l e  a n t i g e n  (SA) w e r e  maximal a t  16 t o  24 h r .  In a d d i ­
t i o n ,  t h e  r e a c t i o n s  t o  SA w e r e  much l a r g e r  a t  16 an d  24 h r  t h a n  w ere  
t h o s e  t o  c o n t r o l  a n t i g e n .  The u s e  o f  CEF in t h e  p r e p a r a t i o n  o f  s k i n  
t e s t  a n t i g e n s  a l s o  a l l o w e d  t h e  d e t e c t i o n  o f  s e n s i t i v i t y  t o  HSV in
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g u i n e a  p i g s  ( T a b l e  9 ) .  CEF c o n t r o l  a n t i g e n  e l i c i t e d  min i ma l  r e a c t i o n s  
wh ic h  d i m i n i s h e d  by 24 h r ,  w h i l e  t h e  r e a c t i o n s  t o  HSV SA p r e p a r e d  in 
CEF w e r e  c o n s i d e r a b l y  l a r g e r  an d  more  p e r s i s t e n t .  E v i d e n c e  f o r  t h e  
s p e c i f i c i t y  o f  t h e  r e a c t i o n  t o  SA in t h e s e  a n i m a l s  i s  p r e s e n t e d  in 
T a b l e  10.  G u i n e a  p i g s  s e n s i t i z e d  w i t h  L c e l l  c o n t r o l  a n t i g e n  and  s k i n  
t e s t e d  w i t h  SA r e s p o n d e d  w i t h  r e a c t i o n s  t h a t  w ere  no l a r g e r  t h a n  t h o s e  
s e e n  a t  c o n t r o l  s k i n  t e s t  s i t e s .  T h e s e  r e s u l t s  o f f e r  p r o o f  t h a t  t h e  
s k i n  r e a c t i v i t y  a t  SA t e s t  s i t e s  in HSV s e n s i t i z e d  g u i n e a  p i g s  i s  
d i r e c t e d  a g a i n s t  an HSV co m p o n en t  and  n o t  a c om po ne n t  o f  L c e l l s ,  MEM, 
o r  h o r s e  s e r u m .
M et hods  o f  S e n s i t i z a t i o n  
Lausch  e t  aj_. ( 5 5 )  r e p o r t e d  s e n s i t i z a t i o n  o f  g u i n e a  p i g s  by a
4
s i n g l e  i n j e c t i o n  o f  mouse  b r a i n  p r o l i f e r a t e d  HSV whi ch  c o n t a i n e d  2 X 10 
PPL) o f  v i r u s / 0 . 1  m l .  S k i n  r e a c t i o n s  m e a s u r i n g  15 mm in d i a m e t e r  w e r e  
o b s e r v e d  a t  HSV SA t e s t  s i t e s  o n e  an d  tw o weeks  a f t e r  s e n s i t i z a t i o n .  
Maximal r e a c t i o n s  ( 1 6  mm o f  e r y t h e m a )  w e r e  o b s e r v e d  a f t e r  t h r e e  w e e k s .  
Maximal r e a c t i o n s  t o  SA o c c u r r e d  24 h r  a f t e r  s k i n  t e s t i n g .  W h i l e  i n ­
d u r a t i o n  was n o t e d ,  i t  was e r r a t i c  and  n o t  a s  c o n s t a n t  a s  t h e  e r y t h e ­
m a t o u s  r e s p o n s e .  The SA u se d  by t h e s e  i n v e s t i g a t o r s  was p r e p a r e d  in 
CEF grown in medium c o n t a i n i n g  %  c a l f  s e r u m .  R e a c t i o n s  e l i c i t e d  by 
CEF c o n t r o l  a n t i g e n  w e r e  maximal ( 6 - 8  mm) by 4 t o  8 h r  and  d i m i n i s h e d  
t o  an a v e r a g e  o f  3 t o  5 mm by 24 h r .  The  SA s k i n  t e s t i n g  p r e p a r a t i o n  
c o n t a i n e d  98 yg o f  p r o t e i n / 0 . 1  m l .
In t h e  p r e s e n t  s t u d i e s ,  s k i n  r e a c t i o n s  a t  SA t e s t  s i t e s  two 
weeks  a f t e r  s e n s i t i z a t i o n  w i t h  1 0 ^ ' ^  TCID^g o f  HSV were  maximal a t  16 
h r  ( 1 2 .1  mm) and  24 h r  ( 7 . 5  mm) ( T a b l e  2 ) .  The s m a l l e r  d i a m e t e r s  o f
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e r y t h e m a  o b s e r v e d  in t h e  p r e s e n t  s t u d y ,  a s  co m pare d  w i t h  t h o s e  r e ­
p o r t e d  by La us ch  et^ ( 5 5 ) ,  may be a t t r i b u t e d  t o  s e v e r a l  f a c t o r s .  
F i r s t ,  t h e  s e n s i t i z i n g  p r e p a r a t i o n s  u s e d  in t h e  two s t u d i e s  w e re  d i f ­
f e r e n t .  Lausc h  e t  aj_. ( 5 5 )  u se d  2 X 10^ PFU o f  HSV p r e p a r e d  f rom HSV- 
i n f e c t e d  mouse b r a i n ,  w h i l e  in  t h e  p r e s e n t  s t u d i e s  10^*^ TCID^Q o f  
HSV p r e p a r e d  f rom L c e l l  m o n o l a y e r s  p r o l i f e r a t e d  in MEM^ ^ Hg was em­
p l o y e d  ( T a b l e  2 ) .  S i n c e  mouse b r a i n  c o n t a i n s  up t o  23$ l i p i d  by 
w e i g h t  ( 1 0 6 ) ,  and  s i n c e  l i p i d s  a r e  known t o  a c t  a s  a d j u v a n t s  ( 1 3 ) ,  t h e  
p o s s i b i l i t y  t h a t  m a t e r i a l  f rom H S V - i n f e c t e d  mouse  b r a i n  a c t e d  a s  an 
a d j u v a n t  in s e n s i t i z a t i o n  o f  g u i n e a  p i g s  t o  HSV c a n n o t  be  o v e r l o o k e d .  
D a t a  f rom t h e  p r e s e n t  s t u d y  w h ic h  s u p p o r t  s u c h  an i n t e r p r e t a t i o n  w i l l  
be  d i s c u s s e d  l a t e r .  A s e c o n d  f a c t o r  w hi ch  may h a v e  p l a y e d  a r o l e  in 
t h e  a p p a r e n t l y  b e t t e r  s e n s i t i z i n g  e f f i c i e n c y  o f  t h e  p r e p a r a t i o n  us ed  
by Lausc h  e t  aj_. c o u l d  h a v e  b e e n  t h e  q u a l i t y  o f  t h e  s e n s i t i z i n g  HSV 
p r e p a r a t i o n .  The  mouse  b r a i n - p r e p a r e d  HSV p r e p a r a t i o n  may ha ve  c o n ­
t a i n e d  l a r g e  q u a n t i t i e s  o f  i n a c t i v e  v i r u s  o r  v i r a l  p r o d u c t s  which  
c o u l d  i n d u c e  a g r e a t e r  d e g r e e  o f  s e n s i t i v i t y .  W h i l e  t h e  washed  p r e p a r ­
a t i o n  u s e d  a s  s e n s i t i z i n g  HSV in t h e  p r e s e n t  s t u d i e s  p r o b a b l y  c o n t a i n e d  
i n a c t i v e  v i r u s ,  many o f  t h e  s m a l l e r  mol w t  p r o d u c t s  w e r e  remo ved .  In 
a d d i t i o n ,  d a t a  a r e  p r e s e n t e d  h e r e ,  and  w i l l  be  d i s c u s s e d  l a t e r ,  whic h  
d e m o n s t r a t e  t h a t  i n a c t i v e  HSV ( T a b l e  4 )  and  low mol w t  v i r a l  c o m p o n e n ts  
( T a b l e  5)  a r e  c a p a b l e  o f  i n d u c i n g  s e n s i t i v i t y  t o  HSV. A t h i r d  f a c t o r  
w h i c h  c o u l d  i n f l u e n c e  t h e  s i z e  o f  s k i n  t e s t  r e a c t i o n s  i s  t h e  p r o t e i n  
c o n t e n t  o f  t h e  s k i n  t e s t  p r e p a r a t i o n .  The p r o t e i n  c o n t e n t  o f  t h e  s k i n  
t e s t  a n t i g e n  u se d  by Lausch  e t _ £ i -  was 98 p g / 0 . 1  mi w h i l e  t h a t  u s e d  in 
t h e  p r e s e n t  s t u d y  was e s t i m a t e d  t o  be  40 0  u g / 0 . 1  m l .  C l e a r l y ,  t h e
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CEF SA p r e p a r a t i o n  o f  Lausc h  e j l  aj_. c o n t a i n e d  more  v i r u s  s p e c i f i c  
m a t e r i a l ,  i f  o n e  a ss u m e s  t h a t  t h e  s i z e  o f  t h e  s k i n  r e a c t i o n  i s  d o s e  
d e p e n d e n t .  I t  s h o u l d  a l s o  be  n o t e d  t h a t  l a r g e  a m o u n t s  o f  n o n - v i r a l  
p r o t e i n  m i g h t  be  e x p e c t e d  t o  be  c o n t a i n e d  in a l l a n t o i c  f l u i d  o f  HSV- 
i n f e c t e d  e m b r y o n a t e d  e g g s ,  s i n c e  c o n t r o l  a l l a n t o i c  f l u i d  c o n t a i n e d  
5 . 5  mg p r o t e i n / m l  ( T a b l e  1 ) .  The r e s u l t s  s e e n  f o l l o w i n g  s e n s i t i z a t i o n  
o f  g u i n e a  p i g s  by a s i n g l e  i n j e c t i o n  o f  HSV p r e p a r e d  in  L c e l l s  and  
s k i n  t e s t i n g  o f  t h e  same a n i m a l s  two weeks l a t e r  w i t h  C E - p r e p a r e d  SA 
s u g g e s t e d  t h a t  c h a r a c t e r i z a t i o n  o f  t h e  s o l u b l e  a n t i g e n  o f  HSV would  
r e q u i r e  a n t i g e n  p r e p a r a t i o n s  w i t h  more  v i r u s  s p e c i f i c  m a t e r i a l  and 
g r e a t e r  d e g r e e s  o f  s e n s i t i v i t y  in t e s t  a n i m a l s .
V a r i o u s  m e th o d s  o f  s e n s i t i z a t i o n  o f  g u i n e a  p i g s  t o  HSV w e r e  
co m p a r e d .  A n im a ls  w e r e  s e n s i t i z e d  by i n j e c t i o n  o f  t h e  f o l l o w i n g :
1) o n e  and tw o  i n j e c t i o n s  o f  i n f e c t i v e  HSV (10^’  ^ TCID^q) p r e p a r e d  in 
L c e l l s ;  2 ) tw o i n j e c t i o n s  o f  h e a t - i n a c t i v a t e d  HSV ( w h ic h  had c o n t a i n e d  
10^*^ TCID50  o f  I n f e c t i v e  v i r u s )  p r e p a r e d  in  L c e l l s ;  and 3)  o n e  i n j e c ­
t i o n  o f  HSV SA ( 1 . 1  mg o f  p r o t e i n )  p r e p a r e d  In L c e l l s  and  shown t o  
c o n t a i n  no i n f e c t i v e  HSV. The l a r g e s t  s k i n  t e s t  r e a c t i o n s  t o  HSV SA 
were  s e e n  in a n i m a l s  s e n s i t i z e d  w i t h  two i n j e c t i o n s  o f  i n f e c t i v e  HSV 
( T a b l e  8 ) .  T h i s  f i n d i n g  p r o v i d e s  a d d i t i o n a l  p r o o f  o f  a d o s e  d e p e n d e n t  
r e s p o n s e  in s e n s i t i z a t i o n  o f  g u i n e a  p i g s  t o  HSV. The d e m o n s t r a t i o n  t h a t  
t h e  s e c o n d  and  t h i r d  s e n s i t i z a t i o n  m e t h o d s  ( a b o v e )  w e r e  c a p a b l e  o f  s e n s ­
i t i z i n g  g u i n e a  p i g s  t o  HSV c o n f i r m s  t h e  e a r l i e r  s u g g e s t i o n  t h a t  n o n -  
i n f e c t i v e  HSV s p e c i f i c  m a t e r i a l s  c a n  c o n t r i b u t e  t o  s e n s i t i z a t i o n .  T h e s e  
f i n d i n g s  s u g g e s t  t h a t  t h e  u s e  o f  a s k i n  t e s t  a n t i g e n  f o r  HSV in human 
s t u d i e s  c o u l d  s e n s i t i z e  p a t i e n t s  t o  HSV, ma k in g  r e t e s t i n g  w i t h  SA o f  no
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v a l u e .  The  f i n d i n g  t h a t  i n f e c t i v e  HSV i n d u c e d  g r e a t e r  s e n s i t i v i t y  in 
g u i n e a  p i g s  t h a n  an e q u a l  am oun t  o f  h e a t - i n a c t i v a t e d  HSV may ha ve  been  
p r e d i c t e d  from s t u d i e s  o f  BCG i m m u n i z a t i o n .  I m m u n iz a t io n  o f  c h i l d r e n  
w i t h  l i v e  BCG i n d u c e d  much l a r g e r  s k i n  r e a c t i o n s  t o  t u b e r c u l i n  t h a n  d i d  
i m m u n i z a t i o n  w i t h  h e a t - k i l l e d  BCG ( 7 1 ) .  L a r g e r  numbers  o f  l i v e  BCG 
o r g a n i s m s  a l s o  p r o d u c e d  g r e a t e r  s e n s i t i v i t y  t h a n  s m a l l e r  n u m b e r s ,  a s  
e v i d e n c e d  by l a r g e r  s k i n  r e a c t i o n s .
I n c o r p o r a t i o n  o f  F r e u n d ' s  c o m p l e t e  a d j u v a n t  (FCA) i n t o  t h e  
s e n s i t i z i n g  HSV p r e p a r a t i o n  r e s u l t e d  in a h i g h  d e g r e e  o f  s e n s i t i v i t y  
in g u i n e a  p i g s ,  a s  shown by s k i n  t e s t s  w i t h  d i a l y z e d  SA ( T a b l e  9 ) .
S i n c e  t h e  s k i n  r e a c t i o n s  o b s e r v e d  in t h e s e  a n i m a l s  tw o  weeks  a f t e r  
s e n s i t i z a t i o n  were  c o m p a r a b l e  in  s i z e  t o  t h o s e  s e e n  f o u r  weeks  a f t e r  
two i n j e c t i o n s  o f  i n f e c t i v e  HSV, u s e  was made o f  HSV in 50$ FCA in 
s e n s i t i z a t i o n  o f  a n i m a l s  f o r  s t u d i e s  on  c h a r a c t e r i z a t i o n  o f  t h e  SA.
The f i n d i n g  t h a t  FCA i n c r e a s e s  t h e  s e n s i t i z a t i o n  t o  HSV l e n d s  f u r t h e r  
s u p p o r t  t o  t h e  h y p o t h e s i s  t h a t  mouse  b r a i n  may a c t  a s  a d j u v a n t  in 
s e n s i t i z a t i o n  o f  g u i n e a  p i g s  w i t h  HSV. O t h e r  i n v e s f I  g a t o r s  h av e  r e ­
p o r t e d  s i m i l a r  s u c c e s s  w i t h  t h e  u s e  o f  FCA In s e n s i t i z a t i o n  o f  a n i m a l s  
t o  mumps v i r u s  (1 0 2 )  and  HSV ( 9 9 ) .
N a t u r e  o f  S k i n  T e s t  R e a c t i o n
A n d e r v o n t  and  Rosenau  ( 4 )  r e p o r t e d  t h a t  v a c c i n i a  v i r u s - i n f e c t e d  
g u i n e a  p i g s  d i d  n o t  d e m o n s t r a t e  s k i n  r e a c t i o n s  o f  s i g n i f i c a n t  s i z e  upon 
c h a l l e n g e  w i t h  HSV s k i n  t e s t  a n t i g e n .  The  r e s u l t s  o f  t h e  p r e s e n t  
s t u d i e s  c o n f i r m e d  t h i s  e a r l i e r  f i n d i n g  an d  a i s o  d e m o n s t r a t e d  t h a t  HSV- 
s e n s i t i z e d  g u i n e a  p i g s  do n o t  r e s p o n d  t o  v a c c i n i a  SA w i t h  s i g n i f i c a n t  
r e a c t i o n s .  T h e s e  f i n d i n g s  i n d i c a t e  t h e  s p e c i f i c i t y  o f  t h e  s k i n  t e s t
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r e a c t i o n s  in HSV s e n s i t i z e d  a n i m a l s .  H ow ever ,  t h e  p o s s i b i l i t y  e x i s t s  
t h a t  a n t i g e n s  o f  o t h e r  v i r u s e s  in  t h e  h e r p e s v i r u s  g r o u p  may c r o s s  
r e a c t  w i t h  t h e  s k i n  t e s t  a n t i g e n  o f  HSV. R e s u l t s  o f  s t u d i e s  u t i l i z i n g  
s i m i a n  h e r p e s v i r u s  and  n e u t r a l i z i n g  a n t i s e r u m  t o  HSV i n d i c a t e d  c r o s s  
r e a c t i v i t y  due  t o  s h a r e d  a n t i g e n s  ( 3 5 ,  7 7 ) .  F u r t h e r  i n v e s t i g a t i o n  o f  
p o t e n t i a l  g r o u p  s p e c i f i c  s k i n  t e s t  a n t i g e n s  in  t h e  h e r p e s v i r u s e s  woul d  
be  d e s i r a b l e .  Type  s p e c i f i c  s k i n  t e s t  a n t i g e n  f o r  HSV t y p e  1 an d  HSV 
t y p e  2 c o u l d  p o s s i b l y  b e  p r e p a r e d .  C o r r e l a t i v e  s t u d i e s  on t h e  i n c i ­
d e n c e  o f  c e r v i c a l  c a r c i n o m a  and  s k i n  t e s t  r e a c t i o n s  t o  HSV t y p e  2 
wou ld  t h e n  be  p o s s i b l e  ( M e l n i c k ,  J .  L . , p e r s o n a l  c o m m u n i c a t i o n ) .  Such  
work  c o u l d  be i n v a l u a b l e  in s t u d i e s  c o n c e r n i n g  t h e  e t i o l o g y  o f  c a n c e r .
The t i m e  o f  a p p e a r a n c e  o f  t h e  maximal  r e s p o n s e  t o  s k i n  t e s t s  
w i t h  SA in HSV s e n s i t i z e d  g u i n e a  p i g s  h a s  b een  r e p o r t e d  t o  be  24 h r  
( 1 0 ,  5 5 ) ,  b u t  in no i n s t a n c e  was t h e  16 h r  r e a d i n g  r e p o r t e d .  La usch  
et^ aj_. ( 55 )  r e p o r t e d  maximal e r y t h e m a  in HSV s e n s i t i z e d  g u i n e a  p i g s  a t  
24  h r ,  b u t  t h e y  n o t e d  t h a t  t h e  s i z e  o f  t h e  e i g h t - h o u r  r e a d i n g s  o f t e n  
a p p r o a c h e d  t h a t  o f  t h e  24 h r  r e a d i n g s .  Brown ( 1 0 )  f o u n d  t h e  s k i n  
t e s t  r e a c t i o n  in HSV s e n s i t i z e d  g u i n e a  p i g s  t o  be  much l a r g e r  a t  24  h r  
t h a n  t h a t  a t  48  o r  72 h r .  R e a d i n g s  a t  e a r l i e r  t i m e  p e r i o d s  t h a n  24  h r  
w e r e  n o t  r e p o r t e d .  In t h e  p r e s e n t  i n v e s t i g a t i o n ,  s k i n  t e s t s  a p p l i e d  
14 d a y s  a f t e r  s e n s i t i z a t i o n  w i t h  a  s i n g l e  i n j e c t i o n  o f  i n f e c t i v e  HSV 
r e a c h e d  maximal i n t e n s i t y  a t  16 h r  a n d  a p p r e c i a b l e  r e a c t i v i t y  p e r ­
s i s t e d  a t  24 h r  ( T a b l e  2 ) .  T h e r e  a r e  c e r t a i n  d i f f e r e n c e s  in  t h e  t i m e s  
a t  w h ic h  r e a d i n g s  w e r e  r e c o r d e d  in  t h i s  s t u d y  a n d  t h o s e  u s e d  by La u sc h  
e t  2 l "  ( 5 5 ) .  In t h e  l a t t e r  s t u d i e s ,  r e a d i n g s  w e r e  made a t  0 . 5 ,  4 ,  8 , 
2 4 ,  48  and  72 h r  a f t e r  s k i n  t e s t i n g  w h i l e  in t h e  p r e s e n t  i n v e s t i g a t i o n  
r e a d i n g s  w e re  t a k e n  a t  0 . 5 ,  4 ,  15,  2 4 ,  48  a n d  72 h r .  I t  i s  p o s s i b l e
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t h a t  Lausch  e t  aj_" m i g h t  a l s o  h a v e  d e t e c t e d  maximal  s k i n  r e a c t i v i t y  a t  
16 h r  I f  t h e y  had e x a m i n e d  t h e  t e s t  s i t e s  a t  t h a t  t i m e .  Maximal r e ­
a c t i o n s  w e r e  o b s e r v e d  a t  16 h r  In g u i n e a  p i g s  s e n s i t i z e d  w i t h  tw o I n ­
j e c t i o n s  o f  I n f e c t i v e  v i r u s  ( T a b l e  3)  o r  a s i n g l e  I n j e c t i o n  o f  SA 
( T a b l e  5 ) ,  b u t  s k i n  r e a c t i o n s  s e e n  In a n i m a l s  s e n s i t i z e d  w i t h  h e a t e d  
HSV were  a p p r o x i m a t e l y  t h e  same a t  4 ,  16,  and  24 h r  ( T a b l e  4 ) .  S k i n  
r e a c t i v i t y  was a l s o  r e a d i l y  a p p a r e n t  a t  48  h r ,  a l t h o u g h  t h e  72 h r  
r e a d i n g s  w e re  z e r o .  The t i m e  r e q u i r e d  f o r  maximal  s k i n  r e s p o n s e  t o  
SA I s  n o t  u n l i k e  t h a t  r e p o r t e d  f o r  t u b e r c u l i n  In M y c o b a c t e r i u m  
t u b e r c u I  o s  I s - s e n s 1 1 1  z ed  g u i n e a  p i g s  ( 2 6 ,  2 7 ) .
Lausch  e t  aj_" ( 5 5 )  d e m o n s t r a t e d  t h a t  s k i n  r e a c t i v i t y  f o l l o w i n g  
I n f e c t i o n  o f  g u i n e a  p i g s  w i t h  HSV was t r a n s f e r r a b l e  by m o n o n u c l e a r  
c e l l s ,  b u t  n o t  by hype r im mune  s e r u m ,  was maximal  a t  24 h r  a s  p r e v i o u s l y  
n o t e d ,  and  was c h a r a c t e r i z e d  by a m o n o n u c l e a r  c e l l  I n f i l t r a t e  a t  t h e  
t e s t  s i t e  24 h r  a f t e r  c h a l l e n g e  w i t h  SA. T h e s e  w o r k e r s  c o n c l u d e d  t h a t  
t h e  c u t a n e o u s  r e s p o n s e  t o  SA In HSV I n f e c t e d  g u i n e a  p i g s  was a c l a s ­
s i c a l ,  d e l a y e d - t y p e ,  h y p e r s e n s i t i v i t y  r e a c t i o n .
In t h e  p r e s e n t  s t u d i e s .  I n d u r a t i o n  was n o t e d  In s k i n  r e a c t i o n s  
t o  SA In g u i n e a  p i g s  s e n s i t i z e d  w i t h  two I n j e c t i o n s  o f  HSV, e i t h e r  I n ­
f e c t i v e  o r  h e a t e d ,  and  In a n i m a l s  s e n s i t i z e d  w i t h  HSV p l u s  50^ FCA 
( T a b l e  8 ) .  T h e s e  r e s u l t s  s u g g e s t  t h e  a t t a i n m e n t  o f  a h i g h e r  d e g r e e  
o f  s e n s i t i z a t i o n  w i t h  t h e s e  m e t h o d s  t h a n  by a  s i n g l e  I n j e c t i o n  o f  HSV. 
S i n c e  I n d u r a t i o n  I s  a c h a r a c t e r i s t i c  o f  t h e  d e l a y e d  s k i n  r e a c t i o n  t o  
t u b e r c u l i n  ( 2 6 ,  2 7 ) ,  t h e  p r e s e n t  f i n d i n g s  s u g g e s t  t h a t  t h e  s k i n  r e a c t i o n  
t o  SA I s  t y p i c a l  o f  a d e l a y e d  h y p e r s e n s i t i v i t y  r e s p o n s e .  E a r l i e r ,
Brown ( 1 0 )  had n o t e d  t h a t  r e p e a t e d  w e e k l y  I n j e c t i o n s  o f  I n f e c t i v e  HSV
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o v e r  a  tw o -m o n th  p e r i o d  s e n s i t i z e d  g u i n e a  p i g s  t o  HSV. D i a m e t e r s  o f  
i n d u r a t i o n  w ere  14 mm a t  24 h r ,  5 mm a t  48 h r  and  2 t o  3 mm a t  72 h r .  
T h e s e  d i a m e t e r s  o f  i n d u r a t i o n  a r e  somewhat  l a r g e r  t h a n  t h o s e  o b s e r v e d  
in t h e  p r e s e n t  s t u d y  ( T a b l e  8 ) .  T h e s e  f i n d i n g s  s u p p o r t  t h e  v i ew  t h a t  
t h e  d e g r e e  o f  s e n s i t i z a t i o n  t o  HSV in g u i n e a  p i g s  i s  d e p e n d e n t  upon 
t h e  amount  o f  v i r u s  s p e c i f i c  a n t i g e n  i n j e c t e d .
S k i n  t e s t  r e a c t i o n s  t o  CEF an d  CE c o n t r o l  a n t i g e n s  u s u a l l y  
a t t a i n e d  maximal  e r y t h e m a  a t  4 h r  ( T a b l e s  2 t h r o u g h  5 ,  9 t h r o u g h  21 ,  
an d  F i g u r e s  21 t h r o u g h  2 5 ) ,  The r e a c t i o n s  t o  SA, p r e p a r e d  in e i t h e r  
CE o r  CEF, w ere  s i g n i f i c a n t l y  l a r g e r  a t  16 h r  in  HSV-FCA s e n s i t i z e d  
a n i m a l s ,  HSV s e n s i t i z e d  a n i m a l s ,  and  SA s e n s i t i z e d  a n i m a l s ,  t h a n  in 
L c e l l  c o n t r o l - F C A  s e n s i t i z e d  a n i m a l s  ( T a b l e s  15 and  17 .  Some e x c e p ­
t i o n s  o c c u r r e d  in  t h e  enzyme t r e a t m e n t  s t u d i e s .  S i n c e  t h e  r e s p o n s e  
t o  b o t h  SA and  t h e  e q u i v a l e n t  c o n t r o l  p r e p a r a t i o n s  w e r e  u s u a l l y  m a x i ­
mal a t  4 o r  16 h r  in L c e l l  c o n t r o l  s e n s i t i z e d  a n i m a l s ,  t h e s e  r e a c t i o n s  
a r e  c o n s i d e r e d  t o  be t h e  r e s u l t  o f  i n h e r e n t  h o s t  r e s p o n s e s  t o  i n t r a -  
c u t a n e o u s  i n j e c t i o n  o f  f o r e i g n  m a t e r i a l s .  Lausch  et_ a]_. ( 5 5 )  a l s o  
o b s e r v e d  an e a r l y  e r y t h e m a t o u s  r e s p o n s e  t o  CEF c o n t r o l  a n t i g e n  in 
HSV s e n s i t i z e d  g u i n e a  p i g s  which  d i m i n i s h e d  g r e a t l y  by 24 h r .
The e r y t h e m a t o u s  n a t u r e  o f  t h e  s k i n  r e a c t i o n  t o  SA a t  24 h r  
in  HSV s e n s i t i z e d  a n i m a l s  r e p o r t e d  by Lausch  e t .  aj_. ( 5 5 )  was c o n f i r m e d  
in  t h e  p r e s e n t  s t u d i e s  ( F i g u r e  3 ) .  In a d d i t i o n ,  t h e  SA was shown t o  
e l i c i t  no e r y t h e m a  a t  24 h r  in L c e l l  c o n t r o l  s e n s i t i z e d  a n i m a l s  
( F i g u r e  9 ) .  A c o m p a r i s o n  o f  t h e  i n t e n s i t y  o f  e r y t h e m a  a t  24 h r  in HSV 
s e n s i t i z e d  a n i m a l s  ( F i g u r e  3 )  w i t h  t h e  r e s p o n s e  a t  24 h r  in SA s e n s i ­
t i z e d  a n i m a l s  ( F i g u r e  5)  r e v e a l s  a mor e  I n t e n s e  r e s p o n s e  in  HSV 
i n f e c t e d  a n i m a l s .  T h i s  i s  i n t e r p r e t e d  a s  f u r t h e r  d e m o n s t r a t i o n  t h a t
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t h e  amoun t  o f  HSV s p e c i f i c  m a t e r i a i  in t h e  s e n s i t i z i n g  p r e p a r a t i o n  
d e t e r m i n e s  t h e  d e g r e e  o f  s k i n  s e n s i t i v i t y  a t t a i n e d ,  C y t o i o g i c  e x a m i n ­
a t i o n  o f  t h e  SA c h a i i e n g e  s i t e s  in i n f e c t i v e  HSV a n d  SA s e n s i t i z e d  
a n i m a l s  a t  0 . 5  h r  r e v e a i e d  s m a l i  numbers  o f  p o l y m o r p h o n u c i e a r  i e u c o -  
c y t e s  ( F i g u r e s  13 an d  i 7 ) .  At 24 h r ,  t h e  i n f i i t r a t e  was composed  o f  
70 t o  Q0% m o n o n u c l e a r  l e u c o c y t e s  and  20  t o  30^  p o l y m o r p h o n u c l e a r  
l e u c o c y t e s  ( F i g u r e s  15 and  1 9 ) .  The m o n o n u c l e a r  c e l l  i n f i i t r a t e  a t  
t h e  SA c h a i i e n g e  s i t e s  was mo re  i n t e n s e  in i n f e c t i v e  HSV s e n s i t i z e d  
g u i n e a  p i g s  t h a n  in SA s e n s i t i z e d  a n i m a l s .  C o n t r o l  p r e p a r a t i o n s  t a k e n  
a t  24 h r  ( F i g u r e s  10 and  18) r e s e m b l e d  t h e  0 . 5  h r  s e c t i o n s  ( F i g u r e s  
8 and  16) t a k e n  f rom SA c h a i i e n g e  s i t e s .  S e c t i o n s  o f  SA c h a i i e n g e  
s i t e s  t a k e n  a t  24 h r  f rom L c e l l  c o n t r o l  s e n s i t i z e d  g u i n e a  p i g s  c o n ­
t a i n e d  s c a t t e r e d  m o n o n u c l e a r  c e l l s  ( F i g u r e  1 1 ) .  T h i s  i n d i c a t e s  t h a t  
SA i t s e l f  may s t i m u l a t e  some m o n o n u c l e a r  c e l l  i n f i l t r a t i o n  b u t  t h e  
number  o f  c e l l s  was n o t  a s  l a r g e  a s  t h a t  o b s e r v e d  in SA s i t e s  f rom 
SA o r  HSV s e n s i t i z e d  a n i m a l s .  The  c e l l u l a r  r e a c t i o n s  a t  SA c h a l l e n g e  
s i t e s  In HSV o r  SA s e n s i t i z e d  g u i n e a  p i g s  a r e  t y p i c a l  o f  t h o s e  
d e s c r i b e d  In d e l a y e d  h y p e r s e n s i t i v i t y  t o  M. t u b e r c u l o s i s  ( 1 6 ,  2 7 ) .
T h e s e  f i n d i n g s  i n d i c a t e  t h a t  a  s i n g l e  i n j e c t i o n  o f  SA can  
s e n s i t i z e  g u i n e a  p i g s  t o  HSV b u t  t h a t  l a r g e r  a m o u n ts  o f  HSV s p e c i f i c  
m a t e r i a l  a r e  n e e d e d  t o  i n d u c e  s e n s i t i v i t y  c h a r a c t e r i z e d  by i n d u r a t e d  
r e s p o n s e s  w i t h  I n t e n s e  e r y t h e m a  a n d  m o n o n u c l e a r  c e l l  i n f i l t r a t i o n .
C h a r a c t e r i z a t i o n  o f  S o l u b l e  A n t i g e n
Up t o  25 d i f f e r e n t  p r o t e i n s  a r e  known t o  be  p r e s e n t  in HSV
( 9 1 ) .  A summary o f  t h e  c h a r a c t e r i s t i c s  o f  t h e  m a t e r i a l s  known t o  a c t
a s  OF o r  s k i n  t e s t  a n t i g e n  i s  p r e s e n t e d  In T a b l e  2 2 .  B r i e f l y ,  t h e  OF
TABLE 2 2
PROPERTIES OF HERPES SIMPLEX VIRUS SOLUBLE ANTIGEN(S)
A c t iv i t y
Treatment CF® Skin T e s t ‘d
Others Refs . Others Refs . Present S tudies ''
Heat
56 C _d 10, 100 +e 10, 47 , 55 t Tab le  2
70 C - 10 + 68 + Table  14
UV I r r a d ia t io n N .D . f + 47 N.D.
LyophI11zatlon + 107 + 107 + Tab le  9 
Figure  1
C e n tr l fu g a t lo n
66 ,000  X g N.D. + 55. 3 + Table  9 
Figure  1
100,000 X g + 100 N.D. N.D.
D ia ly s is
PBS + 100 + 55, 107 + Table  2 
Figure 1
D i s t I 1 led H O
1. Supernatant f l u i d N.D. N.D. + Tab le  9
2. P r e c ip i t a t e N.D. N.D. + Tab le  I I
Acid H ydro lys is - 100 N.D. N.D.
Tab le  12E ther + 100 N.D. +
VOvn
TABLE 2 2 — C o n t i n u e d
A c t iv i t y
Treatment CpS Skin Test^
Others Refs. Others Refs. P resent Studies^
U l t r a f i I t r a t i o n
XM-lOO N.D. N.D. + Tab le  12
XM-50 N.D. N.D. - Table  13
Enzymes *9Trypsin + 100 N.D. Table 14
Pronase N.D. N.D. * Table  16
DNase + 100 N.D. * Table  18
RNase + 100 N.D. + Table  20
VOov
^Complement f i x i n g  a b i l i t y  wi t h  anti-H SV  serum.
^Skin t e s t  reac tio n s  produced in HSV s e n s i t iz e d  hosts. 
^ C h a ra c te r is t ic s  determined in present in v e s t ig a t io n .  
^ In a c t iv a t io n  a f t e r  t re a tm e n t .
^A ctive  a f t e r  t re a tm e n t .
^Not determined.
^ P a r t ia l  in a c t iv a t io n  a f t e r  t re a tm e n t .
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a n t i g e n  o f  HSV ha s  been  shown t o  be o f  low MW; h e a t  l a b i l e ;  r e s i s t a n t  
t o  a c t i o n  o f  t r y p s i n ,  DNase,  RNase an d  e t h e r ;  d e s t r o y e d  by a c i d  h y d r o l ­
y s i s ;  and  n o t  s e d i m e n t e d  a t  1 0 0 ,0 0 0  x  g ( 1 0 0 ) .  The  s k i n  t e s t  a n t i g e n ,  
p r i o r  t o  t h e  p r e s e n t  i n v e s t i g a t i o n ,  had  been  r e p o r t e d  t o  be s t a b l e  t o  
h e a t i n g  t o  56 C and  70 C ( 3 ,  10 ,  5 5 ) ,  n o t  d e s t r o y e d  by UV i r r a d i a t i o n  
( 4 7 ) ,  n o n d i a l y z a b l e  ( 5 5 ) ,  an d  n o t  s e d i m e n t a b l e  by c e n t r i f u g a t i o n  a t  
6 6 , 0 0 0  X  g f o r  0 . 5  h r  ( 5 5 ) .
In t h e  p r e s e n t  s t u d i e s ,  t h e  o b s e r v a t i o n  t h a t  d i a l y s i s  o f  b o t h  
CEF c o n t r o l  and  CEF HSV p r e p a r a t i o n s  r e s u l t e d  in t h e  f o r m a t i o n  o f  l a r g e  
. a m o u n ts  o f  p r e c i p i t a t e  s u g g e s t e d  t h a t  s u c h  t r e a t m e n t  m i g h t  p r o v i d e  
p a r t i a l  p u r i f i c a t i o n  o f  SA. I t  was f o u n d  t h a t  m o s t  o f  t h e  s k i n  t e s t  
a c t i v i t y  in  HSV s e n s i t i z e d  a n i m a l s  was a s s o c i a t e d  w i t h  t h e  s u p e r n a t a n t  
f l u i d  a f t e r  d i a l y s i s  ( T a b l e  9 ) .  The g l o b u l i n  c l a s s  o f  p r o t e i n s  i s  
c h a r a c t e r i z e d  by a d e c r e a s e d  s o l u b i l i t y  a t  low i o n i c  s t r e n g t h  s o  t h a t  
p r e c i p i t a t i o n  o c c u r s  in d i s t i l l e d  w a t e r  o r  upon a d d i t i o n  o f  m e t h a n o l  
t o  t h e  s o l u t i o n  ( 1 0 6 ) .  The  f a c t  t h a t  a c t i v e  SA was o n l y  p a r t i a l l y  
p r e c i p i t a t e d  by d i a l y s i s  a g a i n s t  d i s t i l l e d  w a t e r  s u g g e s t s  t h a t  i t  i s  
n o t  a  g l o b u l i n .  The SA c o u l d  be a  h i s t o n e -  o r  a p r o t a m i n e - t y p e  p r o t e i n ,  
s i n c e  t h e s e  c l a s s e s  o f  p r o t e i n s  a r e  n o t  r e a d i l y  p r e c i p i t a t e d  by 
d i a l y s i s  ( 1 0 6 ) .  The  a c t i v i t y  o f  t h e  p r e c i p i t a t e d  f r a c t i o n  ( T a b l e  11 
and  F i g u r e  21)  may i n d i c a t e  s i m p l e  a b s o r p t i o n  o f  SA t o  CEF g l o b u l i n s  
o r  i t  c o u l d  be  i n t e r p r e t e d  a s  e v i d e n c e  f o r  SA h a v i n g  p r o p e r t i e s  o f  b o t h  
g l o b u l i n s  and  o t h e r  p r o t e i n s ,  s u c h  a s  p r o t a m i n e s .
In t h i s  s t u d y  i t  was o b s e r v e d  t h a t  SA was s t a b l e  t o  h e a t i n g  a t  
56  C o r  70  C f o r  1 h r ,  s t a b l e  t o  l y o p h i I i z a t i o n ,  n o n - d i a l y z a b l e ,  and  
n o t  s e d i m e n t e d  by c e n t r i f u g a t i o n  a t  6 6 , 0 0 0  x g .  T h e s e  f i n d i n g s  c o n f i r m
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e a r l i e r  work  on t h e  n a t u r e  o f  SA ( T a b l e  2 2 ) .  S i n c e  HSV i s  a l i p i d -  
c o n t a i n i n g  v i r u s  ( 5 2 ) ,  I t  seemed o f  i n t e r e s t  t o  d e t e r m i n e  t h e  e t h e r  
s u s c e p t i b i l i t y  o f  SA. I t  was shown in t h i s  s t u d y  t h a t  SA i s  n o t  e x ­
t r a c t e d  by e t h e r  b u t  r e m a i n s  a c t i v e  in t h e  a q u e o u s  f r a c t i o n s  ( T a b l e  
1 2 ) .  T h i s  f i n d i n g  i s  i n t e r p r e t e d  a s  e v i d e n c e  t h a t  t h e  SA i s  n o t  a 
l i p i d  m a t e r i a l .  The o b s e r v a t i o n  t h a t  e t h e r  e x t r a c t i o n  o f  SA d i d  n o t  
remove  i t s  s k i n  t e s t  a c t i v i t y  may be i n t e r p r e t e d  a s  an i n d i c a t i o n  t h a t  
t h e  SA i s  n o t  d e r i v e d  f rom t h e  l i p i d  p o r t i o n  o f  t h e  HSV e n v e l o p e .  HSV 
i s  an e n v e l o p e d  v i r u s  c o n t a i n i n g  up t o  22 ^  p h o s p h o l i p i d s ,  by w e i g h t  
( 5 2 ) .  However ,  a f i r m  c o n c l u s i o n  t h a t  t h e  SA i s  n o t  a p a r t  o f  t h e  
e n v e l o p e  c a n n o t  be made,  s i n c e  v a r i o u s  g l y c o p r o t e i n s  f rom t h e  v i r a l  
e n v e l o p e  ( 9 2 )  c o u l d  be  a c t i n g  a s  SA. C h a r a c t e r i z a t i o n  o f  t h e  p o s s i b l e  
s t r u c t u r a l  o r  a c c e s s o r y  p r o t e i n s  o f  HSV w hi ch  c o u l d  a c t  a s  SA a w a i t s  
s t u d i e s  u t i l i z i n g  r a d i o a c t i v e  l a b e l l i n g  a n d / o r  u l t r a s t r u c t u r a l  t a g g i n g .
In t h e s e  s t u d i e s ,  SA was r e t a i n e d  by s i z e  XM-50 u l t r a f i l t r a t i o n  
membranes  ( T a b l e  13) b u t  i t  p a s s e d  t h r o u g h  s i z e  XM-100 membranes  
( T a b l e  12 and  F i g u r e  2 2 ) .  As suming  t h a t  SA h a s  f i l t r a t i o n  p r o p e r t i e s  
s i m i l a r  t o  o t h e r  m a t e r i a l s  ( 2 ) ,  t h e  mol w t  o f  SA c a n  be  e s t i m a t e d  t o  
be  5 0 , 0 0 0  t o  1 5 0 , 0 0 0 .  An e s t i m a t i o n  o f  mol wt  b a s e d  upon u l t r a ­
f i l t r a t i o n ,  h o w e v e r ,  w a r r a n t s  f u r t h e r  c o n s i d e r a t i o n .  A c c o r d i n g  t o  
d a t a  p r o v i d e d  by t h e  Am ic o n  C o r p o r a t i o n  ( 2 ) ,  t h e  XM-100 membrane r e ­
t a i n s  90?  o f  gamma g l o b u l i n  o f  mol w t  1 6 0 , 0 0 0 ,  20? o f  a l d o l a s e  o f  mol 
wt  1 4 2 , 0 0 0 ,  and  no d e x t r a n  o f  mol w t  1 1 0 , 0 0 0 .  R e t e n t i o n  o f  g r e a t e r  
t h a n  95 ?  o f  a l d o l a s e  (mol wt  1 4 2 , 0 0 0 ) ,  10? o f  d e x t r a n  (mol w t  1 1 0 , 0 0 0 )  
a n d  90?  o f  human se ru m  a l b u m i n  (mol wt  6 7 , 0 0 0 )  i s  r e p o r t e d  f o r  t h e  
XM-50 membrane .  I f  t h e  SA i s  a l i n e a r  m o l e c u l e  w i t h  f i l t r a t i o n  p r o p ­
e r t i e s  s i m i l a r  t o  d e x t r a n ,  i t  c o u l d  be much l a r g e r  t h a n  1 5 0 , 0 0 0  mol w t .
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The d e m o n s t r a t i o n  t h a t  t r e a t m e n t  o f  SA w i t h  a c t i v e  t r y p s i n  d e ­
c r e a s e d  g r e a t l y  i t s  s k i n  t e s t  r e a c t i v i t y  ( T a b l e  14) i s  a s t r o n g  b a s i s  
f o r  a s s u m i n g  t h a t  SA I s  p r o t e i n  in n a t u r e .  Tokumaru (1 0 0 )  r e p o r t e d  
t h a t  t h e  CF a n t i g e n  o f  HSV was n o t  s u s c e p t i b l e  t o  d i g e s t i o n  by t r y p s i n  
b u t  p r o o f  o f  t h e  a c t i v i t y  o f  t h e  enzyme p r e p a r a t i o n  was n o t  p r e s e n t e d .  
In t h e  p r e s e n t  s t u d y  t h e  t r y p s i n  us ed  t o  t r e a t  SA was shown t o  d e g r a d e  
c a s e i n ,  in a d d i t i o n ,  i n a c t i v e  t r y p s i n  was shown t o  h a v e  no a c t i v i t y  
on c a s e i n .  W h i l e  t h e  SA r e s p o n s i b l e  f o r  s k i n  t e s t  r e a c t i v i t y  need  n o t  
n e c e s s a r i l y  be  t h e  same m a t e r i a l  a s  t h e  CF a n t i g e n ,  s u c h  a  p o s s i b i l i t y  
d o e s  e x i s t .
The f i n d i n g  t h a t  t r y p s i n  I n a c t i v a t e s  SA may a l s o  i n d i c a t e  
s o m e t h i n g  o f  t h e  n a t u r e  o f  t h e  p r o t e i n  m o i e t y  o f  SA. T r y p s i n  i s  a  p r o ­
t e o l y t i c  enzyme wh ich  a c t s  o n l y  a t  p e p t i d e ,  a m i d e ,  o r  e s t e r  b onds  a t  
t h e  c a r b o n y l  en d  o f  a r g i n i n e  o r  l y s i n e  r e s i d u e s  ( 5 4 ,  1 0 6 ) .  S i n c e  
t r y p s i n  i s  r a t h e r  s p e c i f i c  in  i t s  a c t i o n .  I t  c an  be  c o n c l u d e d  t h a t  SA 
c o n t a i n s  a p r o t e i n  h a v i n g  a r g i n i n e  o r  l y s i n e  r e s i d u e s .  O l s h e v s k y  and 
B e c k e r  ( 7 4 )  i s o l a t e d  an a r g i n i n e - r i c h  p r o t e i n  a s s o c i a t e d  w i t h  t h e  c o r e  
o f  HSV whi ch  had a mol wt  o f  3 7 , 0 0 0 .  They a l s o  d e s c r i b e d  a n o t h e r  
p r o t e i n  w i t h  a  mol w t  o f  1 1 0 , 0 0 0 , w h ic h  made up t h e  m a j o r i t y  o f  t h e  
v i r u s  s p e c i f i e d  p r o t e i n .  I t  i s  p o s s i b l e  t h a t  t h i s  m a t e r i a l  c o u l d  s e r v e  
a s  a s o l u b l e  s k i n  t e s t  a n t i g e n .  However ,  t h e  e x i s t e n c e  o f  many o t h e r  
HSV s p e c i f i c  p r o t e i n s  ( 9 1 ,  92 )  makes  d i f f i c u l t  a n y  c o r r e l a t i o n  o f  t h e  
SA w i t h  o t h e r  known p r o t e i n s  o f  HSV.
F u r t h e r  s u p p o r t  f o r  t h e  c o n c l u s i o n  t h a t  SA c o n t a i n s  a  p r o t e i n  
m o i e t y  i s  p r o v i d e d  by s t u d i e s  w i t h  p r o n a s e  ( T a b l e  1 6 ) .  A l t h o u g h  a c t i v e  
p r o n a s e  r e d u c e d  t h e  a c t i v i t y  o f  SA, t h e  n o n - s p e c i f i c  r e a c t i o n s  w h ic h  i t
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e l i c i t e d  in L c e l l  c o n t r o l  s e n s i t i z e d  a n i m a l s  ( T a b l e  17) p o i n t  o u t  t h e  
need  f o r  a d e q u a t e  c o n t r o l s  in u s i n g  t h i s  enzyme t o  c h a r a c t e r i z e  a s k i n  
t e s t  a n t i g e n .  I n a c t i v e  p r o n a s e  d i d  n o t  d e g r a d e  t h e  s k i n  t e s t  a c t i v i t y  
o f  SA. The b r o a d  s p e c i f i c i t y  o f  p r o n a s e  makes  i t  a good  c h o i c e  f o r  d e ­
g r a d i n g  p r o t e i n ,  s i n c e  i t  i s  r e p o r t e d  t o  a c t  on  a l l  p e p t i d e  bonds  ( 7 2 ) .
A c t i v e  DNase r e d u c e d  t h e  s k i n  r e a c t i o n  e l i c i t e d  by SA a t  16 h r  
b u t  n o t  a t  24 h r  ( T a b l e  1 8 ) .  T h i s  f i n d i n g  s u g g e s t s  t h a t  t h e  SA c o n ­
t a i n s  a  d e o x y r i b o n u c l e i c  a c i d  m o i e t y .  The  DNase u s e d  in t h i s  s t u d y  
h a s  been  r e p o r t e d  t o  be  a c t i v e  a g a i n s t  b o t h  n a t u r a l  and  d e n a t u r e d  DNA 
( 6 3 ) .  S i n c e  HSV i s  a D N A - c o n t a i n i n g  v i r u s  ( 5 2 ) ,  t h e  e x i s t e n c e  o f  a 
d e o x y r i b o n u c I e o p r o t e i n  s p e c i f i c  f o r  HSV which  c o u l d  a c t  a s  a s k i n  t e s t  
a n t i g e n  i s  n o t  t o o  s u r p r i s i n g .  D e o x y r i b o n u c I e o p r o t e  i n s  w h ic h  e i i c i f  
t h e  p r o d u c t i o n  o f  a n t i b o d i e s  d i r e c t e d  a g a i n s t  n u c l e i c  a c i d  ha v e  been  
r e p o r t e d  ( 4 3 ) .
A c t i v e  RNase had no e f f e c t  on SA ( T a b l e  2 0 ) .  T h i s  f i n d i n g  s u g ­
g e s t s  t h a t  an  RNA m a t e r i a l  d o e s  n o t  a c t  a s  s k i n  t e s t  a n t i g e n  in HSV 
s e n s i t i z e d  g u i n e a  p i g s .  Such a c o n c l u s i o n  seem s v a l i d  s i n c e  t h e  RNase 
u s e d  was d e m o n s t r a t e d  t o  be a c t i v e  a g a i n s t  n a t u r a l  RNA.
The r e s u l t s  o f  t h e  p r e s e n t  s t u d i e s  a g r e e  w i t h  t h o s e  o f  Lausch  
o f  aj_" ( 5 5 )  in s u g g e s t i n g  t h a t  more  t h a n  o n e  HSV a n t i g e n  may a c t  a s  a  
s k i n  t e s t  a n t i g e n .  The  r e s u l t s  o f  t h e  enzyme t r e a t m e n t  s t u d i e s  may be  
i n t e r p r e t e d  a s  e v i d e n c e  f o r  two s e p a r a t e  s k i n  t e s t  a n t i g e n s .  In 
a d d i t i o n ,  t h e  d e m o n s t r a t i o n  o f  s k i n  t e s t  a c t i v i t y  in b o t h  p r e c i p i t a t e  
and  s u p e r n a t a n t  f l u i d  f o l l o w i n g  d i a l y s i s  o f  SA may be i n t e r p r e t e d  a s  
e v i d e n c e  f o r  two s k i n  t e s t  a n t i g e n s .
I t  would  now be p o s s i b l e  t o  i n i t i a t e  s t u d i e s  w i t h  a SA o f  HSV 
which  m i g h t  d i f f e r e n t i a t e  b e tw e e n  s p e c i f i c  r e a c t i o n s  t o  HSV and  i t s
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a n t i g e n s ,  t h a t  i s ,  d e l a y e d  h y p e r s e n s i t i v i t y ,  and  n o n - s p e c i f i c  r e s p o n s e s  
t o  I n t e r f e r o n - i n d u c i n g  a c v n t s .
CHAPTER V
SUMMARY
G u i n e a  p i g s  w e r e  s e n s i t i z e d  t o  h e r p e s  s i m p l e x  v i r u s  (HSV) by 
I n o c u l a t i o n  w i t h  I n f e c t i v e  v i r u s ,  h e a t  I n a c t i v a t e d  v i r u s ,  o r  a HSV s o l ­
u b l e  a n t i g e n  (SA) p r e p a r a t i o n .  S e n s i t i v i t y  was a s s a y e d  by means  o f  
s k i n  t e s t s  w i t h  SA. The  l a r g e s t  s k i n  r e a c t i o n s  ( e r y t h e m a  and  I n d u r ­
a t i o n )  w e r e  o b s e r v e d  In g u i n e a  p i g s  w hi ch  had  r e c e i v e d  two s e n s i t i z i n g  
I n j e c t i o n s  o f  I n f e c t i v e  HSV. I n c o r p o r a t i o n  o f  F r e u n d ’ s  c o m p l e t e  a d j u ­
v a n t  (FCA) I n t o  t h e  I n f e c t i v e  HSV p r e p a r a t i o n  was a l s o  f oun d  t o  be  an 
e f f e c t i v e  m e th o d  f o r  s e n s i t i z i n g  g u i n e a  p i g s  t o  SA. I n a c t i v e  HSV was 
f o u n d  t o  be  a n  e f f e c t i v e  s e n s i t i z i n g  m a t e r i a l ,  s u g g e s t i n g  t h a t  p r o ­
d u c t i o n  o f  c u t a n e o u s  h y p e r s e n s i t i v i t y  t o  HSV c a n  o c c u r  In t h e  a b s e n c e  
o f  v i r a l  I n f e c t i o n .  A s i n g l e  I n t r a c u t a n e o u s  I n j e c t i o n  o f  SA a l s o  
s e n s i t i z e d  a n i m a l s  t o  a  s u b s e q u e n t  s k i n  t e s t  w i t h  SA.
Ba sed  upon t h e  t i m i n g  o f  t h e i r  maximal  r e s p o n s e  and  t h e  mono­
n u c l e a r  n a t u r e  o f  t h e  c e l l u l a r  I n f i l t r a t e  a t  24 h r ,  t h e  s k i n  r e a c t i o n s  
o b s e r v e d  In SA s e n s i t i z e d  a n i m a l s  a r e  b e l i e v e d  t o  be  t h o s e  o f  c l a s s i c a l  
d e l a y e d  h y p e r s e n s i t i v i t y .  W h i le  t h e  s k i n  r e a c t i o n s  s e e n  In t h e s e  
a n i m a l s  w e r e  n o t  a s  l a r g e  a s  t h o s e  In a n i m a l s  s e n s i t i z e d  w i t h  I n f e c t i v e  
o r  I n a c t i v a t e d  HSV, t h e y  w ere  shown t o  be  s p e c i f i c  f o r  SA. A n im a ls  
s e n s i t i z e d  w i t h  I n f e c t i v e  v a c c i n i a  v i r u s  o r  L c e l l  c o n t r o l  a n t i g e n  p l u s
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FCA d i d  n o t  r e s p o n d  t o  s k i n  t e s t s  w i t h  SA, T r e a t m e n t  o f  SA w i t h  DNase,  
p r o n a s e ,  an d  t r y p s i n  g r e a t l y  r e d u c e d  I t s  s k i n  t e s t  r e a c t i v i t y .  R l b o -  
n u c l e a s e  t r e a t m e n t ,  h e a t i n g  a t  70 C f o r  2 h r ,  a n d  e x t r a c t i o n  w i t h  e t h e r  
d i d  n o t  d e g r a d e  SA. SA was r e t a i n e d  by XM-50 b u t  n o t  XM-100 u l t r a -  
f i l t r a t i o n  m em bra ne s .  U l t r a c e n t r i f u g a t i o n  a t  6 6 , 0 0 0  x g f o r  0 . 5  h r  d i d  
n o t  s e d i m e n t  t h e  s k i n  t e s t  a c t i v i t y  o f  t h e  SA. T h e s e  f i n d i n g s  s u g g e s t  
t h a t  SA I s  a l y s i n e  a n d / o r  a r g l n l n e - c o n t a l n i n g  p r o t e i n  o r  d e o x y r l b o -  
n u c l e o p r o t e l n  w i t h  a mol wt  o f  5 0 , 0 0 0  t o  1 5 0 , 0 0 0 .
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